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Summary	  
	  
Myelin reactive T cells are central in the development of the autoimmune response 
leading to central nervous system (CNS) destruction in Multiple Sclerosis (MS) and 
its animal model, Experimental Autoimmune Encephalomyelitis (EAE). The 
underlying cellular and molecular mechanisms, however, are not fully understood. In 
previous mouse studies, we showed that tolerance to the major component of the 
myelin sheath, myelin proteolipid protein (PLP), is crucially dependent on its 
expression in the thymus where central tolerance induction takes place. To analyze 
the phenotypic and functional changes taking place during the induction of tolerance 
in the thymus, we investigated the fate of PLP autoreactive CD4+ T cells in TCR-
PLP11 transgenic mice, which express a transgenic TCR specific for the dominant 
PLP174-181 epitope in B6 mice, a EAE-resistant mouse strain of the H-2
b haplotype. In 
previous work we found that a fraction of CD4+ T cells specific for this region appear 
to escape from tolerance induction. Our data showed that in TCR-PLP11 PLPWT 
mice, where PLP is transcribed in the thymus similar numbers of CD4+ thymocytes 
developed, compared to TCR-PLP11 PLPKO mice where PLP expression in the 
thymus is absent. This indicated that PLP174-181-specific thymocytes were not 
negatively selected. In the periphery, the PLP174-181-specific T cells displayed a naïve 
phenotype and therefore were not tolerized by clonal deletion or anergy induction. 
Potentially autoreactive CD4+ T cells were found in the spleen and lymph nodes of 
TCR-PLP11 mice but only became activated when stimulated in vitro. These cells 
were not spontaneously activated in vivo, indicating that PLP is not 
expressed/presented in the periphery. TCR-PLP11 mice do not develop any clinical 
or histological signs of EAE. Therefore, ignorance but not deletional tolerance is 
considered as main tolerance mechanism to avoid CD4+ T cell-mediated 
autoimmunity in our system. That means that naïve autoreactive CD4+ T cells ignore 
PLP antigens and recirculate in the periphery without causing damage. In contrast, 
immunization of TCR-PLP11 PLPWT mice with the PLP174-181 peptide in Complete 
Freund´s Adjuvant (CFA) reversed this state of immune ignorance as judged by the 
clinical manifestations of EAE in these mice. Furthermore, TCR-PLP11 PLPWT mice 
develop spontaneous EAE after being bred onto a RAGKO background, leading us to 
the speculation that, besides immunological ignorance, dominant mechanism of PLP 
tolerance are crucial for the prevention of CNS autoimmunity. Taken together, this 
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study establish a novel model of immunological tolerance towards a self-antigen 
expressed in the central nervous system involving antigen ignorance of CD4+ T cells.  
 
Somatic recombination of TCR genes in thymocytes not only results in the 
production of useful TCR specificities, but also produces potentially autoreactive 
specificities. Autoreactive CD4+ T cells are censored by two mechanisms, the so-
called clonal deletion and the deviation into regulatory T cells in the thymus both 
requiring the same stimulus, namely the interaction with self-peptide. In order to 
study the mechanisms of central and peripheral tolerance that operate to shape the 
CD4 T-cell repertoire, we have generated a TCR transgenic mouse that expresses 
the α- and β-chains of a PLP11-18-reactive TCR (TCR-PLP1) in the context of H-2b. 
Using this novel TCR-PLP1 transgenic mouse model, we investigated the modalities 
of central tolerance induction to a self-antigen expressed in the thymus at 
physiological levels. We found that Plp1-specific T cells undergo clonal deletion and 
Treg differentiation concomitantly upon encounter of the cognate self-antigen PLP. 
Medullary thymic epithelial cells (mTECs) express and present the endogenous 
antigen PLP and mediate tolerance in an autonomous manner, whereas thymic 
dendritic cells are dispensable for central tolerance induction to PLP. Although 
central tolerance induction to PLP is very potent, it is not complete as a proportion of 
autoreactive T cells also escape to the periphery. However despite the presence of 
potentially dangerous cells in the periphery, the mice do not develop autoimmunity 
indicating that additional tolerogenic mechanisms promote tolerance to PLP in the 
periphery. We could further show that autoreactive Plp1-specific T cells are deleted 
or become functionally inactivated (anergy) by recognition of self peptide on dendritic 
cells in the periphery. In a set of bone marrow transplantation experiments we found 
that PLP was expressed by radioresistant stromal cells and subsequently cross-
presented by dendritic cells. Taken together our results indicate a complementing 
role of the thymus and the periphery for tolerance induction to PLP. 
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Zusammenfassung 
 
Myelin reaktive T Zellen sind von zentraler Bedeutung in der Entwicklung von 
Autoimmunantworten welche zu der Destruktion des Zentralen Nerven Systems 
(ZNS) führen und in Multiple Sklerose (MS) oder dem korrespondierenden 
Tiermodell, Experimentelle Autoimmune Enzephalomyelitis (EAE), resultiertn. 
Jedoch ist noch nicht völlig klar verstanden welche grundlegenden zellulären und 
molekularen Mechanismen diese Krankheiten auslösen.  In früheren Mausstudien 
konnten wir zeigen, dass die Toleranz gegen die Hauptkomponente der 
Myelinscheide, dem Myelin Proteolipid Protein (PLP) entscheidend davon abhängt, 
ob PLP im Thymus, wo die Induktion der Zentrale Toleranz statt findet, exprimiert 
wird. Um die phänotypischen und funktionellen Änderungen welche während der 
Toleranzinduktion im Thymus statt finden zu erforschen, untersuchten wir PLP 
autoreaktive CD4+ T Zellen von T Zell Rezeptor (TZR)-PLP11 transgenen B6 
Mäusen. Diese Mäuse sind EAE resistent und exprimieren einen transgenen TZR 
spezifisch für das dominante PLP174-181 Epitop im Kontext vom H-2
b Haployp. In 
vorhergehenden Studien, fanden wir heraus, dass eine Fraktion von CD4+ T Zellen 
spezifisch für diese Region die Zentrale Toleranz umgingen. Unsere Daten zeigten, 
dass in TZR-PLP11 PLPWT Mäuse, welche PLP im Thymus exprimieren, im vergleich 
zu TZR-PLP PLPKO Mäusen welche PLP im Thymus nicht exprimieren, eine ähnliche 
Anzahl von CD4+ Thymozyten entstehen. Dies deutet darauf hin, dass PLP174-181-
spezifisch T Zellen nicht negative selektioniert werden. In der Peripherie haben 
PLP174-181-spezifisch T Zellen einen naiven Phänotyp was darauf hin deutet, dass die 
Toleranz nicht durch Klonale Eliminierung oder durch die Induktion von Anergie 
etabliert wird. Potentiell autoimmune CD4+ T Zellen konnten in der Milz und in den 
Lymphknoten von TZR-PLP11 Mäusen gefunden werden und konnten nur durch in 
vitro Stimulation aktiviert werden. In vivo jedoch wurden diese Zellen nicht spontan 
aktiviert, was darauf hin deutet, dass in der Peripherie, PLP nicht exprimiert oder 
präsentiert wird. TZR-PLP11 Mäuse entwickeln keine klinischen oder histologische 
Zeichen von EAE. Demzufolge nehmen wir an, dass in unserem System Ignoranz 
und nicht deletionale Toleranz dafür verantwortlich ist, dass CD4+ T Zell-vermittelte 
Auto-Immunität verhindert wird. Dies bedeutet, dass naive autoreaktive CD4+ T 
Zellen das PLP-Antigen ignorieren und in der Peripherie rezirkulieren ohne Schaden 
zu verursachen. Im Gegensatz dazu, die Immunisierung von TCR-PLP11 PLPWT 
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Mäuse mit dem PLP174-181-Peptid in Komplettem Freund’s Adjuvans kehrte diesen 
Status der immunen Ignoranz um, beurteilt durch die klinische Manifestation von 
EAE in diesen Mäusen. Außerdem, TCR-PLP11 PLPWT Mäuse entwickelten 
spontane EAE nach dem diese auf einen RAGKO Hintergrund gezüchtet wurden. 
Dies brachte uns zu der Spekulation dass neben der Immunologischen Ignoranz, 
dominante Mechanismen der PLP Toleranz wichtig für die Verhinderung von ZNS-
spezifischer Autoimmunität sind. Zusammengefasst, in dieser Studie wurde ein 
neues Model von Immunologischer Toleranz gegen ein Eigen-Antigen welches im 
ZNS exprimiert wird etabliert und die Antigen-Ignoranz von CD4+ T Zellen beinhaltet.  
 
Die somatische Rekombination von T Zell Rezeptor (TZR) Genen in Thymozyten 
resultiert nicht nur in der Produktion von brauchbaren TZRs sondern auch in TZRs 
mit potentiell autorreaktiven Spezifitäten. Generell werden autoreaktive CD4+ T 
Zellen im Thymus durch zwei Mechanismen zensiert. Zum einen durch die 
sogenannte Klonale Eliminierung und zum anderen durch die Differenzierung in 
regulatorische T Zellen (Treg), wobei beide Mechanismen den gleichen Stimulus, die 
Interaktion mit Eigen-Peptiden, benötigen. Um die Mechanismen der zentralen und 
peripheren Toleranz, welche das CD4 T Zell Repertoire formt zu untersuchen, haben 
wir eine TZR transgene Mause generiert welche die alpha und beta Kette von einem 
TZR spezifisch für das PLP11-18 im Kontext von H-2
b exprimiert (TZR-PLP1).  Durch 
die Verwendung von diesem neuen TZR-PLP1 transgenen Mausmodell, konnten wir 
die Modalitäten der Zentralen Toleranz Induktion anhand eines Eigen-Antigens 
untersuchten, welches im Thymus physiologisch exprimiert wird.  Wir fanden heraus, 
dass Plp1-Spezifische T Zellen welche durch ihr spezifisches Eigen-Antigen PLP 
stimuliert wurden gleichermaßen in Treg Zellen differenzierten als auch der klonale 
Eliminierung unterlagen.  Unsere Studie zeigte, dass dendritische Zellen im Thymus 
unwesentlich zur Induktion der zentralen Toleranz für PLP bei tragen. Im Gegensatz 
dazu; Epithelzellen in der Medulla des Thymus (mTECs) exprimieren und 
präsentieren das endogene Antigen PLP und vermitteln Toleranz in einer autonomen 
Art und Weise. Obwohl die Zentrale Toleranz für PLP sehr potent ist, ist sie nicht 
komplett und eine kleine Fraktion von autoreaktiven T Zellen kann in die Peripherie 
entweichen. Obwohl in der Peripherie potentiell gefährliche Zellen vorhanden sind, 
entwickeln die Mäuse keine Zeichen von Autoimmunität. Dies weist darauf hin, dass 
in der Peripherie, zusätzliche Mechanismen die Zentrale Toleranz gegen PLP 
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unterstützen. Wir konnten zeige, dass autoreaktive Plp1-spezifische T Zellen 
eliminiert oder funktionell inaktiviert werden, sobald diese Eigen-Peptid, präsentiert 
auf peripheren dendritischen Zellen, erkennen. In Experimenten von 
Knochenmarktransplationen fanden wir heraus, dass PLP auf radioresistenten 
Stroma Zellen exprimiert und anschließend von dendritischen Zellen 
kreuzpräsentiert wird. Zusammengefasst, unsere Resultate deuten darauf hin, dass 
die zentrale Toleranz für PLP durch ein Zusammenspiel zwischen Thymus und 
Peripherie etabliert wird.  
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1. Introduction 
 
1.1 T-cell development 
 
T cell development from hematopoietic cells takes place in the thymus, which is an 
evolutionarily conserved primary lymphoid organ that provides a highly specialized 
microenvironment1-3. The thymus consists two main cellular zones: the major outer 
zone, the cortex, and the smaller central zone, the medulla. Each of which are 
responsible for the keys stages in the thymocytes development. The cortical region 
is populated by pre-T lymphocytes and medullary region contains mature T 
lymphocytes4-7. The thymic microenvironment forms a complex network of 
interaction that comprises non lymphoid cells (e.g., thymic epithelial cells, TEC) that 
are capable of attracting lymphoid progenitor cell, specifying these cells to the T cell 
lineage, and orchestrating positive and negative selection events to complete 
thymocytes development and ensuring central tolerance and in turn, developing 
thymocytes critically regulate the development of TECs8-10. Therefore, the lympho-
stromal communication is a crosstalk between architectural stromal cells and 
traveling thymocytes11, 12. Two chemokine, CC-chemokine ligand 21 (CCL21) and 
CCL25, and adhesive interaction between platelet (P)-selectin glycoprotein ligand 1 
(PSG1) and P-selectin are involved in thymus colonization13-16. 
 
1.1.1 Early T-cell development 
 
Homing of bone marrow (BM)-derived lymphoid progenitors to the thymus is 
essential for T cell development. Early intrathymic progenitor cells are found within 
the most immature subset of thymocyte precursors, which lack CD4 and CD8 
expression and are referred to as double negative (DN) cells17, 18. During intrathymic 
differentiation, the immature DN subset is subdivided into four defined 
developmental stages (DN1-4) on the basis of the expression profiles of adhesion 
molecular CD44 and CD25 (Interleukin-2 (IL-2) receptor alpha subunit)19. Differential 
expression of these markers reflects developmental changes in the thymocytes 
when they enter the thymus at the cortico-medullary junction (CMJ) and 
subsequently migrate to the subcapsularzone of the thymic cortex20, 21 (Figure 1).  
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Differentiation to the DN1 stage, the earliest chronological subset is recognized as a 
CD44highC-Kit+CD25- population22, proceeds in proximity to the site of thymic entry23. 
The DN1 cell population is a heterogeneous mixture while c-Kithigh DN1 cells have 
been shown to possess most T progenitor potential24. In addition to T cell precursor 
activity, early thymic progenitors (ETPs) have the potential to give rise to αβ T cells, 
γδ T cells, dendritic cells, natural killer (NK) cells, macrophages, and B cells when 
transferred intravenously into irradiated hosts25, 26. 
 
DN1 cells begin to proliferate with concomitant expression of CD25 and mark the 
progression to the T lineage–specified DN2 stage showing the CD44highC-Kit+CD25+ 
phenotype27. DN2 cells migrate toward the outer thymic cortex under the influence of 
CXCL12, CCL19 and CCL12 produced by cortical thymic epithelial cells (cTECs). 
These DN2 cells still express considerable numbers of ‘legacy’ stem cell genes, 
cTEC continue to deliver strong Notch signals favoring T-lineage commitment and 
differentiation28, 29. IL-7 is essential for the survival and maturation of the IL-7Rα-
expressing DN2 and DN3 cells that follow them. IL-7-deficiet mice exhibit an abrupt 
block at DN2 stage of thymocytes30-32. A transcription factor, Sox13, has been 
associated with DN2 cell commitment33.  
 
The DN2 thymocytes then start to rearrange their T cell receptor (TCR) genes and 
downregulate the expression of CD117 and CD44 to become CD44lowC-kitlowCD25+ 
DN3 subset34. Thymocytes undergo recombination-activating gene (RAG)-mediated 
somatic rearrangements of the TCRβ, TCRγ, and TCRδ loci, which are required for 
the assembly of the TCR35-37. At the DN3 stage, the final commitment to the αβ and 
γδ T lineages is made38. While only rearrangement of the TCRβ locus is completed 
to initiate αβ T-cell maturation, both TCRγ and TCRδ must be productively 
rearranged to generate functional γδ T lineages39. However, how the commitment 
decision is made is still little understood due to the difficulty in distinguishing between 
these cells prior to TCR expression40. Sox13 is the only specific γδ-T cell lineage 
transcription factor identified so far. In mice, deficiency for Sox13 has impaired γδ-T 
cell development. For cells that proceed along the αβ TCR pathway, the newly 
formed functional TCR-β chains together with the invariant pre-TCR α chain41-44 and 
CD3 to form the pre-TCR complex43, 45. This checkpoint is known as β-selection, 
which is the result from the formation and expression of the pre-TCR complex on 
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DN3 thymocytes: proliferation, rescue from apoptosis, allelic exclusion at the TCR-β 
gene locus, initiation of TCR-α gene expression, upregulation of CD4 and CD8 
expressions, and downregulation of CD25 expression46-47 ensures that only those 
thymocytes that have a successful TCRβ gene-segment rearrangement, initiation of 
TCR-α gene expression, upregulation of TCR on their surface are permitted to 
survive and to undergo further differentiation48. At least two additional signals, 
Notch1 and CXCR4 via cTEC ligands contribute to the differentiation and expansion 
at the β-selection checkpoint49, 50. 
 
 
 
Figure 1. Schematic view of early T-cell development. T-cell development from less 
mature to more mature cells with distinct phenotype proceeds from left to right. DN, double 
negative; RAG, recombination-activating gene; DP, double positive; SP, single positive; TCR, 
T-cell receptor; MHC I, major histocompatibility complex class I; MHC II, major 
histocompatibility complex class II. 
 
Thymocytes that emerge from β-selection undergo TCRα-VJ rearrangement, 
recombine and express a functional TCRα chain what leads to the second 
component chain of the mature αβ antigen receptor. They stop to express receptors 
characteristic of hematopoietic cells, and become unresponsive to cytokine signals, 
e.g., interleukin-7 (IL-7)51, 52.  They also initiate CD4 and CD8 expression what 
further drives DN4 cells to become double-positive (DP) immature T cells is referred 
to the DN4 or pre-DP stage53-55. If a rearranged β-chain does not lead to any 
signaling, the cell may die by neglect56. In this stage, the cells become 
phenotypically CD44-CD25- and migrate to the outermost cortex, the subcapsular 
zone. As soon as DPs express a functional αβ-TCR on their surface, cells undergo 
two major rounds of selection: positive and negative selection57.  Along with positive 
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selection, DP cells become committed either to CD4 single positive (SP) or to CD8 
SP thymocytes22, 38, 56, 59 depending on the ability of their TCR to bind to peptide-
MHC class II or peptide-MHC class I complexes, respectively60, 61.  
 
During the specification and commitment processes, numerous signaling molecules 
and transcription factors must be completed before cells reach DN4 stage. To date, 
a number of molecules have been identified involved in T-cell development by “loss-
of-function” and “gain-of-function” approaches. Notch is a signaling receptor 
molecule to Delta or Jagged ligands, and the Notch signaling is involved in many 
aspects of development28, 29, 62-64. Notch1-delta-like 4 (DL4) signaling has been 
shown to be required for DN1-DN2 transition. The absence of Notch-1 led to arrest T 
cell development at early stage and to ectopic differentiation of intrathymic B cells 65, 
66. An interesting observation in mice in which Notch1 is deleted by CD4-Cre was the 
lack of perturbed T-cell development from late DN3 stage, suggesting that Notch1 is 
involved in maintaining lineage integrity in early, but not late and mature, thymocyte 
development67. Other transcription factors, including Runx1, GATA-3 and two E-
proteins (E2A and HEB), cooperate with Notch1, play multiple roles during T cell 
development68-71. We still do not understand how these transcription factors function 
within the same transcriptional network and whether there is a single factor that acts 
as the master regulator in T lineage, similar to Pax5 in B cells72. To investigate this, 
more efforts will be required. 
 
1.1.2 T cell selection 
 
The population of DP-thymocytes contains the unselected T-cell repertoire. The 
recognition of αβ TCR with peptide: MHC (pMHC) complexes presented in the 
cortical microenvironment is regarded as the central event in positive and negative 
selection, leading to the fate decision of DP thymocytes. The selection procedure is 
known as positive and negative selection56, 73, 74. Only those thymocytes that receive 
low avidity TCR interactions with self-pMHC will receive a signal for survival and 
differentiate into single-positive (SP) thymocytes. In contrast, high-avidity interactions 
elicit signals that lead to the deletion of tissue-specific-antigen-reactive T cells by 
negative selection or induced the differention into Foxp3+ regulatory T cells and 
thereby avoiding autoimmunity75-77 (Figure 2).  
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1.1.2.1 Positive selection 
 
To generate peptides for MHC class I presnetation, cTECs uniquely express the 
proteasome subunit β5t56. Proteasomes are multicatalytic protease complexes 
responsible for producing antigenic peptides that can bind efficiently to MHC class I 
molecules as well as degradating cytoplasmic proteins78, 79. β5t-containing 
proteasomes, termed thymoproteasomes, favoring the production of peptide that are 
less stably bound to MHC class I molecules compared with the other types of 
identified proteasomes, one is β5i-containing immuno-proteasomes, the other is 
standard proteasomes containing β5 subunits80.  The reason is because β5t have 
the different catalytic properties from those of β5i/β5. The importance of the unique 
catalytic activity of β5t was showed by the analysis of β5t-/- mice. These mice 
exhibited a substantially reduced positive selection of MHC class I-restricted CD8+ T 
cells and had an altered CD8 T-cell repertoire79. These data indicates that β5t-
dependent peptides are essential for positive selection of CD8+ T cells and also 
critical to generate of an immunocompetent repertoire of CD8+ T cells. Furthermore, 
the study showed by Katsuhiro et al., demonstrated that unique cleavage motifs in 
β5t-dependent MHC class I-associating peptides are enriched with low-affinity TCR 
ligands that efficiently induce positive selection. Taken together, these aspects 
indicate that cTECs regulate positive selection of CD8 T cells by producing a unique 
set of MHC class I-associating peptides that exhibit low affinity for TCR80-83.  
 
With respect to the positive selection of MHC II-restricted CD4+ T cells, many 
lysosomal proteases produce peptide antigens. cTEC highly but not exclusively 
express lysosomal proteases Prss16 (also known as thymus-specific serine protease 
(Tssp))84 and cathepsin L85, which are necessary for optimal positive selection of 
CD4 T cells86, 87. Analyses of mice deficient in Prss16 have indicated a defective 
positive selection of CD4+ T cells with certain TCR specificities, including 
diabetogenic self-reactive CD4+ T cells88. Cathepsin L-deficient mice also show a 
greatly reduced repertoire, which is manifested by a reduced number and diversity of 
MHC-II restricted CD4+ T cells89. It is also shown that macroautophagy is required 
for the generation of pMHC complexes for positive selection90-92, which is a protein 
degradation process that facilitates loading of intracellular antigens onto MHC II 
Introduction 
	   	   	  11	  
molecules. Mice lacking the essential autophagy gene Atg5 showed altered 
repertoire selection of the CD4+ T cell compartment93, 94. These data strongly 
supports the idea that cTECs display a specific set of unique self-peptides to induce 
positive selection of a functionally competent repertoire of CD4+ T cells. 
  
1.1.2.2 Negative selection 
 
Negative selection is based on the interaction of self-peptides presented by MHC 
molecules, i.e. high affinity and/or avidity interaction between the TCR and self-
peptie-MHC complexes will undergo apoptosis57. The process of negative selection 
enriches ‘useful’ T cells that are potentially reactive to foreign antigens, but not to 
self-antigens, presented by self-MHC molecules and thereby avoiding 
autoimmunity95.  
 
To achieve successful negative selection, thymocytes interact with stromal cells 
presenting self-antigens that are expressed ubiquitously or are tissue-restricted in 
the thymic microenvironment. Medullary thymic epithelial cells (mTECs) and thymic 
dendritic cells (tDCs) are the key players for negative selection (also see section 
1.1.3). mTECs as the main stromal cell subset in the medulla are capable of 
expressing  a large number of  tissue restricted self-antigens (TRAs)96. This 
phenomenon has been termed promiscuous gene expression and is mediated at 
least partially by the autoimmune regulator (AIRE)97, 98. While mTEC express and 
present TRAs both on MHC class I molecular and MHC class II molecular, tDC are 
important for cross-presentation of mTEC-derived TRAs. Both populations require 
B7:CD28 interactions to promote clonal deletion of T cells reactive to TSAs99-101. 
However, evidence for an autonomous role of mTEC as negatively selecting APC 
has obtained in several mouse models. It has been shown that siRNA-mediated 
reduction of MHC class II expression in mice rescues CD4SP compartment from 
clonal deletion102. Furthermore, genetic ablation of DCs in mice also showed that 
tDCs are capable to delete autoreactive CD4+ T cells without the contribution of 
mTECs103, 104. It has been shown that after transferring TCR transgenic CD8+ H-Y T 
cells into recipients, T cells recognizing the male antigen were detected in the 
periphery of female mice, but are deleted in males, and highlights the efficiency of 
negative selection in preventing the release of autoreactive T cells into the 
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periphery105. In contrast to mTECs, there is little evidence to support an autonomous 
role of cTECs in the promotion of clonal deletion in vivo106. 
 
1.1.3 Antigen presenting cells in the thymus 
 
Within the discrete thymic microenvironments, developing T cells interact with 
individual stromal cells which display self-antigen-derived epitopes on their surface 
and are involved in T cell development and seletion, particularly shape the repertoire 
of pMHC complexes on their surface and therefore in the development and 
generation of T cells. Thus, it is important to understand the contribution of the 
various thymic APC subsets and their distinct properties regarding antigen 
presentation. APCs in the thymus consists of cTEC, mTEC, DCs and also B cells. 
However, compared with other APC lineages, B cells only present as a tiny 
population in the thymus84, 107 and their role in negative selection remains elusive73, 
108. 
 
Cortical thymic epithelial cells (cTEC) 
 
cTECs are the essential component that forms the architecture of the thymic cortex 
and supports early T-cell development and positive selection of immature 
thymocytes. Besides that, some studies indicated that cTECs also contribute to 
negative selection106 as well as to induction of regulatory T cells109, 110 (Figure 2). 
However, the mechanism how cTECs induce TCR-mediated positive selection is 
unknown. One of the concepts addressed this selection paradox using an ‘altered 
peptide’ model. It suggested that cTECs present positively selecting “specially 
tailored” peptides and might be different from those tolerance-inducing APCs in the 
medulla111. Two other hypotheses claimed an affinity/avidity model, which predicted 
the quality/quantity of TCR-peptide-MHC interaction and therefore shaping 
lymphocyte repertoires somatically112, 113. The first evidence of the peptide 
machinery in cTECs was addressed to cathepsins in CD4+ T cells. Interestingly, 
cTECs preferentially express cathepsin L but not cathepsin S, which is expressed by 
other haematopoietic APCs and mTECs. The phenotype of Ctsl–/– mice indicate that 
lysosomal proteases are necessary for positive selection of CD4SP cells 88, 114, 115. 
Although cTECs express high levels of MHC class II molecules116-118, they are 
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inefficient in presenting exogenous proteins using the classical endocytic pathway. 
Instead, cTECs use macroautophagy to deliver the intracellular antigens to the MHC 
II pathway to generate a functionally competent repertoire of CD4+ T cell 
compartment119.  
 
Medullary thymic epithelial cells (mTEC) 
 
mTECs are the unique cell type capable of expressing a broad range of tissue-
restricted antigens in a promiscuous fashion120, 121. Beside that, mTECs constitutively 
express MHCII and CD80 on their surface. Thus, one can distinguish two subsets of 
mTEC with respect to these markers: mTEClo and mTEChi expressing low to 
intermediate and high levels of MHC class II and CD80, respectively122, 123. It has 
been proposed that mTEChi are the most mature, terminally differentiated subset of 
mTEC with antigen presentation characteristics of professional APC124, 125. The 
transcription factor Aire is primarily found in lymphoid organs, particularly in the 
nuclei of mature, highly MHC II–expressing mTECs in the thymus and is the only 
known regulator that induces the expression of some but not all TRAs. The initial 
report by Anderson et al. suggested that Aire promotes the promiscuous expression 
of TRAs in mTECs101.
  The importance of Aire controlling the transcription of TRAs in 
mTEC and thus in T-cell tolerance is highlighted by the fact that mutations in Aire 
gene lead to the human autoimmune syndrome known as autoimmune 
polyendocrinopathy candidiasis ectodermal dystrophy (APECED)126, 127. Similarly, 
mice with mutations in the Aire gene suffer from spontaneous multi-organ 
autoimmune disease characterized by multiorgan lymphocytic infiltration and 
autoantibody production128. In addition, Aire has been described to enhance the 
antigen-presentation capability of mTEC101.  
 
Despite the low frequency (1–3%) of mTECs expressing a particular TRA98, 129, 130, it 
would still be feasible that antigen expression and direct presentation by mTECs is 
sufficient for the induction of both dominant and recessive modes of central tolerance. 
However, such a mandatory division in mTECs is still a matter of intensive research. 
TCR transgenic mice specific for human C-reactive protein (hCRP) rises evidence 
that promiscuous expression of hCRP in mTECs acts autonomously to tolerize CD4+ 
T cells speicifc for an endogenous antigen99.  In another system where the function of 
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mTEC for the induction of dominant tolerance was shown is the AIRE-HA model. In 
this model, mTEC-specific expression of hemagglutinin (HA) led to the deviation of 
antigen specific T cells into the regulatory T cells (Treg) lineage in a cell autonomous 
way, independent of antigen transfer and presentation by haematopoietic APCs102, 
131.  
 
Since very few mTECs express a given TRA in the medulla, there is another 
scenario that explains how TRAs are presented to developing thymocytes. This 
thought argues for the cross-presentation of mTEC expressed self-antigens 
presented by DCs. Although mTECs synthesize the TRAs, they do not directly 
present antigen to delete TRA-reactive T cells. Instead, mTECs serve as TRAs 
suppliers, eventually spread these antigens in the thymic medulla where 
neighbouring DCs would present these antigens and increase the probability of 
TRAs being encountered by SP T cells. This concept received experimental support, 
utilizing the RIP-mOVA system, the authors showed that intercellular antigen transfer 
from mTECs to BM-derived APCs is necessary for the deletion of autoreactive 
CD4SP and CD8SP T cells132. It seems highly plausible that both antigen 
presentation by mTEC and DCs can mediate negative selection and Treg cell 
differentiation to establish central tolerance (Figure 2). 
 
Dendritic cells (DC) 
 
The dendritic cells (DCs) are highly specialized APCs in the medullary region of the 
thymus. Thymic DCs are subdivided into two major subsets based on their cell 
surface markers expression and functional properties: conventional CD11chigh DC 
(cDC) and CD11cmidCD45RA+ plasmacytoid-derived DC (pDC). cDCs can be further 
divided into lymphoid resident and migratory DCs according to Sirpα expression133. 
Sirpα- cDC develop from intrathymic precursor cells, while Sirpα+ DCs and pDCs 
immigrate from the periphery, home to the thymus at steady state and therefore are 
called migratory DCs134-136. 
  
DCs present a broad range of self-antigens, including TRAs expressed and 
transferred from mTEC, circulating antigens captured by thymic DCs from the blood 
and antigens acquired from peripheral tissues by Sirpα+ DCs and pDCs homing to 
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the thymus132, 137-139. DCs play an important and sufficient role in negative selection 
of CD4+ thymocytes. Accordingly, in mice that lack antigen presentation specifically 
in DCs diminished negative selection of bulk polyclonal CD4SP T cells was found103, 
140. Using transgenic mouse models also confirmed an indispensible role of DCs in 
negative selection104, 141. DCs interact with antigen-specific thymocytes with high 
affinity, could also drive the interacting thymocytes to become Treg cells142. However, 
the underlying mechanisms by which thymic DCs mediate negative selection and 
Tregs induction remain to be better established. 
 
1.2 Central tolerance 
 
A major challenge for the immune system is to preclude the release of self-reactive 
thymocytes. If they proceed through the terminal maturation stage and migrate to the 
periphery, they could recognize the body's own components and attack host tissues 
leading to autoimmunity. In order to prevent autoimmunity, T cell development needs 
to be controlled by the mechanisms of central tolerance, which occurs in the thymus 
and peripheral tolerance, which occurs in the secondary lymphoid tissue.   
 
The central tolerance mechanisms are distinguished into recessive (negative 
selection/clonal deletion) and dominant (Treg generation). Central tolerance can be 
regarded as a consequence of minimizing the release of functionally competent 
autoreactive T cells from the thymus. In contrast, dominant tolerance involves 
generation of a subset of CD4+ T cells with immunosuppressive function (regulatory 
T-cell; Treg), which can dampen the activation and expansion of potentially 
hazardous cells that have avoided negative selection and enter the peripheral 
tissue144-146.  
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Figure 2. T cells undergo selection and maturation processes on the basis of their 
TCR reactivity. cTECs are uniquely responsible for inducing positive selection of 
functionally distinct T cells. T cells recognize low-affinity self peptide-MHC complexes 
inducing survival signals and further differentiation into CD4SP or CD8SP thymocytes as 
they migrate from the cortex to the mudulla. This process is referred to as positive selection. 
The remaining T cells, which TCR bind too strongly or do not even recognize pMHC 
complexes are destined to die through apoptosis. mTECs and DCs are the key players for 
negative selection. Self-reactive T cells bearing TCRs with high affinity for self-peptide: MHC 
complexes are deleted. Alternatively, strong TCR signals can induce CD4SP cells to 
differentiate into regulatory (Treg) T cells. Figure adapted from Li et al.143. 
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1.2.1 Clonal deletion  
 
The so-called ‘clonal selection theory’, a seminal landmark of modern immunology, 
was published in 1959 by Frank Macfarlane Burnett. It proposed that lymphocytes 
that are potentially dangerous self-reactive will be eliminated from the T-cell 
repertoire to prevent autoimmunity147. The elimination of autoreactive lymphocytes is 
implicated in the process of clonal deletion or negative selection is T-cell progenitors 
expressing TCRs with high affinity (that is, above a certain quantifiable threshold) for 
self-antigens will die by induced apoptosis148-150. There was outstanding 
experimental support for the ‘clonal deletion model’ by Marrack et al. They 
demonstrated that superantigen (SAg)-specific T cell expressing Vβ17a TCR were 
efficiently eliminated in mice expressing SAg derived from the mouse mammary 
tumor virus, when SAg expression was lacking, the same T cells escaped clonal 
deletion and migrated to the periphery144. Furthermore, many TCR transgenic mouse 
models expressing T cell receptor specific for a self-antigen was generated to 
validate the clonal deletion model. In these model systems, mice were designed to 
express antigens from transgenes, for example, Hemagglutinin (HA); in some others 
TCR transgenic mice recognized a naturally expressed antigen, e.g. H-Y57.  
 
The fundamental questions of clonal deletion are where does self-reactive T cells 
undergo deletion and at which stages of thymocytes are removed? The questions 
which relevant APCs and what the molecular signals are involved have been studied 
broadly. The medulla is generally thought to be the place for negative selection, 
which provides the most complex ligandome as well as a wide range of restricted 
tissue-specific antigens. However, whether clonal deletion also occurs in the cortex 
is controversial. It is clear that the nature of thymocyte TCR and self-antigen 
expression have an effect on the timing of clonal deletion. For example, Hogquist 
et.al recapitulated the H-Y TCRa expression at the physiological DP stage (H-Ycd4 
mice)151. It was shown that thymocytes deletion occurs at the transition from DP to 
SP. Thus, in general, polyclonal thymocytes are specific for ubiquitous self-antigens 
seem to be deleted in the cortex. In contrast, deletion occurs in the medulla when 
those cells are restricted to tissue-specific antigens, superantigens and circulating 
antigens. The process of negative selection was mediated by mTECs and tDCs via 
presentation of TRAs. mTECs express and present TRAs on MHC class I and MHC 
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class II, while tDCs are essential for cross-presentation of mTEC-derived TRAs. It 
has been described that several TCR co-stimulatory molecules are contribute to 
apoptosis, among these are CD5, CD28, CD43 and Fas152, 153. More work is needed 
to understand how the different affinity ligands can be discriminated by a TCR to 
induce the distinct outcomes of positive and negative selection. With respect to the 
proximal TCR signaling events, several molecules have been identified to regulate 
negative selection, including the mitogen activated protein kinase (MAPK) family 
members Jun N-terminal kinase (JNK) and p38, which is initiated in part by pro-
apoptotic BCL2 family members BIM154, 155. Another important activator of the 
JNK/p38 with a fundamental role in negative selection is Misshapen/Nck interacting 
kinase (NIK)-related kinase (MINK) and Grb-2156. Furthermore, Nur77, an orphan 
nuclear receptor, has been found to interact with the anti-apoptotic molecule Bcl-2 in 
the mitochondria, thereby leading to cell death157. More recently it was found that 
CTLA-4 signaling diminish the efficacy of clonal deletion of thymocytes158, 159.  
 
1.2.2 Clonal diversion  
 
Self-reactive T cells bearing TCRs with high affinity for self-peptide: MHC complexes 
are deleted. However, negative deletion is an inevitably incomplete process and 
raises the question whether tolerance is maintained by additional tolerance 
mechanisms. In the late eighties, the so-called dominant tolerance had been 
discovered, which represented a yet unknown mode of tolerance at that time. The 
elegant work from Le Dourain has implicated that the existence of dominant 
tolerance operating in the thymus160, 161. They found that transplantation of 
embryonic tissues from quail into age-matched chicken embryos induced the 
rejection of graft soon after birth. Importantly, this graft rejection would be prevented 
by simultaneous transplantation of limb buds with embryonic thymi. In such chimeras, 
embryonic thymi were grafted before when they had been colonized by 
hematopoietic precursors, which indicated that tissue-specific tolerance induction 
was established by thymic epithelium (TE). Since a recessive tolerance induction 
mechanism could not explain why the transplanted limb was accepted, this 
unexpected finding revealed that a special type of T cells could be generated in the 
thymus and have the capacity to inhibit graft-reactive T cells162. Sakaguchi and 
colleagues identified a subset of T cells with a regulatory function (hereafter referred 
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to as Treg) and mediate dominant tolerance that is essential to prevent autoimmunity. 
Those CD4+ T cells constitutively express the CD25 with the capacity to suppress 
potentially harmful cells that are activated upon encounter their cognate antigen149, 
163. In 2003, the transcription factor forkhead box protein P3 (Foxp3) has been 
demonstrated to be the key regulator and is required for Treg development and 
function in thymus as well as in periphery77, 164, 165. This comes from the finding that 
in the ‘scurfy’ mouse and in humans carrying a mutation in the gene encoding Foxp3 
suffers from severe autoimmune manifestations due to impaired Treg induction166, 167. 
 
TCR interaction with self-peptide-MHC complexes in the thymus is regarded as the 
essential driving force for thymocytes development, this raises the interesting 
question how these autoreactive thymocytes avoid clonal deletion and deviate into 
the Treg lineage? Except the affinity model, several studies indicate that avidity 
might play a role in thymic selection. Direct evidence for autonomous, DC-
independent contribution of mTECs in both negative selection and deviation of Tregs 
was observed using mTEC-specific Ciita silencing in the TCR-HA x Aire-HA model131, 
168. In C2TAkd mice, the presentation of mTEC is diminished to about 10% of the 
wide type amounts. For mTECs mediated negative selection, C2TAkd mice have 
enlarged polyclonal CD4SP population (increase of -20%) and enhanced selection of 
Tregs (increase of -46%)102. Thus, how Tregs are rescued from clonal deletion and 
what particular features of APC are needed for Treg differentiation remains to be 
determined. In addition to TCR signals, CD28-B7 signaling has a cell-intrinsic role in 
Treg differentiation. With genetic ablation of either CD28 or its ligands, thymic Tregs 
were strongly reduced in these mice169, 170. Cytokine signaling co-operating with a 
TCR stimulus was found to crucially contribute to the maintenance and survival of 
Tregs. IL-2//IL-15- or STAT5-deficiency in mice will inhibit effector T cell proliferation, 
and therefore, will hinder an immune response171-174. Furthermore, it has been 
proposed that TGFβ signaling is required for Treg generation, a requirement that is 
later compensated for by IL-2. However, the combined deficiencies in both TGF-β 
and IL-2 signaling led to the complete absence of thymic Tregs175. 
 
1.3 Peripheral tolerance 
 
Although central tolerance very efficiently deletes T cell precursors whose TCRs 
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have high avidity for self-pMHC complexes expressed on DCs and mTECs, it is an 
imperfect process. In part because not all self-antigens are expressed in the thymus, 
and by the existence of self-reactive, functional T cells in the periphery could induce 
autoimmune disease both in human and mice. Therefore, the T-cell selection 
process does not end with emigrating in the thymus, rather T cells undergo further 
selection process after entering the periphery to maintain unresponsiveness to self-
antigens that are expressed outside of the thymus. The escaping autoreactive T cells 
are controlled by peripheral tolerance mechanisms that mainly include the functional 
unresponsiveness of anergic T cell, deletion of peripheral T cells, ignorance and 
regulatory T cells conversion176 (Figure 3). Thus, multiple mechanisms will help to 
control T-cell responses and maintain tolerance in the periphery. 
 
1.3.1 Anergy 
 
T cells encounter with self-antigen might lead to intrinsic functional inactivation, but 
these cells remain alive in a long-term hyporesponsive state, termed as anergy177. 
Anergic T cells are characterized by a variety of functional limitations, including cell 
differentiation, cell division and cytokine production. The anergic state of CD4+ T 
cells can be induced through TCR ligation in the absence of co-stimulation or high in 
co-inhibition signals such as cytotoxic T lymphocyte antigen-4 (CTLA-4)178. Co-
stimulation provides a second signal to T cells in conjunction with signaling via their 
TCR upon recognition of antigen presented by MHC. However, costimulatory signals 
can also function as a negative regulator that inhibit T cell responses and mediate 
tolerance179. The CD28/B7 pathway of co-stimulation is critical in preventing anergy 
induction180. The development of anergic T cells is antagonized by CD28 signaling, 
which induces copious amounts of IL-2 and facilitates subsequent PI3K/AKT-mTOR 
dependent anergy reversal. Nonetheless, the role of CD28 ligands co-stimulatory 
ligands B7-1 (CD80) and B7-2 (CD86) in the induction of anergy is still unclear. 
McConnell et al. demonstrated that blocking the CD80 and CD86 inhibited tolerance 
instead of promoting it, was resolved by the observation that CTLA-4 engagement 
was required to induce anergy in vivo181, 182 (Figure 3).  
 
CTLA-4, express at a late stage in T cell activation, binds to CD80 and CD86 with 
higher affinity than CD28, which plays an essential role in maintaining 
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unresponsiveness. Genetic CTLA-4 deficiency shows autoimmunity and lethal 
lymphoproliferative disorders183-185. Notably, Ctla4-/- CD4+ T cells and wild-type T 
cells resist anergy induction when these cells are treated with CTLA-4-specific mAb 
following soluble antigen administration in the absence of adjuvant or infection186. 
Although results from Wing et al showed that CTLA-4 is required for natural Tregs to 
suppress immune responses, adoptive transfer of OVA-specific CD4+ T cells from 
CTLA-4-/- DO11.10 Tg mice into RIP-mOVA Ragko recipients induce acute insulitis 
and diabetes, whereas CTLA-4+/+ DO11.10 T cells are unable to break tolerance187.  
 
Programmed death 1 (PD-1) molecular is an immunoinhibitory receptor, as another 
candidate for regulating anergy induction. Animals deficient for PD-1 or its ligand PD-
L1 and PD-L2 exhibit a breakdown of peripheral tolerance and demonstrate 
autoimmune disorders188-190. PD-1 signaling can inhibit cytokine secretion as well as 
block tissue migration ‘stop signals’ that are necessary for productive TCR 
engagements. As more members of the CD80/CD86 family and their rececptors 
emerge191, we might have a better chance to discover how T cell anergy is controlled 
through TCR and other cell-surface receptors. 
 
Tolerogenic DCs sample self-antigens and present it to antigen-specific T cells but 
cannot deliver adequate costimulatory signals inducing anergic and IL-10-producing 
T cells with regulatory properties. In an immunosuppressive environment, 
immunosuppressive cytokines IL-10 and TGF-β support the generation of 
tolerogenic DCs192. Mature DCs efficiently initiate effector T cell response, while 
immature DCs are involved in silencing T cell-mediated immune responses193. In 
steady state, it is believed that tolerogenic DCs are generated by incomplete 
maturation. On CD4+ T cells, the expression of ICOS, an activation-induced member 
of the CD28 family, which can also contribute to induction of anergy. The mechanism 
by which DCs promote tolelogenic responses involves the express of the enzyme 
indoleamine 2,3-dioxygenase (IDO), which is induced through ligation of CTLA-4 by 
CD80/CD86. On one hand, IDO catalyzes the degradation of the essential amino 
acid tryptophan, which leads to the inhibition of T cell proliferation. On the other hand, 
IDO+ regulatory DCs and Tregs might interact and suppress local T-cell responses 
and promoting systemic tolerance194. 
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Figure 3. Mechanisms to maintain peripheral tolerance. A. T cells encounter with self-
antigen might lead to intrinsic functional inactivation, termed as anergy, possibly involving 
interaction of the T-cell molecules such as CTLA-4 or PD-1 with their ligands (CD80/86, 
PDL1/2). B. Self-reactive lymphocytes engaged by self-pMHC complexes die by apoptosis, 
which occurs through a combination of the death receptor Fas and its ligand, FasL. C. Naïve 
self-reactive autoaggressive T cells might never encounter the self-protein they recognize, 
termed as immunologic ignorance. CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; 
PD-1; programmed cell death 1; PDL, PD-1 ligand; FasL, Fas ligand (Figure modified from 
Walker et al.176). 
 
1.3.2 Peripheral deletion 
 
Another important mechanism to maintain peripheral tolerance is peripheral deletion. 
Self-reactive lymphocytes engaged by self-pMHC complexes die by apoptosis, a 
process called ‘Activation induced cell death’ (AICD) which occurs through a 
combination of the death receptor Fas (CD95) and its ligand, FasL (CD178)195, 196 
and Bim-dependent triggering of the Bcl-2 and Bcl-xL-mediated mitochondrial 
pathway of apoptosis (Figure 3). Although Fas- and Bim-mediated AICD are 
mechanistically different, these pathways are coordinated and cooperate in killing 
mature T cells that are stimulated by self-antigens. 
 
Surprisingly, AICD of peripheral T cells is regulated by the Fas signaling pathway 
which is enhanced by IL-2. IL- 2 is traditionally thought to be a survival and growth-
promoting cytokine197. Interest in this pathway came from the observation that T cells 
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from two strains of mice with defects in Fas (FaslprMRL mice) and FasL (gld mice) 
fail to undergo peripheral deletion and develop spontaneously lymphoproliferative 
disease198. Interestingly, some studies indicated that the death of activated T cells 
during the shutdown of an acute immune response is mediated Bim, but not Fas199, 
200. Bim is a natural antagonist of the survival protein Bcl2. Bim binds and activates 
Bax and Bak, lead to the permerbilization in the mitochondrial outer membrane and 
subsequent caspase activation and what eventually leads to cell death. Experiments 
with Bim-deficient mice have shown that antigen-specific T cells accumulation in the 
spleen and lymph node as well as development of autoimmunity201. Thus, for at least 
some self-pMHC complexes, the induction of peripheral deletion is an important 
contributor to peripheral tolerance. 
 
1.3.3 Ignorance 
 
Naïve self-reactive autoaggressive T cells are readily found in disease-free 
individuals, termed as immunologic ignorance, and establishes a barrier to self-
pMHC complex recognition. This situation is thought to result mainly from the 
physical segregation of autoreactive T cells from most non-lymphoid tissues. The low 
expression level of the target autoantigen does not reach the threshold and/or the 
avidity of the T cells that are specific for a given autoantigen is too low, which is 
required to trigger a T-cell response (Figure 3). In a pioneering study of the 
development of murine diabetes, where they showed antigen-presenting cells are 
absent or deficient in the connective tissue between the blood vessles and the islets, 
T cells do not encounter pancreatic antigen in processed and recognized form202. 
Nevertheless, by peripheral immunization of rodents with organ-specific self-peptides 
has shown that the reversal of ignorant reigns could lead, in susceptible strains, to 
the development of organ-specific autoimmune disease203.  
 
1.4 Experimental Autoimmune Encephalomyelitis  
 
Animal models have been used extensively in investigating molecular mechanisms 
of neuroinflammation and development of new therapeutic options. Multiple Sclerosis 
(MS) is an inflammatory demyelinating disease of the central nervous system204. The 
classical animal model to mimic MS-like symptoms in the CNS is experimental 
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autoimmune encephalomyelitis (EAE), which can be induced either by injecting 
myelin sheath protein with Complete Freund’s Adjuvant (CFA) or by passive 
transferring Th1 cell lines specific for the myelin proteins into susceptible animals. In 
addition, spontaneous models that make use of T cell receptor (TCR) transgenic T 
cells exist205-207. The genetic background of mouse strains and the nature of proteins 
of the CNS used for immunization determine the pathology and the disease course. 
In EAE, the three main myelin proteins, including proteolipid protein (PLP), myelin 
basic protein (MBP), and myelin oligoglycoprotein (MOG) have been shown to 
induce autoaggressive T cells. 
 
1.4.1 Target autoantigen-Proteolipid protein (PLP) in EAE 
 
The most abundant CNS myelin protein proteins are PLP constituting 50% of whole 
myelin proteins composition. PLP is a highly hydrophobic and integral 
transmembrane protein of the myelin membrane and encoded on the X 
chromosome208.  In mice, two main transcripts of PLP has been described: one 
encodes for the full-length 276 amino acid isoform, the other DM20 isoform lacks the 
residues 116-150 in the cytosolic loop of PLP. In different species, PLP/DM20 is 
highly conserved in its amino acid sequence, which suggests that the protein plays 
an important role in forming myelin sheaths209 (Figure 4). The differential peripheral 
expression of one major encephalitogenic and immunodominant PLP139−151 peptide 
that is present in full-length PLP, but is absent in the splice variant of PLP-DM20, 
results in the escape of PLP139-151 reactive cells from central tolerance
210. 
Furthermore, SJL/J TCR transgenic mice specific for PLP do develop spontaneous 
disease206. 
 
Naturally occurring mouse mutants such as Jimpy and the Jimpymsd mouse, or the 
myelin-deficient rat, exhibited myelin defects such as dysmyelination and 
hypomyelination211. In other species, some of these myelin defects resulted in 
Pelizaeus-Merzbacher (PMD) and the X-linked spastic paraplegia (SPG-2) 
disease212, 213. Due to point mutations, the primary structure of PLP is altered. This 
leads to misfolded polypeptides are incapable of exiting form intracellular 
compartment, interfering with oligodendrocyte differentiation and its survival. 
Surprisingly, mutant mice that lack expression of a targeted PLP gene do not 
Introduction 
	   	   	  25	  
develop the known dysmyelinated phenotype
214.  
 
 
Figure 4. Topoloy representation of PLP and its isoform DM20. PLP is a highly 
hydrophobic and integral transmembrane protein of the myelin membrane204. In different 
species, PLP/DM20 is phylogenetically highly conserved in its amino acid sequence205. The 
amino acids of the molecule that are absent in the splice variant of DM20 (residues 116–150) 
are shaded dark grey. The core position of PLP11-18 (Plp1) and PLP174-181 (Plp11) is 
highlighted in blue and red, respectively. Figure modified from Greer et al.215. 
 
1.4.2 Central tolerance to PLP 
 
The expression of PLP might play an important role in the induction of central 
tolerance to PLP. A number of studies identified that the expression of full-length 
PLP is mainly located to the brain and spinal cord, whereas the DM20 isoform is 
predominantly expressed in peripheral lymphoid organs216. It has been identified that 
immunization with synthetic PLP epitopes can induce EAE in several strains of 
mice217. In the SJL/J (H-2s) strain, there are two major encephalitogenic epitopes of 
PLP, PLP139–151 and PLP178-191. Both of these epitopes bind highly with I-A
s molecule, 
but the immune response to PLP139–151 is dominant. Immunization of SJL/J mice with 
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either of these two epitopes can induce EAE, indicating that low-affinity binding of 
these autoantigenic peptides to I-As molecule or formation of unstable pMHC 
complexes could form the autoreactive repertoire in the periphery218. Actually, 
different mouse strains show differences in their susceptibility to EAE. Whereas 
SJL/J mice are highly susceptible, C57BL/6 strain (H-2b) are relatively resistant to 
the development of EAE when immunizing them with the same protein/peptide217.  
 
Using thymus transplantation experiments in B6 PLPKO animals, Klein et al. showed 
that the intrathymic expression of PLP in radioresistant thymic stromal cells is 
sufficient for tolerance induction219. In the C57BL/6 strain, the full spectrum of the 
immunogenic regions of PLP in the context of H-2b was identified. Previous work 
was done by Klein et al. where they immunized B6 PLPWT and B6 PLPKO mice with 
purified PLP protein and subsequently re-stimulated the primed lymph node T cells 
with a set of overlapping peptides (24 amino-acids in length) which span the whole 
PLP protein with a shift of 16 amino-acid residues, revealed four immunogenic 
regions of PLP react against CD4+ T cells. When the authors used 8-12 amino acids 
to re-stimulate the draining lymphocytes further indicated four core-epitopes in the 
context of H-2b, termed PLP11-18 (Plp1), PLP174-181 (Plp11), PLP205-213 (Plp13), and 
PLP240-247 (Plp15). Importantly, subsequent to immunization of B6 PLP
WT animals 
with whole protein, restimulation with the individual core regions demonstrated a 
residual response to the epitope Plp11, indicating incomplete tolerance towards this 
region.  By contrast, no detectable recall response could be elicited against other 
three identified epitopes (Figure 5). Indeed, immunization of C57BL/6 mice with 
epitope Plp11 can induce EAE, consistent with this other three epitopes fail to induce 
EAE (unpublished data).  
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Figure 5. The four immunogenic regions of PLP react against CD4+ T cells in the 
context of H-2b. B6 PLPWT and B6 PLPKO mice were immunized with purified PLP protein 
and subsequently re-stimulated the primed lymph node T cells with a set of overlapping 
peptides (24 amino-acids in length) which span the whole PLP protein with a shift of 16 
amino-acid residues, revealed these four immunodominant regions. Tolerance induction to 
PLP epitope1 was very efficient, while tolerance induction to PLP epitope 11 is leaky in B6 
PLPWT mice. Figure adapted from Klein et al. 219. 
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1.5 Aim of the thesis 
 
This study was undertaken with the following objectives: 
 
1) Why tolerance induction to PLP174-181 is leaky in B6 WT mice?  
2) How do PLP174-181-reactive T cells escape thymic deletion? 
3) How is tolerance to PLP maintained in the presence of PLP174-181 specific T cells?  
4) Whether PLP174-181-specific T cells have different cell fates compared with PLP11-
18-specific T cells?  
5) What are the contributions of the individual thymic antigen presenting cell types 
to central and periphery tolerance to PLP?  
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2. Results 
 
2.1 Lack of tolerance induction to a self-antigen in the central nervous system 
 
2.1.1 Generation of a PLP174-181-specific TCR-transgenic mouse 
 
One of the dominant PLP epitopes in H-2b mice is contained within the amino acid 
sequence 174-181 of PLP. T cells recognizing this epitope are restricted to antigen 
recognition in the context of MHC class II I-Ab molecules.  Previous research has 
shown that a fraction of CD4 T cells specific for this region was not tolerized against 
PLP174-181 and induced autoimmunity upon EAE induction
219. We sought to determine 
the mechanisms of  tolerance induction towards PLP174-181, therefore, we have 
constructed a transgenic mouse expressing genes encoding a rearranged T cell 
receptor specific for PLP174-181.  
 
2.1.1.1 Production of T Cell hybridomas specific for PLP174-181 peptide 
 
In order to obtain a TCR specific for PLP174-181, we produced PLP174-181-specific T 
cell hybridomas. To do so, lymph node cells of PLPKO mice 9 days after 
immunization with the 24-mer peptide PLP160-184 in CFA were stimulated in vitro with 
PLP174-181 peptide. Subsequently, antigen-specific T cells were restimulated with 
irradiated spleen cells and antigen. After one round restimulation in vitro, T cell 
blasts were fused with BW5147 cells in order to generate T cell hybridoma. BW5147 
cells lack functional TCR-α and -β genes, and have been used to analyze the 
specificity of TCRs expressed by heterogeneous populations of T cells220. Once 
produced, the T cell hybridomas were cloned and screened for specificity and 
expression of antibody stainable TCR variable Vα and Vβ regions. The clone A43-
11-5 was chosen for the generation of the TCR transgenic mouse after being tested 
for specificity and TCR-α and -β expression.   
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2.1.1.1.1 A43-11-5 hybridoma is specific for PLP protein and PLP174-181 peptide 
 
 
 
 
Figure 6. Reactivity of A43-11-5 hybridomas against self-MHC-peptide ligands. A) IL-2 
production of A43-11-5 hybridomas (105 cells/well) was measured after 48 hours incubation 
in wells coated with PLP174-181 peptide together with splenocytes (10
6 cells/well), as described 
in Materials and Methods. A43-11-5 hybridoma responded highly to stimulation with its 
cognate antigen in a dose-dependent manner. The hybridoma cells were stimulated with 
OVA as negative control.  B) IL-2 secretion of A43-11-5 hybrid T cells were stimulated with 
PLP protein and OVA protein, respectively. The T cell hybrid responded to stimulation with 
PLP protein in correlation with the amount of protein that was given, but not to stimulation 
with OVA protein. The results are representative of at least three independent experiments. 
 
One crucial criteria for the selected T cell hybridoma clone A43-11-5 was its 
specificity for PLP174-181. To test this, we stimulated the hybridoma clone with titrated 
concentrations of PLP174-181 peptide and measured IL-2 secretion. The result in 
Figure 6A demonstrates a dose-dependent reactivity and specificity for the desired 
peptide. As expected, cells did not produce significant levels of IL-2 in response to 
stimulation with non-cognate peptide (OVA), showing its specificity to PLP174-181. 
Subsequently the A43-11-5 clone was also tested for the capacity to specificaly 
recognice PLP protein. For that bone-marrow derived dendritic cells (BmDCs) were 
pulsed with PLP protein and control OVA protein respectively and co-cultured with 
the A43-11-5 clone in vitro. Supernatants were collected 48 hours later and IL-2 
cytokine levels were measured. As shown in Figure 6B, PLP protein specifically 
induced the production of IL-2. The strength of the stimulation response correlated to 
the amount of PLP protein given to the BmDCs culture. In contrast, antigens that did 
not specifically interact with the hybridoma, such as OVA, did not induce production 
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of the IL-2. Taken together, the A43-11-5 hybridoma clone was specific to PLP 
protein as well as to the relevant PLP174-181 peptide. 
 
2.1.1.1.2 A43-11-5 hybridoma expresses TCRAV2 and TCRBV14 
 
 
 
Figure 7. Flow cytometry staining of the TCR of T cell hybridoma clone A43-11-5. A43-
11-5 clone express TCRAV2 and TCRBV14 at their surface.  
 
To be able to visualize the transgenic T cells in PLP174-181 transgenic mice, the 
transgenic TCR must be stainable by available TCR antibodies. To that end 
hybridomas were analyzed for the expression of CD4 and TCR using flow cytometry 
showing that the PLP174-181-specific A43-11-5 clone expressed both the TCRAV2- 
and TCRBV14-TCR gene segments to which specific antibodies were commercially 
available (Figure 7). A hybridoma, which did not express a known TCR at its surface, 
was used as negative control. The ability for staining both TCR variable chains via 
antibodies, facilitated to trace the fate of transgenic T cells in the TCR-PLP11 mouse 
by flow cytometry. 
 
Taken together, the T cell hybridoma clone A43-11-5 was an optimal candidate for 
the generation of the PLP174-181-specific TCR-transgenic mouse since it was highly 
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responsive and specific to the relevant PLP174-181 peptide (Figure 6), and stainable by 
available of TCR-α and-β antibodies (Figure 7). 
 
2.1.1.2 Cloning of full-length TCR pairs used by the Vα2+Vβ14+ PLP174-181-
specific T cell hybridoma  
 
 
 
Figure 8. Diagram depicting cassette vectors pTα and pTβ. pTα/pTβ cassette vectors 
contain V-region (Vα and Vβ, respectively) promoter and the complete constant-region (Cα 
and Cβ, respectively) gene sequences221. Vector sequences were removed by a combined 
XmaI and SacI restriction enzyme digest for TCRα chain and by a combined XhoI and SacII 
restriction enzyme digest for TCRβ chain. 
 
To generate a transgenic mouse line that expresses a TCR recognizing PLP174-181 
peptide in association with H-2b, genomic DNA fragments, including rearranged 
TCRVα-Jα and TCRVβ-Dβ-Jβ sequences, were obtained from A43-11-5 hybridoma 
DNA, which has TCR complexes composed of Vα14-1-201 and Jα23-201 for the α 
chain, and Vβ31-01, Dβ1-01, and Jβ1-1 for the β chain, which were annotated in 
Ensembl [www.ensembl.org]. Using primers complementary to the upstream region 
of the TCRVα14-1-201 gene segment and to the downstream UTR of the TCRJα23-
201 gene segment, the rearranged TCRVα-Jα gene segments were cloned and 
XmaI and SacI restriction sites were induced, respectively. Similarly, the TCRβ 
Chain was cloned using XhoI and SacII restriction sites, respectively. These Vα14-1-
201 and Jα23-201 and Vβ31-01, Dβ1-01, and Jβ1-1 PCR products were then 
subcloned into unique pTα and pTβ cassette expression vectors, containing V-region 
(Vα and Vβ, respectively) promoter and the complete constant-region (Cα and Cβ, 
respectively) gene sequences221, generating a pTα and pTβ DNA transgene 
expression constructs, respectively (Figure 8). The designation Vα2 and Vβ14, which 
were mentioned below, refer to the antibodies that specifically stained the 
rearranged Vα- and Vβ-regions, respectively. 
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2.1.1.3 In vitro verification of the expression and functionality of the TCR-
PLP11 cassette vectors 
 
In order to test expression and functionality of the cloned Vα2 and Vβ14 cassette 
vector respectively, the recombinant pTα-PLP11 and pTβ-PLP11 vectors were 
digested with SacI and KpnI, respectively and linearized prior to microinjection of 
TCR α and β gene constructs into fertilized eggs of C57BL/6 mice.  
 
Surface expression on 293 T cells 
 
 
 
Figure 9. 293T cells transfected with linearized pTα-PLP11 and pTβ-PLP11 vectors or 
the empty pTα/pTβ cassette vectors were stained with mAbs against TCR Vα2 and 
Vβ14. Flow cytometry showing the expression of cloned TCR on the surface of transfected 
293T cells. 
 
The linearized recombinant pTα-PLP11 and pTβ-PLP11 vectors were transiently co-
transfected at a ratio of 1:1 into 293T cells with the calcium phosphate method. Vα2 
and Vβ14 expression (54.5%) were detectable on the surface of HEK293T cells after 
transfection (Figure 9). Signals of the TCR expression was not detected on the cell 
surface of HEK293T cells transfected with empty pTα/pTβ cassette vectors.  
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Specificity 
 
To further test the functionality and specificity of the recombinant vector, A5 T-cell 
hybridomas were transduced with linearized pTα-PLP11 and pTβ-PLP11 vectors 
encoding Vα2 and Vβ14, respectively. A5 is a derivative of the T helper line 16.2, 
which is specific for a hemagglutin in peptide of influenza virus presented by class II 
I-Ed MHC molecules222. These CD4+ T cells also contained an NFAT (Nuclear Factor 
of Activated T cells) linked to green fluorescent protein (GFP) and therefore, NFAT-
activation could be determined by analyzing induction of GFP expression223.  Stable 
transfectants were selected in medium containing puromycin and were subsequently 
screened for the expression of the introduced TCR on the surface. In TCR-PLP11 
transfected A5 T cell hybridoma cells, more than 80% of cells expressed PLP174-181-
specific TCR was detected by staining with antibodies for TCR Vα2 and TCR Vβ14 
(Figure 10A). Among the Vα2+Vβ14+ cells, transfected hybridomas showed antigen-
induced NFAT activity in the presence of PLP174-181 peptide as detected by GFP 
expression (Figure 10B). Taken together, recombinant pTα-PLP11 vector and pTβ-
PLP11 vector have been tested successfully for functionality of the TCR and 
reactivity to PLP174-181. 
 
These constructs were co-microinjected into fertilized C57BL/6 eggs to generate 
TCR-PLP11 transgenic mice. Offspring were screened by PCR and transgenic 
offspring was crossed to PLPKO mice to generate TCR-PLP11 PLPKO mice. 
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Figure 10. Flow-cytometric analysis of PLP174-181-specific TCR expression and GFP 
expression in A5 cells by electroporation with linearized pTα-PLP11 and pTβ-PLP11 
vectors. The transfected A5 cells were stimulated with non-cognate peptide used as 
negative control. A) TCR-PLP11 transfected A5 cells showed expression of the PLP174-181-
specific TCR (Vα2+ and Vβ14+) on the cell surface. B) When TCR-PLP11 transfected A5 
cells were stimulated with PLP174-181, leading to activation of the hybridoma cells, this is 
translated into an NAFT driven GFP expression. The transfected A5 cells did not respond to 
non-cognate peptide (OVA), confirming the functionality and specificity of the pTα-PLP11 
and pTβ-PLP11 cassette vectors. 
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2.1.2 Analysis of T cell subsets in TCR-PLP11 mice 
 
We studied the thymocyte cellularity and the developmental cell subsets from TCR-
PLP11 Tg mice to determine whether thymic clonal deletion participated to PLP 
tolerance. Central tolerance eliminates thymocytes that recognize self-peptide: MHC 
avidly. Thymic cellularity of TCR-PLP11 PLPWT thymus was 161 × 106 cells, on 
average, which was comparable to that of TCR-PLP11 PLPKO thymus (126 × 106) 
(Figure 11A). Morover, the percentage of single positive CD4+ thymocytes (30%, on 
average) was similar in the presence and absence of cognate antigen. The 
frequency and number of cells in each thymic developmental subset (DN, DP, 
CD8SP, CD4SP) were undistinguishable in TCR-PLP11 Tg mice (Figure 11B).  
 
Furthermore, CD4SP thymocytes in both groups equally expressed the transgenic 
TCR (Figure 11C). Within the transgenic CD4SP population no difference was 
observed with respect to the maturation stage of those cells in PLPWT and PLPKO. 
(Figure 11D).  Thus, despite the expression of the PLP self-antigen in the thymus, 
there was no evidence for intrathymic deletion or modulation of TCR expression of 
PLP-specific CD4+ T cells in TCR-PLP11 PLPWT mice. We also examined the 
development of TCR-PLP11 Tg Foxp3+ regulatory T cells, however also this subset 
was not affected by the presence of PLP in the thymus. Thus no Plp11-specific Treg 
cells were induced in PLPWT mice.  
 
Taken together, by comparing T cell development of TCR-PLP11 Tg mice in the 
presence and absence of the cognate self-antigen PLP, we can conclude that there 
is no central tolerance induction to PLP in TCR-PLP11 mice. 
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Figure 11. Flow cytometry analysis of the thymocytes of TCR-PLP11 PLPWT and 
TCRPLP11 PLPKO mice.  A and B) The absolute numbers of the total thymus (A) and the 
absolute number of double negative (DN), double positive (DP), CD4 single positive (SP), 
CD8 single positive (SP) in TCR-PLP11 PLPWT and TCR-PLP11 PLPKO mice at 3 weeks with 
the standard error of the mean (SEM). A) No difference was observed in total thymic 
cellularity in TCR-PLP11 PLPKO and TCR-PLP11 PLPWT mice. (B) Absolute cell number of 
thymocytes in the respective compartment of T cell development: DN, DP, CD8SP and 
CD4SP cells were also demonstrated no difference. C and D) Thymocytes were enumerated 
and analyzed by flow cytometry. The percentage of thymocytes in each subset is indicated 
for each quadrant (C) and in absolute cell numbers (D). Anti-CD4 and CD8 staining of 
thymocytes (first column), level of expression of the TCR Vα2Vβ14 on CD4SP cells (second 
column), Foxp3+ Tregs in the TCR-PLP11+ cell population (third column) and mature cells 
within the TCR-PLP1+ cell population in the thymus (fourth column). It indicated that 
absence of thymic deletion in TCR-PLP11 PLPWT mice.  
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Figure 12. Flow cytometry analysis of peripheral phenotype in PLP-TCR11 transgenic 
mice. Anti-CD4 and CD8 staining of splenocytes (first column) from TCR-PLP11 PLPKO 
(n=8) and TCR-PLP11 PLPWT mice (n=8), level of expression of TCR Vα2Vβ14 on CD4+ T 
cells (second column), Foxp3+ Tregs in the TCR-PLP11+ cell population (third column), and 
CD62L-CD44hi antigen experienced T cells in the TCR-PLP11+ cell population (fourth 
column). It indicated that no deletion of PLP-specific T cells in TCR-PLP11 PLPWT mice.  
The numbers above the gates represent the mean average ± the standard error of the mean 
(SEM).  
 
In the periphery, presentation of autoantigen can lead to the deletion of autoreactive 
T cells224, 225. We thus analyzed the frequency and number of CD4+ subset in spleen 
of TCR-PLP11 Tg mice. Our results showed that the proportion, as well as the 
absolute number of CD4+ T lymphocytes present in peripheral lymphoid organs is 
not different between TCR-PLP11 PLPWT and TCR-PLP11 PLPKO mice, and that 
these cells express similar levels (83.0 ± 1.8% vs 80.5 ± 2.7%) of the transgenic 
TCR (Figure 12). Again, a very small population of Plp11-specific Tregs were 
detectable in the periphery of TCR-PLP11 Tg PLPWT and PLPKO mice. Moreover, 
CD4+ TCR-PLP11+ T cells appeared naïve, as they displayed mainly a 
CD62LhighCD44low phenotype (Figure 12).  Therefore, there is no deletion of PLP-
specific T cells in TCR-PLP11 mice, and central or peripheral deletion is not the main 
tolerance mechanism operating in TCR-PLP11 Tg mice. 
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2.1.3 Transgenic T Cells from TCR-PLP11 Tg mice proliferate in response to 
PLP174-181 
 
Figure 13. Proliferation of Plp11-specific T cells in response to PLP174-181. Plp11-specific 
T cells were established from TCR-PLP11 Tg mice and cultured with spleen cells with 
PLP174-181 with different concentration for 48 hours, and 
3H thymidine uptake was measured 
over an additional 16 hours.  
 
To determine whether Plp11-specific T cells can recognize naturally processed PLP 
peptides, as well as exogenously added PLP174-181 in the context of I-A
b, splenocytes 
from TCR-PLP11 PLPWT mice and TCR-PLP11 PLPKO mice were cultured with 
PLP174-181 peptide. Splenocytes isolated from TCR-PLP11 mice proliferated in 
response PLP174-181. Dose response proliferation assays revealed no difference in 
the dose-response curve of TCR-PLP11 PLPWT mice and TCR-PLP11 PLPKO mice 
resepectively (Figure 13). Our results indicated that Plp11-specific CD4+ T cells were 
functional in response to the cognate antigen in vitro.  
 
 
 
 
 
 
 
 
Results 
	   	   	  40	  
2.1.4 Plp11-specific T cells can proliferate specifically in vivo 
 
Because Plp11-specific T cells are not deleted, we speculated that one possible 
mechanism of tolerance in our mouse model was ignorance, defined by the non-
detection of Ag by the immune system. We thus investigated whether the specific 
PLP174-181 peptide was readily available for TCR recognition in the periphery. To this 
end, we performed adoptive transfer of purified CFSE-labeled CD4+ T cells from 
TCR-PLP11 PLPWT mice or TCR-PLP11 PLPKO mice into congenic B6 PLPWT mice. 
CD4+TCR-PLP11+ cells were analyzed four days later for proliferation by flow 
cytometry. We did not observe any T cell proliferation after transfer into B6 PLPWT 
recipients (Figure 14A), no matter whether the T cells came from TCR-PLP11 PLPWT 
or TCR-PLP11 PLPKO background.  
 
Next, we want to know whether the cells are at all capable of proliferation and not 
affected by the CFSE labeling procedure. So we immunize the recipient mice with 
PLP174-181 peptide in CFA. The lymphocytes from the immunized recipient mice 
proliferate specifically as early as two days after immunization (Figure 14B and 14C). 
At day 1, Plp11-specific T cells remained undivided; the first cell divisions occurred 
at day 2, at day 3, a marked T cells division was observed and continued to day 4. 
This indicated that the T cells from TCR-PLP11 mice proliferate specifically in vivo. 
These results suggest that the PLP-specific T cells in TCR-PLP11 Tg mice remained 
ignorant either as a consequence of low TCR affinity and/or low levels of I-Ab: 
PLP174-181 complex expression on APCs failed to reach the threshold of T-cell 
stimulation. 
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Figure 14. Tracking Plp11-specific T cell division using CFSE. (A) CD4+ Plp11-specific 
cells were labelled with CFSE and then 5 × 106 cells were adoptively transferred i.v. into 
congenic B6 mouse. Three days later, various lymph nodes were harvested and analyzed by 
flow cytometry. Histograms are gated on CD4+TCR-PLP11+CFSE+ cells. (B) PLP11-specific 
T cells proliferate in the draining lymph nodes of B6 mice immunized with PLP174-181. CD4
+ 
Plp11-specific T cells were labeled with CFSE and then 5 × 106 cells were adoptively 
transferred i.v.into congenic B6 mice.  Before transferred the cells, mice were immunized 
with 50ug PLP174-181 via the footpad for 1, 2, 3, 4 d before being harvested inguinal lymph 
nodes and analyzed by flow cytometry. Histograms are gated on CD4+TCR-PLP11+CFSE+ 
cells. Results are representative of three experiments with five mice per groups. (C) The 
proportion of cells in each division cycle that were CD4+TCR-PLP11+ CFSE+ cells at each 
time point.  
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2.1.5 TCR-PLP11 mice are susceptible to EAE 
 
 
Figure 15. EAE induction in TCR-PLP11 transgenic mice. (A) TCR-PLP11 PLPWT mice 
and TCR-PLP11 PLPKO mice littermates were immunized with PLP174-181 in CFA plus 
pertussis toxin and observed for the development of EAE over time. The data are shown as 
the Mean ± SEM of five independent experiments. (B) TCR-PLP11 mice are susceptible to 
EAE and also accompanied by an impressive loss in body weight. 
 
Experimental autoimmune encephalomyelitis (EAE) is a well-characterized murine 
model of multiple sclerosis (MS) that is extensively used to understand the role of 
specific molecules and cell subsets the disease pathology of MS. We determined 
whether EAE could be induced in the TCR-PLP11 Tg mice by the standard 
immunization protocol that comprises the immunization with PLP174-181 peptide in 
CFA and additionally injection of two doses of pertussis toxin at days 0 and 2. The 
severity and incidence of disease were monitored. TCR-PLP11 PLPWT mice and 
TCR-PLP11 PLPKO mice were mixed littermates that were clinically scored without 
prior knowledge of their genotype. PLP-immunized TCR-PLP11 PLPWT mice 
developed EAE in which first symptoms of disease were observed around day 8 
post-immunization. At the peak of the disease, at day 13, the TCR-PLP11 PLPWT 
mice displayed most severe symptoms. The clinical data from more than 5 weeks of 
observation of five independent experiments (Figure 15) indicated that immunization 
of TCR-PLP11 mice with PLP11 can induces EAE and also accompanied by an 
impressive loss in body weight only in TCR-PLP11 PLPWT mice. A total of five 
independent experiments confirmed comparable days of onset, maximal clinical 
scores and 100 % incidence in TCR-PLP11 PLPWT after immunization with specific 
peptide. Of note, TCR-PLP11 PLPKO mice also showed light symptoms of EAE, 
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which might be a result of the immunization procedure is the background of 
immunization. These results indicate that TCR-PLP11 mice are susceptible to EAE.  
 
2.1.6 TCR-PLP11 mice lacking endogenous TCR α and β chains develop EAE 
spontaneously 
 
Figure 16. Spontaneous EAE was observed in TCR-PLP11 PLPWTRAGKO mice with 
100% incidence (n=18). Age-matched TCR-PLP11 PLPKORAGKO (n=20), TCR-PLP11 
PLPWT (n=50) and TCR-PLP11 PLPKO (n=50) were free of clinical disease during the same 
observation period. Data indicate the percentage of mice that developed EAE within each 
group.   
 
Despite the lack of tolerance towards PLP, the vast majority of TCR-PLP11 mice 
never developed EAE spontaneously. To eliminate the effect of endogenous TCR 
rearrangements on thymic and peripheral development of Plp11-specific CD4+ T 
cells, the TCR-PLP11 mice were crossed with RAGKO mice. Surprisingly, 100% of 
TCR-PLP11 PLPWTRAGKO mice developed EAE spontaneously. The disease onset 
was accelerated, with approximately 23% of the TCR-PLP11 PLPWTRAGKO mice first 
exhibiting symptoms of EAE by the age of 40 days, and the disease often remained 
stable. All mice developed EAE by 80 days of age (Figure 16). In contrast, TCR-
PLP11 PLPKORAGKO, TCR-PLP11 PLPWT and TCR-PLP11 PLPKO remained disease-
free during 6-month observation period under the same conditions. These data 
suggest that TCR-PLP11 PLPWT mice lacking endogenous TCR α and β chains 
develop EAE spontaneously. 
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2.1.7 Rag1-deficient TCR-PLP11 mice do not express Foxp3 
 
 
Figure 17. Analysis of thymic Foxp3+ regulatory T cells in TCR-PLP11 and Rag1-
deficient TCR-PLP11 mice. (A) Foxp3 analysis was gated on CD4+CD8- cells. The 
numbers above the gates represent the mean average ± the standard error of the mean 
(SEM). (B) The percentage of Foxp3+ Tregs (first column) and absolute cell numbers 
(second column) in CD4SP cells in the thymus of TCR-PLP11 and Rag1-deficient TCR-
PLP11 mice. Results are representative of three independent experiments with five mice per 
groups. 
 
Rag1 deficient TCR-PLP11 mice display a monoclonal Plp11-specific CD4+ T cell 
repertoire in both TCR-PLP11 PLPWTRAGKO and TCR-PLP11 PLPKORAGKO mice 
(data not shown). It has been known that TCR-PLP11 healthy mice harbor non-
tolerant autoreactive CD4+ T cells, these cells might be kept under control by one, or 
a combination of tolerance mechanisms. Therefore, we measured the presence of 
Foxp3+ regulatory T cells in the thymus, which might be more effective at controlling 
self-reactive cells and hence prevent autoimmunity. When we analyzed the 
frequency as well as the absolute number of CD25+Foxp3+ thymocytes within CD4+ 
T cells, thymocytes from Rag1-deficient TCR-PLP11 mice produced virtually no 
Foxp3+ T cells.  In contrast, a clearly expression of Foxp3 was detectable in 3-week-
old TCR-PLP11 PLPWT and TCR-PLP11 PLPKO mice (1.3 ± 0.1% vs 0.9 ± 0.02%) 
within CD4+ compartment, this population was comparable and independent on the 
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expression of PLP in the thymus (Figure 17A and 17B). Taken together, no Foxp3+ T 
cells are generated in Rag1-deficient TCR-PLP11 mice. 
 
2.1.8 Foxp3+ T cells presence in CD4+ T cells expressing TCR encoded by the 
endogenous TCR loci  
 
Since TCR-PLP11 mice and TCR-PLP11 mice on Rag1-deficient mice differ only in 
their capacity to express endogenous TCR chains, which lead to the differences in 
EAE susceptibility. In Rag1-sufficient TCR-PLP11 mice, approximately 90% of CD4+ 
T cells express the Plp11-specific TCR, the remaining 10% of CD4+ T cells express 
endogenous TCR-α or –β genes (Figure 11 and Figure 18). When we analyzed TCR 
expression within CD4+ compartment in TCR-PLP11 PLPWT and TCR-PLP11 PLPKO 
mice, we observed the dominant Vβ14 together with three populations of Vα2: 
Vα2high cells that express exclusively the transgene-encoded Plp11-specific TCR; 
Vα2intermediate cells that express two α chains, one is transgene-encoded α chain and 
the other is encoded by the endogenous TCR loci; Vα2low cells that express TCR-α 
chain encoded by endogenous loci. To correlate the EAE susceptibility with the T cell 
repertoire, we stained Foxp3 of the three Vα2 populations. We observed a high 
frequency of Foxp3+ T cells among Vα2intermediate and Vα2low populations both in TCR-
PLP11 PLPWT and TCR-PLP11 PLPKO mice. However, in Vα2high cells, the frequency 
of Foxp3+ T cells is remarkably low compared with WT mice (Figure 18). These data 
further suggest that CD4+ T cells expressing TCR encoded by the endogenous TCR 
loci have a protect TCR-PLP11 mice from spontaneous EAE.  
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Figure 18. Foxp3 analysis of thymocytes of TCR-PLP11 Tg mice expressing different 
levels of Vα2. The numbers above the gates represent the mean average ± the standard 
error of the mean (SEM).  
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2.2 Mechanisms of central and peripheral T cell tolerance to an antigen of the 
central nervous system 
 
2.2.1 Thymic development of PLP11-18-specific T cells in TCR-PLP1 mice 
 
Previous work performed by Klein et al. using a set of overlapping 24-mer peptides 
subsequent to immunization of PLPKO mice with purified PLP protein, revealed four 
immunogenic MHCII-PLP epitopes219. Among these four regions, PLP11-18 yielded a 
strong recall response in PLPKO mice, whereas no response in PLPWT, indicating a 
tightly controlled tolerance towards this region. We want to understand the tolerance 
mechanism to PLP11-18. For this reason, a TCR Tg mouse model specific for PLP1 
was generated in our lab (Winnewisser J., PhD thesis). Briefly, a CD4 PLP11-18-
specific T cell clone (D9-11-9) was derived from B6 PLPKO mice upon immunization 
with PLP. The D9-11-9 clone expressed a TCR composed of Vα3.2 and Vβ6. The 
rearranged TCRα and TCRβ chain DNA segments were subcloned into the cassette 
vectors pTα and pTβ221, respectively and injected into B6 oocytes (H-2b) to generate 
TCR-PLP1 TCR transgenic mice.  
 
Age-matched TCR-PLP1 PLPKO thymocytes were analyzed in parallel. The thymic 
expression of PLP in TCR-PLP1 PLPWT had little effect on the percentage of DN and 
DP thymocytes, but the proportions of CD4SP cells (4.0 ± 0.4%) were significantly 
reduced in TCR-PLP1 PLPWT mice compared with TCR-PLP1 PLPKO mice (16.9 ± 
1.9%) in Figure 19. This profile indicated the presence of negative selection of 
thymocytes expressing TCR-PLP1 within the thymus in PLPWT mice. We then 
compared the abundance of transgenic TCRα and TCRβ chain expressing CD4 T 
cells between TCR-PLP1 PLPWT and TCR-PLP1 PLPKO mice. Staining with anti-
Vα3.2 and anti-Vβ6 demonstrated that 85.5 ± 3.2% of the CD4SP cells of TCR-PLP1 
PLPKO mice were found to express PLP1-speicifc T cell receptor, compared with a 
reduction of Plp1-specific CD4+ T cells in TCR-PLP1 PLPWT mice (51.1 ± 4.1%) 
(Winnewisser J., PhD thesis).  
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Figure 19. Flow cytometry analysis of the thymocytes of TCR-PLP1 PLPWT and TCR-
PLP1 PLPKO mice. Thymocytes were enumerated and analyzed by flow cytometry. Anti-
CD4 and CD8 staining of thymocytes (first column), level of expression of the TCR 
Vα3.2Vβ6 on CD4SP cells (second column), Foxp3+ Tregs in the TCR-PLP1+ cell population 
(third column) and mature cells within the TCR-PLP1+ cell population in the thymus (fourth 
column). The numbers above the gates represent the mean average ± the standard error of 
the mean (SEM). TCR-PLP1 PLPWT: n=10; TCR-PLP1 PLPKO: n=8. 
 
Previous work showed that negative selection is linked clonal deletion of 
autoreactive thymocytes with thymus-derived regulatory T cells (Tregs)231. Tregs 
expressing Foxp3 and high levels of CD25 are required for controlling immune 
responses by inhibiting the activation of effector T cells. Furthermore, Tregs 
development in the thymus seem to depend on the presence of self-antigen 
recognition, When we analyzed the induction of regulatory T cells in thymi, while in 
TCR-PLP1 PLPKO mice only a small fraction of TCR-PLP1+ T cells was deviated into 
Foxp3+ Treg cells (0.4 ± 0.1%), in TCR-PLP1 PLPWT mice was 10-times higher (4.1 
± 0.6%) (Figure 19) (Winnewisser J., PhD thesis). Taken together, deletion of TCR-
PLP1+ CD4+ T cells and selection of T regulatory cells both operate for this important 
self-antigen PLP in central tolerance. 
 
 
 
 
 
Results 
	   	   	  49	  
2.2.2 Contribution of thymic antigen presenting cells to tolerance induction to 
PLP 
 
Presentation of self-antigens by thymic APCs result in different cell fates of the 
autoreactive T cells through positive selection74, negative selection141 and induction 
of Tregs149. The role of thymic APCs in mediating tolerance has been studied 
showing both specialized and overlapping functions among them117, 232, 233. Central 
tolerance to PLP is operated by two mouse models (TCR-PLP1 x Foxn1-Cre x 
PLPfl/fl  mice and TCR-PLP1 PLPWT ΔDC mice), which have been recently shown by 
us (Winnewisser J., PhD thesis). 
 
2.2.2.1 Expression and presentation of PLP by mTEC is sufficient to mediate 
negative selection and concomitant Treg induction 
 
Firstly, we investigated that whether PLP expression and presentation in 
radioresistant cells are sufficient and necessary to induce tolerance. We crossed 
TCR-PLP1 Tg mice to Foxn1-Cre x PLPfl/fl mice (hereafter called TCR-PLP1 
PLPΔTEC mice). The resulting Foxn1-Cre x PLPfl/fl mice ablated PLP expression 
only in TEC. Our study demonstrated that PLP expression by TECs is essential and 
sufficient for negative selection and concomitant Treg induction in the thymus (Figure 
20).  
 
2.2.2.2 Thymic Dendritic cells do not present PLP for tolerance induction  
 
It has been demonstrated that thymic DCs are very efficient in mediating negative 
selection of developing thymocytes106, 234-236. To study DCs contribution to T cell 
homeostasis and maintenance of tolerance, we crossed TCR-PLP1 Tg mice to ΔDC 
mice. The loss of DCs in TCR-PLP1 Tg mice does not exhibit defective negative 
selection (Figure 21).  It indicated that hematopoietic antigen presenting cells such 
as medullary DCs which cross-present mTEC-derived antigens, do not contribute 
negative selection in our experiment system. 
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Figure 20. Deletion of PLP expression exclusively in TECs abrogated central tolerance 
to PLP. CD4 T-cell development in 3-week-old TCR-PLP1 PLPWT mice, TCRPLP1 PLPKO 
mice and TCR-PLP1 PLPΔTEC mice. The plots depict that the average percentage ± the 
standard error of the mean (SEM) of CD4SP profiles (first column), level of expression of the 
TCR Vα3.2Vβ6 among CD4SP cells (second column) and the percentage of Foxp3+ Tregs in 
the TCR-PLP1+ cell population (third column). TCR-PLP1 PLPWT: n=10; TCR-PLP1 PLPKO: 
n=8; TCR-PLP1 PLPΔTEC: n=2. 
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Figure 21. Central tolerance to PLP is not dependent on DCs. CD4 T cell development in 
3-week-old TCR-PLP1 PLPWT mice, TCR-PLP1 PLPKO mice and TCR-PLP1 PLPWTΔDC 
mice. The plots depict that the average percentage ± the standard error of the mean (SEM) 
of CD4SP profiles (first column), level of expression of the TCR Vα3.2Vβ6 among CD4SP 
cells (second column) and the percentage of Foxp3+ Tregs in the TCR-PLP1+ cell population 
(third column). TCR-PLP1 PLPWT: n=10; TCR-PLP1 PLPKO: n=8; TCR-PLP1 PLPWTΔDC: 
n=6. 
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2.2.3 Peripheral tolerance to PLP carried out by deletion 
 
In accordance with thymic characteristics, splenic profiles demonstrated that 
proportions of CD4+ T cells were significantly lower in TCR-PLP1 PLPWT mice (1.2 ± 
0.2%) than those of TCR-PLP1 PLPKO mice (5.8 ± 1.3%). Regulatory T cells are 
required for maintaining peripheral tolerance to self-antigen by inhibiting the 
activation of effector T cells. Therefore, we also examined the frequency of Foxp3+ 
Treg cells in the TCR-PLP1 Tg mice. Notably, TCR-PLP1+ Foxp3+ T cells were 
significantly enhanced in the spleen of TCR-PLP1 PLPWT mice (38.4 ± 1.7%) when 
compared to the low percentage of TCR-PLP1+ Foxp3+ Treg cells in TCR-PLP1 
PLPKO mice (1.2 ± 0.3%) (Figure 22).  Taken together, in the periphery we observed 
pronounced reduction of TCR-PLP1+ T cells and increased frequencies of Tregs in 
the presence of the cognate self-antigen PLP.  
 
In order to assess contribution of the periphery to tolerance to PLP we abrogated 
central tolerance by using TCR-PLP1 PLPΔTEC. In this mouse model we 
previousely showed that in the absence of PLP in thymic epithelium central tolerance 
was eliminated. When the splenic profiles of the TCR-PLP1 PLPΔTEC mice were 
compared with TCR-PLP1 PLPKO mice, the proportions of CD4＋ cells (1.9 ± 0.3%) 
were obviously reduced in the spleen of TCR-PLP1 PLPΔTEC mice (Figure 22), 
indicating the deletion of autoreactive T cells of the spleen when PLP expression 
was ablated in TEC. In addition, while in TCR-PLP1 PLPWT mice a large proportion of 
Tregs was present (38.4 ± 1.7%), in TCR-PLP1 PLPΔTEC mice, this population was 
not observed (2.5 ± 1.1%), and had a similar size as in the complete absence of PLP 
in PLPKO mice.  
 
To study DCs contribution to peripheral tolerance, we analyzed the splenocytes in 
TCR-PLP1 PLPWTΔDC. The numbers of splenocytes as well as the percentage of 
CD4＋ T cells in TCR-PLP1 PLPWTΔDC mice were reduced (0.8 ± 0.1%), which is 
similar compared with DC-sufficient TCR-PLP1 PLPWT littermates (1.2 ± 0.2%). 
Furthermore, the induction of TCR-PLP1+ Foxp3+ regulatory T cells were 
comparable between TCR-PLP1 PLPWTΔDC (43.3 ± 2.1%) and TCR-PLP1 PLPWT 
mice (38.4 ± 1.7%) (Figure 22). 
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Altogether, peripheral deletion in response to PLP is one mechanism by which the 
immune system could eliminate PLP-specific T cells that escape thymic deletion.   
 
 
 
Figure 22. Flow cytometry analysis of peripheral phenotype in TCR-PLP1 Tg mice. 
Anti-CD4 and CD8 staining of splenocytes (first column) from TCR-PLP1 PLPKO (n=8), TCR-
PLP1 PLPWT mice (n=10), TCR-PLP1 PLPΔTEC mice (n=2) and TCR-PLP1 PLPWTΔDC 
mice (n=6) level of expression of the TCR Vα3.2Vβ6 on CD4+ cells (middle column), Foxp3+ 
Tregs in the TCR-PLP1+ cell population (third column). The numbers above the gates 
represent the mean average ± the standard error of the mean (SEM).  
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2.2.4 ICOS and FR4 are highly expressed on TCR-PLP1 anergic CD4+ T cells 
 
 
 
Figure 23. Flow cytometric analysis of ICOS and FR4 expression among CD4+TCR-
PLP1+Foxp3- T cells in TCR-PLP1 PLPWT (red line histogram), TCR-PLP1 PLPKO mice 
(green line histogram) and TCR-PLP1 PLPΔTEC mice (blue line histogram). Data is 
representative of results obtained from six indicated mice analyzed in two independent 
experiments.  
 
 
Albeit central and peripheral deletion of PLP reactive CD4+ T cells takes place, there 
is still a large proportion of autoreactive T cells that seem to escape tolerance 
induction. Despite this fact, surprisingly, the mice do not develop CNS autoimmune 
disease. We wondered whether additional mechanisms are required to silence self-
reactive periphery T cells, such as anergy induction. T cell anergy is defined as a 
defect in TCR-dependent proliferation in response to challenge with antigen237. First 
of all, we examined phenotypic characteristics of this escapee population. FACS 
cytometric analysis of surface inducible costimulator (ICOS) and Folate receptor 4 
(FR4), two novel anergy marker238, 239, expression among CD4+TCR-PLP1+Foxp3- T 
cells was performed. As you seen in Figure 23, while low levels of ICOS and FR4 
showed low expression in TCR-PLP1 PLPKO mice (green line histogram) compared 
with high expression on CD4+TCR-PLP1+Foxp3- T cells both in TCR-PLP1 PLPWT 
(red line histogram) and TCR-PLP1 PLPΔTEC mice (blue line histogram). 
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2.2.5 Anergy is another mechanism of periphery tolerance to PLP 
 
 
 
Figure 24. CFSE-labeling CD4+TCR-PLP1+Foxp3- T cells from different mouse strains 
for in vivo monitoring of adoptively transferred cells. 5 x 106 of CD4+TCR-PLP1+Foxp3- 
T cells were sorted and labeled with 0.5 µM CFSE and adoptively transferred into C57BL/6 
recipient. Three days later, splenocytes and lymph node cells were analyzed for cell division. 
Significant proliferation was observed when the cells come from TCR-PLP1 PLPKO mice 
measured as decreasing flurosence of CFSE (green histogram), or undivided cells with a 
single, bright CFSE peak were seen both in TCR-PLP1 PLPWT mice (red histogram) and 
TCR-PLP1 PLPΔTEC mice (blue histogram). 
 
Next, we performed functional analysis to directly compare CD4+TCR-PLP1+Foxp3- 
T cells among different mouse strain. To do so, congenically marked CD4+ TCR-
PLP1+ T cells were depleted from Foxp3+ Treg cells, labeled with CFSE and 
transferred into PLPWT mice (5 x 106 cells/recipient) that express PLP in the 
periphery. Proliferation of CD4+TCR-PLP1+Foxp3- T cells was examined by CFSE 
dilution 3 days later. In case of TCR-PLP1 PLPKO mice, when naïve CD4+ T cells 
were transferred into PLPWT recipient, CD4+TCR-PLP1+ T cells readily recognized 
PLP-MHC complexes and proliferated, so the first conclusion would be the PLP 
epitope was expressed and presented in the periphery. The second conclusion 
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would be the Plp1-specific T cells proliferate specifically and heavily (90.2 ± 5%). In 
marked contrast, if we took the cells from TCR-PLP1 PLPWT mice, TCR-PLP1 PLPWT 
T cells had a strongly impaired proliferative capacity (25.7 ± 12%) even when 
antigen was obviously presented in the periphery of the host (Figure 24). We 
concluded that clonal anergy was induced in the periphery of our model system. 
Similarly, when the CD4+TCR-PLP1+ T cells were taken from TCR-PLP1 PLPΔTEC 
mice, where PLP was presented in the periphery, but self-antigen PLP was ablated 
in the thymus, the proliferation response of CFSE-labeled CD4+TCR-PLP1+Foxp3- T 
cells to PLP was significantly reduced (29.2 ± 11%), meaning the CD4+ T cells are 
anergic from TCR-PLP1 PLPΔTEC mice (Figure 24).  
 
These results indicated that escaping CD4+TCR-PLP1+ T cells from both TCR-PLP1 
PLPWT and TCR-PLP1 PLPΔTEC mice are anergic, demonstrated that anergy is yet 
another mechanism of periphery tolerance to PLP in our model system. 
 
2.2.6 The presence of TCR-PLP1 PLPWT+ T cells did not hinder TCR-PLP1 
PLPKO+  T cells to proliferate 
 
In addition to thymus-derived regulatory T cells (nTreg), induced regulatory T cells 
(iTreg) are generated from conventional CD4+ T cells in the periphery. Both of them 
have the potential to suppress a variety of immune response in the periphery in vitro 
and in vivo240. To exclude the possibility that the impaired proliferative response of 
TCR-PLP1 PLPWT T cells was dampened by residual PLP-specific Treg cells, 
CD4+Foxp3- T cells from CD45.1+/CD45.2+ TCR-PLP1 PLPKO was mixed with 
CD4+Foxp3- T cells from CD45.2+ homozygote TCR-PLP1 PLPWT at a 1:1 ratio, 
using CFSE-labeled before transfer into CD45.1+ homozygote WT mice. Three days 
after transfer, CFSE profiles and percentages of donor-derived CD4+TCR-PLP1+ 
cells were determined in recipient mice. As shown in Figure 25, TCR-PLP1 PLPWT + 
T cells still did not proliferate in WT host. In contrast, TCR-PLP1 PLPKO+ T cells 
proliferated vigorously in the presence of PLP in the periphery (Figure 25). Therefore, 
the presence of TCR-PLP1 PLPWT+ T cells did not hinder TCR-PLP1 PLPKO+ T cells 
to proliferate. Thus, these results exclude the possible inhibition of residual PLP-
specific Treg cells, which might be lead to unresponsive of peripheral TCR-PLP1 
PLPWT+ T cells.   
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Taking these observations together, T cells from TCR-PLP1 PLPWT mice displayed 
an anergic phenotype. Moreover, TCR-PLP1 PLPWT and TCR-PLP1 PLPKO PLP-
specific T cells were functional different with respect to their proliferative capacities. 
 
 
 
Figure 25. Co-transfer of CFSE-labeling CD4+TCR-PLP1+Foxp3- T cells from TCR-PLP1 
PLPWT and TCR-PLP1 PLPKO into WT recipient for monitoring of adoptively transferred 
cells. Three days later after co-transfer, splenocytes and lymph node cells were analyzed 
for cell division. Significant proliferation was observed when the cells come from TCR-PLP1 
PLPKO mice measured as decreasing flurosence of CFSE (green histogram) and undivided 
cells with a single, bright CFSE peak were seen in TCR-PLP1 PLPWT mice (red histogram). 
 
2.2.7 PLP expression by radioresistant cells in the periphery, but to be 
presented by hematopietic cells 
 
In order to determine the source of PLP as well as the type of APC that presents 
PLP in the periphery, we compared PLP stimulated proliferation in various bm 
restonstitution experiments. We reconstituted WT or PLPKO mice with 
MHCIIWTPLPWT or MHCIIKOPLPWT BM and afterwards adoptively transfered 
congenically marked CD4+ TCR-PLP1+ Foxp3- T cells population from TCR-PLP1 
PLPKO mice. In our bone marrow chimera setting, TCR-PLP1 PLPKO+ T cells 
proliferated when transferred into WT mice with MHCII expression (MHCIIWTPLPWT 
→ PLPWT, 70.9 ± 4.2%, Figure 26, first column). In the situation where hematopoietic 
cells were PLPWT and MHCII-sufficient but PLP-deficient in radioresistant cells, those 
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TCR-PLP1 PLPKO+ T cells did not proliferate (MHCIIWTPLPWT → PLPKO, 4.8 ± 1.1%, 
Figure 26, second column). This indicated that in the periphery, PLP was not 
expressed by BM-derived APCs but instead only by radioresistant cells. This is in 
agreement with our observation that in the thymus PLP expression by mTECs alone 
mattered. Importantly, TCR-PLP1 PLPKO+ T cells exposed to PLP environment after 
reconstitution of the WT mice with MHC-deficient BM showed poorly proliferation 
(MHCIIKOPLPWT → WT, 4 ± 1.7%, Figure 26, third column). As negative control 
setting, TCR-PLP1 PLPKO+ T cells did not proliferate in PLPKO mice reconstituted with 
MHCIIKOPLPKO BM (MHCIIKOPLPKO → PLPKO, 4.3 ± 1.2%, Figure 26, fourth column). 
Thus, this result confirmed that PLP was presented by hematopoietic cells to 
autoreactive TCR-PLP1+ T cells in the periphery. In summary, although these APCs 
of hematopoietic origin were not responsible for expressing PLP, they are crucial for 
mediating efficient MHC II-restricted PLP presentation to TCR-PLP1+ T cells. Once 
the antigen-presentation capacity of haematopoietic APCs was impaired due to MHC 
deficiency, TCR-PLP+ T cells did not proliferate. 
 
 
 
Figure 26. PLP expression by radioresistant cells in the periphery, but to be presented 
by hematopietic cells. Chimeric mice were generated by reconstituting WT or PLPKO host 
mice with MHCIIWTPLPWT or MHCIIKOPLPWT bone marrow. FACS analysis of TCR-PLP1+ T 
cells labeled with CFSE which were transferred to the indicated chimeric mice. TCR-PLP1+ T 
cells were stained for the expression of CD4, CD8, Vα3.2 and Vβ6. CFSE dilution was 
assessed within CD4+TCR-PLP1+ population three days later in the lymph node of chimeric 
mice. Histograms show the mean ± SEM for each group. 
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2.2.8 DCs are necessary for PLP presentation and anergy induction 
 
To identify the haematopoiectic APC that is necessary for PLP presentation we first 
elucidated the role of DCs. To that end, we transferred CFSE-labeled CD45.1+ 
PLP11-18-specific naïve CD4
+ T cells from TCR-PLP1 PLPKO mice into CD45.2+ WT 
or ΔDC mice and analyzed their proliferation. ΔDC mice lacking DC would be a 
useful tool to determine the role of DC in T cell priming in vivo and tolerance 
establishment. We demonstrated that Plp1-specific CD4+ T cells proliferated when 
injected into WT recipient (Figure 27A), however, when the CD4+ T cells were 
injected into a DC free environment, little proliferation was observed in the 
CD4+TCR-PLP1+ T cells (27.4 ± 2.7%), which confirmed that PLP is really presented 
by DCs (Figure 27B). The conclusion is peptide presentation by DCs is necessary for 
CD4+ T cells proliferation in TCR-PLP1 Tg mice.  
 
 
 
Figure 27. CFSE-labeling CD4+TCR-PLP1+Foxp3- T cells from different mouse strains 
for in vivo monitoring of adoptively transferred cells. 5 x 106 of CD4+TCR-PLP1+Foxp3- 
T cells were sorted from TCR-PLP1 PLPKO mice and labeled with CFSE and adoptively 
transferred into either WT recipient (A) or ΔDC recipient (B). CD4+TCR-PLP1+Foxp3- T cells 
were sorted from either TCR-PLP1 PLPWT mice (C) or TCR-PLP1 PLPWTΔDC mice (D), 
labeled with CFSE and adoptively transferred into WT recipient. Three days later, 
splenocytes and lymph node cells were analyzed for cell division.  
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DCs were shown that promote immune homeostasis by inducing and maintaining 
peripheral T cell tolerance12. Are DCs necessary for anergy induction? To this end, 
we transferred CFSE-labeled CD45.2+ CD4+ T cells either from TCR-PLP1 PLPWT or 
TCR-PLP1 PLPWTΔDC mice into CD45.1+ WT recipient where PLP is expressed in 
their periphery. We previously analyzed surface anergy marker expression (ICOS 
and FR4, Figure 23) and functionality among CD4+TCR-PLP1+ T cells in TCR-PLP1 
PLPWT mice, indicating the escaping Plp1-specific T cells from TCR-PLP1 PLPWT are 
anergic (Figure 24 and Figure 27C). If DCs are responsible for anergy induction, 
these escaping CD4+ T cells should maintain anergic state in the periphery. 
Therefore, when CD4+ T cells were taken from TCR-PLP1 PLPWTΔDC mice (Figure 
27D), with a greater percentage of the CD4+TCR-PLP1+ T cells demonstrating 
proliferation (73.9 ± 3.1%). In sum, we conclude that DCs are not only necessary for 
peptide presentation, but also necessary for anergy induction.  
 
2.2.9 Breakdown tolerance to PLP in TCR-PLP1 Tg mice lead to EAE 
 
 
 
Figure 28: Differential EAE progression in TCR-PLP1 Tg mice when the tolerance 
induction to PLP was broken down. TCR-PLP1 PLPWT Tg mice, TCR-PLP1 PLPKO Tg 
mice and TCR-PLP1 PLPΔTEC mice were immunized with 200 µg PLP11-18, and these mice 
were protected from EAE. EAE can be induced after transferring of naïve CD4+ T cells 
derived from TCR-PLP1 PLPKO mice with subsequent immunization of PLP11-18 on WT mice 
and ΔTEC mice.  
 
 
TCR-PLP1 Tg mice were observed for a time period longer than one year. These 
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mice did not develop EAE spontaneously. In order to determine the tolerance state 
of TCR-PLP1 Tg mice to EAE induction, we immunized TCR-PLP1 PLPWT and TCR-
PLP1 PLPKO mice with PLP11-18 in CFA. CFA contains heat-inactivating 
Mycobacterium tuberculosis thus predominantly activating the CD4+ T cells with a 
bias toward a Th1/Th17 response type241. The disease severity was monitored 
according to the classical EAE score. This challenge failed to induce clinical EAE 
development within 35 days of observation after treatment of TCR-PLP1 PLPWT or 
TCR-PLP1 PLPKO mice concluding that TCR-PLP1 mice are tolerant to EAE 
induction.  
The interesting question is what is happening if we take away central tolerance or 
periphery tolerance or what if take away both central and periphery tolerance? To 
this end, we first immunized TCR-PLP1 PLPΔTEC mice. This mouse strain is lacking 
of central tolerance induction to PLP. We observed that TCR-PLP1 PLPΔTEC mice 
fail to evoke EAE onset after immunization with PLP11-18. In order to take away 
periphery tolerance, CD4+ splenocytes from TCR-PLP1 PLPKO mice were transferred 
into the naïve WT recipients. 6 hours post transfer recipients were immunized with 
PLP11-18  in CFA. In this setup, WT mice receiving CD4
+TCR-PLP1+ naïve T cells 
developed EAE from day 7 post immunization which was accompanied by typical 
weight loss. In order to take away both central tolerance and periphery tolerance, 
CD4+TCR-PLP1+ naïve T cells from TCR-PLP1 PLPKO mice were transferred into 
ΔTEC recipients. Interestingly, all ΔTEC mice have increased severity of EAE 
compared to WT EAE but did not alter the disease duration (Figure 28).  
 
These results strongly suggest that both central tolerance and periphery tolerance 
mechanisms, contribute to tolerance state of C57BL/6 mice to PLP.  
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3. Discussion 
 
3.1 Lack of tolerance induction in Plp11-specific autoreactive T Cells  
 
Central and peripheral tolerance prevents autoimmunity by deleting those CD4+ T 
cells posing the greatest threat. T cells recognizing epitope PLP174-181 are restricted 
to antigen recognition in the context of I-Ab. Previous results have shown that a 
fraction of CD4+ T cells specific for this region appear to incomplete tolerance 
induction219. We would like to understand this phenomenon more detail, therefore, 
we have constructed a transgenic mouse expressing genes encoding a rearranged T 
cell receptor specific for PLP174-181. Firstly, T-cell hybridomas were generated by 
immunization of PLPKO mice with purified PLP protein. These immunizations yielded 
PLP174-181-specific T-cell hybridomas from the subsequent immunized draining lymph 
nodes cells of the PLPKO mice with PLP174-181 peptide. Next, the TCR-α/β genes 
derived from selected PLP174-181-specific T-cell hybridomas were sequenced and 
cloned the TCR variable regions Vα2 and Vβ14 into the pTα- and pTβ-vector for 
using the generation of TCR-PLP11 mice. Last, we present the characterization of a 
new transgenic mouse, as a novel model of immunological tolerance to PLP 
involving PLP ignorance for CD4+ T cells, in which EAE can be induced by 
immunization with specific peptide PLP174-181. Key features of this model are: 1) no 
deletion of the Plp11-specific T cells occurred in the thymus and periphery, 2) 
functional autoreactive T cells were found in the spleen and lymph nodes of TCR-
PLP11 mice in vitro but not spontaneously activated in vivo, 3) development of 
autoimmune disease in response to PLP immunization in CFA, and 4) EAE 
developed spontaneously in TCR-PLP11 transgenic RAG-1-deficient mice. Taken 
together, these results establish a novel model of immunological tolerance towards a 
self-antigen expressed in the central nervous system involving antigen ignorance for 
CD4+ T cells, which affords a unique opportunity to elucidate why and how 
autoreactive T cells can escape from central tolerance. 
 
In TCR-PLP11 mice, a pronounced skewing toward the CD4+ T cell population 
specific for epitope PLP174-181 was expected, as the transgenic TCR genes were 
isolated from a MHC class II–restricted CD4+ T cell clone. Despite large numbers of 
myelin-specific T cells, they failed to develop any clinical signs of central nervous 
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system autoimmunity. In order to determine the mechanisms of T cell tolerance in 
the thymus or periphery that could account for the missing incidence of spontaneous 
EAE in TCR-PLP11 mice, we monitored the fate of CD4+TCR-PLP11+ T cells during 
their development. The presence of the self-antigen PLP in the thymus of TCR-
PLP11 PLPWT mice did not affect the development of CD4SP T cells as wells the 
expression of TCR-PLP11 on the surface of those cells when compared to TCR-
PLP11 PLPKO mice (Figure 11). This clearly indicated that Plp11-specific thymocytes 
were not negatively selected in TCR-PLP11 PLPWT Tg mice. This implied that 
periphery tolerance mechanisms might play a role in maintaining tolerance to PLP11 
in TCR-PLP11 PLPWT mice. Analysis of peripheral Plp11-specific CD4+ T cells 
revealed similar numbers and frequencies of the CD4+TCR-PLP11+ T cells in 
secondary lymphoid organs of TCR-PLP11 PLPWT mice as compared with TCR-
PLP11 PLPKO littermates. Importantly, CD4+TCR-PLP11+ cells from TCR-PLP11 
PLPWT mice displayed a naïve phenotype, and were not anergic, as they proliferated 
in a dose-dependent response to PLP174-181 and comparably to Plp11-specific CD4
+ 
T cells originating from TCR-PLP11 PLPKO mice when stimulated with their specific 
peptide in vitro and in vivo (Figure 13). Thus, on both TCR-PLP11 PLPWT and the 
TCR-PLP11 PLPKO background, the T cells were fully capable of responding to 
PLP174-181 in a comparable fashion. The lack of proliferation upon adoptive transfer 
into PLPWT mice could result from two not mutually exclusive scenarios: 1) TCR 
affinity of TCR-PLP11 Tg CD4+ T cells is too low to reach the threshold for activation 
in the periphery, 2) The peptide PLP174-181 is not efficiently presented on MHC class 
II molecular. We do not have proof evidence for one of these scenarios, however 
bioinformatic analysis of the binding of PLP174-181 to MHC class II revealed a very 
poor binding capacity which might be in favour for the latter explanation. Finally, to 
test the tolerance state of our TCR-PLP11 Tg mice, we immunized TCR-PLP11 Tg 
animals with PLP174-181 peptide in CFA. Because of the large number of Plp11-
specific T cells in the periphery of TCR-PLP11 mice (Figure 12) and their activation 
into effector cells upon immunization the mice developed clinical signs of EAE 
(Figure 15).  
 
The absence of thymic deletion in TCR-PLP11 mice could be explained either by the 
absence of the PLP protein in the thymus, by low avidity of the TCR-PLP-MHC 
interaction or by a defect in the processing/presentation of the PLP174-181 peptide. In 
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the thymus, expression of PLP promotes protection through elimination of 
autoreactive T cells, which has been shown in TCR-PLP1 Tg mice, a mouse model 
that has been previously described in our lab (Winnewisser J., PhD thesis). In the 
presence of the self-antigen PLP in the thymus of TCR-PLP1 PLPWT mice, we 
observed strong negative selection of TCR-PLP1+ T cells (Figure 19). This implies 
that the PLP protein is indeed expressed in the thymus of TCR-PLP1 PLPWT mice. 
Furthermore, we could verify the expression of PLP in the thymus by quantitative 
real time PCR, showing that PLP was expressed by mTEC as well as cTEC in the 
thymus (data not shown).  
 
Next we want to determine the mechanisms of periphery tolerance preventing the 
development of autoimmunity in the TCR-PLP11 Tg model. In the periphery we 
could not find any evidence for deletion of Plp11-specific T cells nor could we detect 
any modification of their phenotype or alteration of their function in TCR-PLP11 
PLPWT mice. Our results suggest that one important mechanism for the prevention of 
autoimmune disease in TCR-PLP11 PLPWT mice is ignorance of PLP11 self-antigen 
by specific T cells. Ignorance could be due to the absence of presentation or the lack 
of appropriate T cell activation conditions176. In order to determine the mechanisms 
of whether this state of ignorance could be due to an impaired in PLP processing 
and/or PLP174-181 presentation, we adoptively transferred naïve CD4
+ T cells were 
labeled with CFSE from TCR-PLP11 PLPKO mice into B6 mice. A high level of the 
CFSE fluorescence was maintained in the recipients, indicating that no cell division 
had occurred (Figure 14A). In control mice, the proliferation of CD4+TCR-PLP11+ T 
cells were observed for draining lymph nodes of WT mice immunized with PLP174-181 
as shown by the progressive dilution of CFSE (Figure 14B and 14C). Plp11-specific 
T cells rapidly underwent extensive cell division, suggesting CD4+ T cells are 
activated by the antigen encounter following immunization. This observation 
suggested that the adoptively transferred PLP-specific cells didn’t encounter PLP in 
the periphery of the recipients. In TCR-PLP11 mice, this situation could be related to 
the low level of expression of the PLP self-antigen or the low affinity of the PLP-TCR 
for its ligand, or to an impairment of PLP174-181 processing/presentation.  
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3.2 Active EAE induction in TCR-PLP11 Transgenic Mice 
 
EAE is a commonly used mouse model for multiple sclerosis, which can be induced 
either by injection of myelin antigen in CFA or by transfer of activated myelin-reactive 
CD4+ T cells. Activating stimuli leads to an augmentation of the density of peptide-
MHC complexes, which trigger the induction of a pathogenic autoimmune response. 
To analyze the impact of the PLP-specific T cells on EAE development, we 
immunized TCR-PLP11 mice with the PLP174-181 peptide in CFA combined with 
injection of pertussis toxin (PT). Because TCR-PLP11 PLPWT and TCR-PLP11 
PLPKO littermates appear physically identical, genotype-blind disease scoring and 
thus elimination of bias was feasible. Our results showed that the TCR-PLP11 
PLPWT  transgenic mice were susceptible to the induction of EAE (Figure 15). As the 
majority of CD4+ T cells expressed the transgenic T cell receptor, the accelerated 
disease onset could be explained by the high number of Plp11-specific CD4+ T cells 
present in their immune repertoire. The immunized sick mice exhibited partial or 
complete recovery from symptoms. In contrast, due to the absence of PLP 
expression in TCR-PLP11 PLPKO mice, the PLP-induced immune response should 
not induce CNS tissue damage. When TCR-PLP11 PLPKO mice were immunized 
with PLP174-181 peptide, all animals exhibited very low-grade EAE which likely results 
from immunization background (Figure 15). These data suggested that TCR-PLP11 
Tg CD4+ T cells were potentially pathogenic and can be activated to access and 
attack the CNS and induce EAE. Indeed, in a similar model226, immunological 
ignorance could be overcome in mice expressing a transgenic TCR specific for a 
myelin-specific peptide (MBP) upon immunization with MBP accompanied by 
injections of pertussis toxin as well as with administration of pertussis toxin alone. 
 
The presence of CD4+CD25+ regulatory T cells is a critical parameter for the 
suppression of autoimmunity146. To examine regulatory T cells in the TCR-PLP11 Tg 
mice, we determined the number of CD4+CD25+ T cells in spleens and lymph nodes 
by flow cytometry. Our analysis in TCR-PLP11 Tg mice revealed a generally lower 
number of CD25+Foxp3+ cells in the CD4+TCR-PLP11+ T cell population than the 
expected 10% in nontransgenic littermates. Moreover, there is no difference in the 
number of CD4+Foxp3+ T cells between TCR-PLP11 PLPWT and the TCR-PLP11 
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PLPKO mice (Figure 11). It will be of interest to investigate whether other types of 
regulatory T cells suppress more fulminant disease development in our system. 
 
3.3 EAE developed spontaneously in TCR transgenic RAG-1-deficient mice 
 
A crucial feature of the TCR-PLP11 PLPWT mouse is that it spontaneously develops 
EAE on the RagKO background (Figure 16). The TCR-PLP11 Tg mice are particular 
valuable because they allow us to evaluate the pathogenic and regulatory 
mechanisms. By contrast, the occurrence of spontaneous EAE is not detected in our 
TCR-PLP11 Tg mice during routine care of the animals. The only difference between 
these two strains of mice is that in these immunodeficient mice, mature CD4+ T cells 
exclusively express the transgenic TCRs specific for Plp11 and no endogenous 
TCRs could rearrange and consequently no Tregs were generated, which express 
TCRs encoded by the endogenous TCR α and TCRβ loci. In contrast, in TCR-PLP11 
Tg mice include some nontransgenic lymphocytes, indicating that a protective role of 
a small population of non-Tg TCR specificities. Three most popular models were 
also reported to develop spontaneous EAE when bred onto the RAG knockout 
background, including TCR transgenic mice specific for myelin oligodendrocyte 
glycoprotein (MOG)207 and mice specific for myelin basic protein (MBP)205, as well as 
TCR transgenic mice recognizing PLP139-151
206. Lafaille’s group demonstrated that a 
single administration of as few as 2 × 105 CD4+ splenocytes from naïve 
immunocompetent mice could protect against spontaneous EAE occurring in MBP-
specific TCR transgenic/RAG1-/- mice (referred to as T/R-)227. Although these studies 
preceded the discovery of Foxp3, which is expressed in regulatory T cells and is the 
specific lineage maker for their identification, the transferred CD4+ splenocytes 
undoubtedly included Treg cells as well as other regulatory T cells. MBP-specific 
TCR transgenic mice (referred to as T/R+) do not develop EAE spontaneously 
perhaps due to the presence of small population of non-Tg TCR specificities. 
Actually, the presence of Tregs has been reported to impact the course of disease in 
different models. Hori et al., using Lafaille’s model system, evaluated the ability of 
CD4+CD25+ Tregs to control the development of spontenous EAE. They 
demonstrated that MBP-specific CD4+CD25+ Tregs contributed the suppression. 
Meanwhile, other types of CD4+CD25+ Tregs with different specificities also indicated 
a protective role. The CD4+CD25+ Tregs could transfer protection of animals against 
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EAE significantly228, and depletion of Treg cells with anti-CD25 antibody from EAE-
susceptible SJL/J mice and EAE resistant B10.S mice exacerbated EAE229, 230. 
 
In TCR transgenic mice, T lymophocytes expressing the transgenic TCR-β chains 
results in allelic exclusion of endogenous β chains, whereas the transgenic TCR-α 
chains expression does not. Therefore, in TCR transgenic mice a proportion of T 
cells will express the transgenic β chain together with an endogenous α chain. When 
we analyzed the Plp11-specific TCR expression within the CD4+ compartment, we 
observed the dominant Vβ14 together with α chains other than that the Tg Vα2, a lot 
of them expressing Foxp3 (Figure 18). This might partly explain why spontenous 
EAE is observe in TCR-PLP11 PLPWTRAGKO mice but not in TCR-PLP11mice. A 
very low frequency of CD4+CD25+ T cells (<1%) in TCR-PLP11 PLPWTRAGKO mice 
might be due to a restricted endogenous TCR-encoded repertoire (Figure 17). These 
finding suggest that regulatory TCR expressing Treg cells from TCR-PLP11 mice 
recongnize a not necessarily different one self-antigen, that mediate specific 
regulatory function. One feature of particular interest for future studies is to remove 
of endogenous T cells (putative regulatory), cells of PLP-specific TCR transgenic 
mice, and the monitor whether transfer of polyclonal T cells completely prevented 
EAE in TCR-PLP11 PLPWTRAGKO mice. Moreover, It will be of very interest to 
address the question of whether the transferred CD4+CD25+ regulatory T cells from 
different antigen specificity could recruit PLP-specific T cells to regulatory function in 
TCR-PLP11 PLPWTRAGKO mice.  Together with our results in RagKO animals showed 
a potential contribution of dominant tolerance to the prevention of CNS autoimmunity 
in TCR-PLP11 mice. 
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3.4 Central tolerance to PLP is induced by clonal deletion and concomitant 
Treg induction of TCR-PLP1+ T cells  
 
Immunological tolerance is a fundamental property of the immune system which is 
maintained by central and peripheral mechanisms, allowing the immune system to 
respond to non-self antigens and unresponsive to self-antigens.  In central tolerance, 
the two major mechanisms include clonal deletion and clonal diversion (Treg 
differentiation) of thymocytes with high-affinity TCRs specific for self-peptide-MHC 
complexes, thereby eliminating potentially dangerous self-reactive T cells. However, 
self-reactive T cells can still escape central tolerance checkpoints. Therefore, 
peripheral tolerance exists which ensures those escaping cells remain unresponsive 
in peripheral organs, involving the deletion of self-reactive T cells or induction of 
functionally unresponsiveness (anergy) after encountering self-antigens outside of 
the thymus. Breakdown of either central or periphery tolerance can lead to 
autoimmunity. 
 
In TCR-PLP1 Tg mice, thymocytes that bear the PLP1 specific TCR are negatively 
selected upon interactions with PLP-MHC class II complexes. Concomitantly, in the 
presence of the cognate self-antigen PLP, a large proportion of the Plp1-specific 
CD4+ T cells undergo selection to become CD4+CD25+ Foxp3+ T cells. It is known 
that high affinity/avidity of TCRs to self-antigens is prerequisite for negative selection 
thymus. It is worth noting that when PLP is present in TCR-PLP11 Tg mice, the 
failure of thymocytes bearing the PLP11 specific TCR undergo negative selection as 
well as become regulatory T cells might be due to the low affinity/avidity of the TCR 
for PLP174-181-MHC interaction. These data suggest that negatively selected Plp1-
specific CD4+ T cells as well as the selection of regulartory T cells in TCR-PLP1 
mice depends on the high affinity/avidity of the TCR for PLP11-18-MHC complex.  
 
CD4+ T cells bearing T cell receptors that recognize self-antigens can be eliminated 
by negative selection, this mode of tolerance was also observed in other TCR 
transgenic models. For instance, in the liver-antigen transgenic system, intrathymic 
hCRP expression, showing that tolerance is mediated by intrathymic deletion of 
immature thymocytes. Another experimental system from TCR-HA x AIRE-HA131, 168, 
a substantial fraction of the TCR-HA+ thymocytes differentiates into Treg cells as well 
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as two-thirds of the thymocytes are subjected to negative selection. In our TCR-
PLP1 mouse model, clonal deletion of the mature Plp1-specific T cells and 
concomitant the differentiation of antigen-specific T cells into the Treg lineage both 
operate for the tolerance towards self-antigen PLP. 
 
3.5 PLP is expressed and presented by medullary thymic epithelial cells 
autonomously  
 
The process of generating and presenting of self-antigens is complex. For positive 
selection, cortical epithelial cells are the predominant stromal cell in the cortex and 
are vital for that process. In contrast, multiple APCs types contribute to T cell 
tolerance in thymic medulla. Although previous work has suggested contributions of 
each APCs subset to T cell tolerance, it remained unclear if these components 
functioned uniquely or redundantly. We addressed the importance of thymic PLP 
expression by individual thymic APC subsets in mediating immune tolerance towards 
Plp1-specific T cells.  
 
mTECs as the major PLP-expressing cells in the thymus  
 
Firstly, we determined the PLP expression in specific thymic cell populations. To 
examine the PLP mRNA expression in hematopoietic (CD45+) and stromal cell 
populations as well as in the thymic epithelial cell subsets (CD45-) by cell separation 
and subsequent reverse transcriptase PCR. We found that PLP transcripts were 
predominately expressed in mTEC. Specifically, mTEChi as the major PLP-
expressing cells in the thymus in our study (Winnewisser J., PhD thesis). Using 
transplantation experiments, we clearly showed that expression of PLP by 
radioresistant stromal cells, leading to deletion and Treg cells induction of TCR-
PLP1+ T cells (data not shown). While TCR-PLP1+ T cells were not tolerized when 
PLP was expressed by hematopoietic cells, indicating that expression of PLP by 
hematopoietic compartment was not crucial for tolerance induction to PLP.  
 
To elucidate the essential role of this mTEC-derived PLP expression, we developed 
a mouse mode in which the PLP gene was specifically deleted in TECs due to the 
Foxn1-Cre-driven excision of the floxed PLP gene. In TCR-PLP1 PLPΔTEC mice, 
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we observed an impaired negative selection of TCR-PLP1+ T cells in the thymus and 
also no Plp1-specific Tregs were generated when PLP expression was abolished in 
TECs (Figure 20). This suggests that hematopoietic APCs (mainly thymic DCs 
and/or B cells) were not capable of altering the fate of PLP-specific CD4+ T cells. 
Thus, it seemed that PLP expression by TECs could orchestrate both thymocytes 
fates in parallel. However, we cannot rule out the possibility of tolerance induction to 
PLP expressed by cTECs. We found the numbers of DP thymocytes were not 
reduced when compared TCR-PLP1 PLPWT with TCR-PLP1 PLPKO, indicating that 
no deletion in the cortex. In contrast, Plp1-reactive T cells initiated apoptosis at the 
CD4SP stage in the medulla. These results showed that deletion of autoreactive 
PLP-specific thymocytes do require expression of PLP by mTECs to preserve 
tolerance.  
 
mTEC present PLP autonomously  
 
In theory, there are a number of ways that will allow PLP epitopes to be presented to 
T cells in the thymus to mediate central tolerance: bone marrow-derived APCs can 
take up and transport circulating PLP to the thymus; radio-resistant stromal cells, 
express and present PLP to the T cells directly; or PLP11-18 peptide derived from the 
PLP protein, dreived from mTECs, subsequently cross-presented by DCs to mediate 
the deletion of the autoreactive T cells within the thymus. We quantified the impact of 
BM APCs and mTECs on the processes of clonal deletion and Treg cells selection. 
 
It has been described that mTEC-derived self-antigens spread to DCs to resolve the 
issue of how antigens expressed by a minor fraction of mTECs can induce T cell 
tolerance. Although MHC class II-bound peptides can be autologously presented on 
mTECs via autophagy93, 94, DCs present peptides via classical, exogenous MHC 
class II loading. When the antigens are transferred from mTEC to DCs, it may blur 
the distinction between antigens that are displayed on DCs and APCs. This 
phenomenon was observed in TCR transgenic models or MHC class II tetramer at 
the level of individual antigens. We used a model system in which DCs could be 
specifically ablated, TCR-PLP1 PLPWTΔDC to rule out the possibility of mTEC-
derived PLP was transferred from mTECs to DCs. We analyzed the frequency of 
thymocyte populations in TCR-PLP1 PLPWTΔDC and TCR-PLP1 PLPWT mice (DC 
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deficiency versus DC sufficiency) in Figure 21. Irrespective of whether DCs were 
experimentally eliminated or not, this resulted in the similar frequencies of CD4SP 
negatively selected, indicating that medullary DCs which cross-present mTEC-
derived antigens, do not contribute to negative selection in our experiment system. 
We wanted to directly test the PLP presentaion within different APC subsets ex vivo 
by using a Plp1-specific hybridoma, but PLP presenting APCs in the thymus seemed 
to be very rare that the sensitivity of our assay was not sufficient to measure any 
PLP presentation.   
 
Previously, Hinterberger et al. demonstrated that autonomous role of mTEC in CD4+ 
T cell tolerance by using C2TAkd mice102. In C2TAkd mice, MHC class II expression 
is diminished to approximately 10% of WT levels. We crossed C2TAkd mice with 
TCR-PLP1 PLPWT mice, analysis of TCR-PLP1 PLPWT C2TAkd mice (Winnewisser J., 
PhD thesis) indicated that residual MHC class II expression on mTEC, led to a 
diminished efficacy of negative selection, but not a complete loss of tolerance and 
more induction of Treg cell lineage to PLP. This observation also argued that our 
TCR-PLP1 model favour avidity hypothesis. In vitro stimulation assay revealed that 
PLP11-18 peptide in the femtogram-range triggered a stimulation of CD4
+TCR-PLP1+ 
peripheral T cells indicating a high affinity to PLP. In contrast, the concentration 
required to stimulate an equivalent response in TCR-PLP11 Tg mice was 50 times 
higher with the PLP174-181, indicating PLP174-181 peptide does not bind MHC class II 
efficiently. Other stromal APCs, like cortical TECs, may have the similar dual function 
in tolerance to PLP, which shape of the CD4+ repertoire only apparent when the 
contribution of mTEC is diminished. Taken together, this finding is consistent with 
PLP expression and also shows that mTEC has impact on the antigen presentation 
of self-antigen PLP to auto-reactive T cells.  
 
Taken together, these data substantiates the idea that automonous APC function of 
mTECs, that is expression and subsequently presentation of a self-antigen by mTEC 
serve an essential function to both deletion and Treg development mechanisms of 
tolerance induction and thymic DCs does not mediate central tolerance to PLP. 
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Figure 29: Graphical summary of central and peripheral tolerance mechanisms in 
maintaining tolerance to PLP. When TCR transgenic (TCR-PLP1) mice that bears T cells 
specific for the major I-Ab determinant of PLP1, we could monitor the fate of Plp1-specific 
CD4+ T cells at physiologic levels. Moreover, we investigated the contribution of the 
individual thymic antigen presenting cells to central tolerance to PLP. Since autoreactive T 
cells can still eacape to the periphery, we could also show the mechanisms of the periphery. 
Furthermore, we found out the type of APC was presenting PLP to TCR-PLP1+ T cells in the 
periphery to induce anergy. Key features of this model are: 1) Plp1-specific T cells undergo 
clonal deletion and Treg differentiation concomitantly upon encounter of the cognate self-
antigen PLP, 2) PLP is presented by medullary thymic epithelial cells, 3) Autoreactive Plp1-
specific T cells are deleted or become functionally inactivation (anergy) by recognition of 
PLP on dendritic cells in the periphery, 4) PLP is expressed by radioresistant stromal cells 
and subsequently cross-presentent by dendritic cells. Our studies demonstrate the 
importance of both central and peripheral mechanisms in maintaining tolerance to PLP. 
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3.6 Autoreactive Plp1-specific T cells are deleted or become functionally 
inactivation (anergy) by recognition of PLP on dendritic cells in the periphery 
 
Central tolerance to PLP is not complete; a fraction of PLP-reactive T cells are not 
deleted by central tolerance and thus released into the periphery. Yet, TCR-PLP1 
mice did neither develop EAE spontaneously nor was it possible to induce EAE by 
immunization with PLP11-18 (Figure 28). Therefore, many of these T cells are silenced 
by peripheral tolerance mechanisms, which are necessary to prevent the 
development of autoimmune disease. Peripheral deletion is one mechanism by 
which self-reactive T cells are removed that escaped thymic tolerance mechanisms. 
In TCR-PLP1 mice, we demonstrated that Plp1-specific CD4+ T cells were deleted in 
the presence of the cognate self-antigen PLP as compared to the absence of PLP 
expression in the periphery of TCR-PLP1 PLPKO mice. This view is further supported 
by the observation that PLP-specific CD4+ lymphocytes are strongly reduced even in 
the absence of central tolerance in TCR-PLP1 PLPΔTEC mice. These data confirm 
that peripheral deletion is one mechanism by which plp specific escapees can be 
controlled in the periphery Noteworthy, a large fraction of the Plp1-specific CD4+ T 
cells are deviated into regulatory T cells in TCR-PLP1 PLPWT mice. However, in 
TCR-PLP1 PLPΔTEC mice, escaping cells are not deviated into Foxp3+ Tregs cells. 
This suggests that peripheral Treg induction of PLP specific T cells that have 
escaped from negative selection in the thymus does not take place in or model 
system.   
 
Another potential mechanism by which self-reactive periphery T cells are silenced is 
functional inactivation, referred to as anergy. Importantly, TCR-PLP1 PLPWT mice as 
well as TCR-PLP1 PLPΔTEC mice with defective thymic clonal deletion of T cells 
have an increased frequency of CD4+ T cells in the periphery with an anergic 
ICOShiFR4hi phenotype (Figure 23). We further characterized the functionality of 
CD4+Foxp3- in TCR-PLP1 PLPWT as well as TCR-PLP1 PLPKO Tg mice. The 
adoptive transfer system studied in this investigation showed that, naive PLP-specific 
CD4+ T cells from TCR-PLP1 PLPKO mice (CD4+TCRPLP1+) expanded vigorously in 
recipient mice expressing physiological PLP in the periphery. In contrast, upon 
transfer of CD4+TCRPLP1+T cells that came from TCR-PLP1 PLPWT mice, no 
proliferation to PLP could be detected (Figure 24). Using TCR-PLP1 PLPΔTEC T 
Discussion 
	   	   	  74	  
cells confirmed that the functional inactivation of PLP specific cells was carried out in 
the periphery, not in the thymus. These cells represent escaping Ag-specifc T cells 
from the thymus and were anergized in secondary lymphoid organs. It is also 
possible that in vivo functional unresponsiveness was associated with immune 
deviation or suppression by residual PLP-specific Treg cells (Figure 24).  We ruled 
out this possibility by co-transfer CD4+Foxp3- T cells from TCR-PLP1 PLPWT and 
TCR-PLP1 PLPKO mice into PLP-expressing recipients. We demonstrated that under 
the co-transfer situation, which would be expected to contain putative suppressive 
environment, TCR-PLP1 PLPKO+ T cells still proliferated vigorously compared with 
TCR-PLP1 PLPWT+ T cells displayed functional defects (Figure 25). This finding 
highlighted the fact that TCR-PLP1 PLPWT and TCR-PLP1 PLPKO PLP-specific T 
cells were functional different with respect to their proliferative capacities. Thus, 
there is no evidence that suppressive mechanism contribute to the functional 
unresponsiveness to PLP of the tolerized TCR-PLP1+ T cells in PLPWT animals. It is 
worthwhile pointing out that, in KRN x NOD mice model, autoreactive T cells were 
likewise detected in the periphery and developed arthritis in those mice242. In TCR-
PLP1 PLPΔTEC mice (no central tolerance), however, no signs of autoimmune 
disease was seen, indicating the existence of deletion and anergy as periphery 
tolerance mechanisms that are particularly important when central tolerance fails. It 
also will be important to establish the precise requirement for inducing deletion 
versus anergy in future experiments.  
 
The proliferation of transferred TCR-PLP1+ T cells was dependent on whether the 
host was sufficient or deficient for PLP. Bone marrow chimeras were used in which 
only radioresistant cells could express PLP (MHCIIWTPLPWT→PLPWT, 
MHCIIWTPLPWT→PLPKO), and only hematopoietic cells could present PLP 
(MHCIIKOPLPWT→WT, MHCIIKOPLPKO→PLPKO). These chimeras were then 
transferred with naïve TCR-PLP1+ T cells from TCR-PLP1 PLPKO mouse. We 
observed expansion of CD4+TCR-PLP1+ T cells in which both hematopoietic cells 
and radioresistant cells can express PLP (MHCIIWT PLPWT →PLPWT). In contrast, in a 
chimera lacking PLP expression on radioresistant cells, but expressing PLP and 
class II on hematopoietic cells (MHCIIWTPLPWT →PLPKO), TCR-PLP1 PLPKO+ T cells 
proliferation was not observed, indicating PLP was expressed only by radioresistant 
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cells but not expressed by hematopoietic cells (Figure 26). To determine the possible 
role of hematopoietic cells to present PLP to TCR-PLP1+ T cells in the periphery for 
tolerance induction, we created bone marrow chimeric mice taking advantage of 
MHCIIKO mice. Hematopoietic cells with MHCII deficiency are not able to stimulate 
Plp1-specific T cells in response to PLP1, allowing for the restriction of antigen 
presentation to hematopoietic cells but not radioresistant cells. To this end, we used 
class II-deficiency bone marrow to reconstituted PLP-expressing hosts 
(MHCIIKOPLPWT→WT). This system did not generate a significant Plp1-specific T cell 
population which responded to periphery PLP of the recipients. This data indicated 
that PLP was present by hematopoietic cells, once its presentation capacity was 
impaired by the abrogation of MHCII expression, no proliferative response to PLP 
was observed (Figure 26).  Taken together, although these APCs of hematopoietic 
origin were not responsible for expressing PLP autonomously, obviously they were 
able to pick up from non-hematopoietic cells and subsequently present and induced 
the robust expansion of TCR-PLP1+ T cells.  
 
We speculated that peripheral DCs are playing a role in tolerance induction of PLP-
specific T cells by deletion and/or anergy. To resolve such an issue, it is important to 
develop in vivo systems where DCs are not capable of presenting antigen. We 
performed adoptive transfers of mature naive CD4+ T cells from TCR-PLP1 PLPKO 
mice into ΔDC mice. We observed the impaired capacity of TCR-PLP1+ T cells to 
proliferate to PLP in such a DC free environment. We concluded that presentation of 
PLP by DCs is necessary for proliferation of specific T cells. Next we asked whether 
DCs were also instrumental for anergy induction of autoreactive T cells. To this end, 
we took out the CD4+ T cells from either TCR-PLP1 PLPWT or TCR-PLP1 
PLPWTΔDC mice and transferred into PLP-expressing recipients. If DCs are 
responsible for anergy induction, these cells should not proliferate as the CD4+ T 
cells from TCR-PLP1 PLPWT mice. As shown in Figure 27, when the cells were taken 
from DC free environment, CD4+ T cells cannot become anergic, they are capable of 
responding to the peptide. Therefore, the adoptive transfer experiments performed 
here showing in a definite and conclusive manner that peripheral DC can induce 
periphery tolerance of remaining TCR-PLP1+ T cells by anergy induction.  
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3.7 Both central and peripheral tolerance mechanisms in maintaining tolerance 
to PLP 
 
EAE can be provoked by the immunization with self-antigen indicates that potentially 
autoreactive T cells escape from thymic selection and are present in the periphery T-
cell repertoire of healthy individuals. To test the tolerance state of TCR-PLP1 Tg 
mice to EAE induction, we used a classic protocol for immunization: TCR-PLP1 Tg 
mice were immunized with PLP11-18 emulsified in CFA. Mice treated in this fashion 
are protected from EAE concluding that TCR-PLP1 mice are tolerant. The 
maintenance of tolerance to PLP11-18 is orchestrated by a complex sequence of 
tolerance mechanisms. It is important to investigate the central tolerance and 
periphery tolerance mechanisms mediating the tolerant state in TCR-PLP1 mice, we 
used three different mouse models (Figure 28). In the first scenario, we immunized 
TCR-PLP1 PLPΔTEC mice. This mouse strain is a lack of central tolerance to PLP. 
We observed that TCR-PLP1 PLPΔTEC mice do not develop EAE after 
immunization with PLP11-18, indicating periphery tolerance mechanisms are required 
to prevent autoimmunity. In the second scenario, to identify the role of periphery 
tolerance that maintains T-cell tolerance to PLP, adoptive transfer of naïve CD4+ T 
cells from TCR-PLP1 PLPKO mice into WT recipient animals following immunization 
with PLP11-18 in adjuvant was used to break periphery tolerance. This treatment 
triggers mild EAE. This indicates that impair the function of periphery T cell tolerance 
against PLP causes PLP-specific T cells activation in vivo and would be poised to 
initiate an autoimmune attack. In an effect to break the central tolerant and periphery 
tolerance state of PLP1-specifc T cells, the same protocol (take away periphery 
tolerance as in the second scenario) was applied to ΔTEC recipients. Our results 
showed that all ΔTEC mice have increased severity of EAE compared to WT EAE. 
This interesting difference in EAE severity is a result of lacking total immune 
tolerance to PLP in ΔTEC mice. These observations indicate that both central 
tolerance and periphery tolerance mechanisms must exist to prevent autoimmunity in 
TCR-PLP1 Tg mice that remain healthy. The TCR-PLP1 Tg mice provided an 
excellent tool to investigate the extent and mechanisms underlying immune 
tolerance of CD4+ PLP-specific T cells. 
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4. Materials and Methods 
 
 
4.1 Materials 
 
4.1.1 Mice 
 
All animals used in thisTand specific pathogen-free (SPF) mouse facilities of the 
Institute for Immunology at the LMU Munich. PLPKO mice were obtained from Klaus 
Nave from the Max-Planck-Institute for Experimental Medicine, Göttingen, which are 
described in Klugmann et al.214. The TCR-PLP1 transgenic mice specific for the 
PLP11-18  were generated by Hinterberger et al. (unpublished data). The TCR-PLP11 
Tg mice for the PLP174-181 were generated during this work. Pro-nuclear injections for 
generating the TCR-PLP Tg mouse were performed by the transgenic animal facility 
of the Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden by 
Ronald Naumann. Foxn1-Cre mice were described in Gordon et al. 243. PLPfl/fl mice 
were generously provided by Hauke Werner, Max-Planck-Institute for Experimental 
Medicine, Göttingen. ΔDC mice were a kind gift from David Voehringer and are 
described in Ohnmacht et al. 103.  
 
Mice were analyzed at 3 weeks old and used under protocols approved by the 
Animals Studies Committee. 
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4.1.2 Antibodies 
 
Table 1: The following antibodies were used in this study for flow cytometry. All 
antibodies and Second Step reagents are listed with the respective clone and conjugated 
fluorophore. 
Specificity Label Clone Isotype  Supplier 
CD3 PE-Cy7 145-2C11 Armenian Hamster IgG Biolegend 
CD4 APC-Cy7  GK1.5 Rat IgG2b, κ Biolegend 
CD4 V500  RM-4-5 Rat (DA) IgG2a, κ BD 
CD8 PE-Cy5  53 - 6:7 Rat (DA) IgG2a, κ Biolegend 
CD24 Pacific Blue  M1/69 IgG2b, kappa eBioscience 
CD25 PE-Cy7 PC61 Rat IgG1, λ Biolegend 
CD44 APC-Cy7  IM7 Rat IgG2b, κ Biolegend 
CD45.1 PB A20 Mouse(A.SW) IgG2a, κ Biolegend 
CD45.2 Alexa647 104 Mouse (SJL) IgG2a, κ Biolegend 
CD62L APC MEL-14  Rat IgG2a, κ Biolegend 
CD69 PE-Cy7  H1.2F3 Armenian Hamster IgG Biolegend 
Foxp3 APC  FJK-16s IgG2a, kappa eBioscience 
TCR Vα2 PE B20.1 Rat (LOU) IgG2a, λ BD 
TCR Vα2 Biotin B20.1 Rat IgG2a, λ Biolegend 
TCR Vα3.2 Fitc RR3-16 Fischer, CDF IgG2b, κ BD 
TCR Vα3.2 Biotin RR3-16 IgG2b, κ Biolegend 
TCR Vβ6 Fitc   RR4-7 Rat IgG2b, λ Biolegend  
TCR Vβ6 PE RR4-7 Rat IgG2b, λ Biolegend 
TCR Vβ14 Fitc  14-2 Fischer, CDF IgM, κ BD 
TCR Vβ14 Biotin 14-2 Fischer, CDF IgM, κ Biolegend 
Streptavidin APC-Cy7 
  
Biolegend 
Streptavidin PE-Cy7 
  
BD 
PD-1 PE-Cy7 RMP1-30 Rat IgG2b, κ Biolegend 
ICOS FITC C398.4A Armenian Hamster IgG Biolegend 
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4.1.3 Peptides 
 
PLP peptides were synthesized by using solid-phase techniques and purified by 
HPLC at BioTrend in a quantity of 20 mg and a purity of >80% (HPLC). These stock 
solutions were stored at -20°C. 
 
        Table 2: Sequences of synthetic peptides. 
Peptide Sequence Supplier 
PLP1-24 peptide GLLECCARCLVGAPFASLVATGLC BioTrend 
PLP9-20 peptide CLVGAPFASLVA BioTrend 
PLP11-18 peptide VGAPFASL BioTrend 
PLP160-184 peptide VVWLLVFACSAVPVYIYFNTWTTCQ BioTrend 
PLP172-183 peptide PVYIYFNTWTTC BioTrend 
PLP174-181 peptide YIYFNTWT BioTrend 
MOG35-55 peptide MEVGWYRSPFSRVVHLYRNGK BioTrend 
 
 
4.1.4 Primers 
 
Synthetic primers were purchased from ThermoHybaid Ulm and were delivered 
HPLC-purified and lyophilized. Oligonucleotides were dissolved at a concentration of 
100 mmol/µl in ddH2O. These stock solutions were stored at -20 ºC. 
 
 
 
 
 
 
 
 
FR4 PE-Cy7 12A5 Rat IgG2b, κ Biolegend 
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      Table 3: List of all primer sequences used for genotyping.  
Genotype Primer name Oligo Sequence (5’-> 3’) 
PLP 
 
PLP common fwd GAAAGGTTCCATGGTCAAGG      
PLP WT rev CTGTTTTGCGGCTGACTTTG           
 PLP KO rev CTTGCCGAATATCATGGTGG 
TCR-PLP1 Vα3.2  
 
Vα3.2 fwd ACAACAGAGCTGCAGCCTTC        
Vα3.2 rev GCAGTGCTAGGAAGGGCGGC       
TCR-PLP1 Vβ6 Vβ6 fwd CCCAGAGCCAAAGAAAGTC           
 Vβ6 rev AGCCTGGTCCCTGAGCCGAA        
TCR-PLP11 Vα2  Vα2 fwd GAGTTTCCCCCAAGCTTCAGT        
 Vα2 rev GCCAGATCCTAACCAGGGAG     
TCR-PLP11 Vβ14 Vβ14 fwd AGTGCAGAGTAGACAAGCCT           
 Vβ14 rev AGACTTCTGTGTTAGCCGTCC         
PLP-floxed PLP-floxed fwd    GACATAGCCCTCAGTGTTCAGG    
 PLP-floxed rev GAATCCTGCATGGACAGACAG      
Foxn1-Cre Foxn1-Cre fwd CTCTCCTCCGAGTATCCAATCTG   
 Foxn1-Cre rev CCCTCACATCCTCAGGTTCAG       
CD11c-Cre CD11c-Cre fwd CGATGCAACGAGTGATGAGG        
 CD11c-Cre rev GCATTGCTGTCACTTGGTCGT       
Rag1 
 
Rag1 WT fwd GAG GTT CCG CTA CGA CTC T 
Rag1 KO fwd CCG GAC AAG TTT TTC ATC GT 
Rag1 Common rev CCG GAC AAG TTT TTC ATC GT 
DTA DTA fwd TACATCGCATCTTGGCCACG         
 DTA rev CCGACAATAAATACGACGCTG      
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4.1.5 Reagents and commercial kits 
 
       Table 4: List of commercial kits 
Kit  Company 
Fixation/Permeabilization solution BD Bioscience 
Qiaquick Gel extraction kit Qiagen 
GeneJET Plasmid Miniprep Kit  Thermo Scientific 
QIAGEN Plasmid max kit  Qiagen 
 
4.1.6 Buffers and Solutions 
 
         Table 5: Composition of buffers and solutions. 
Buffer Composition 
Gitocher digestion buffer 
(10×) 
670 mM Tris pH 8.8 
166 mM ammonium sulfate 
65 mM MgCl2 
0.1% Gelatin 
Tail digestion buffer 
 
3 µl Proteinase K (10mg/ml stock) 
2.5 µl Triton (10% stock) 
5 µl Gitocher Buffer (10×) 
0.5 µl β-Mercaptoethanol 
39 µl H2O 
PBS (10×) 
 
1.5 M NaCl, 
30 mM KCl 
80 mM Na2HPO4 
20 mM KH2PO4 
pH adjusted to 7.2-7.4 
FACS buffer 
 
500 ml PBS  
1% bovine serum albumin (BSA)  
0.1% sodium azide 
PCR Red-buffer (5×) 250 mM KCl 
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 50 mM Tris pH8.3 
43% Glycerol 
7.5 mM MgCl2 
2 mM Cresol Red 
10x TBE  
 
900 mM Tris 
900 mM Boric acid 
20 mM EDTA (pH 8) 
Ack Buffer 0.15 M NH4Cl 
10 mM KHCO3  
0.1 mM EDTA  
LB agar 1 % tryptone  
0.5 % yeast extract  
10 mM NaCl  
1.5 % agar 
 
 
4.1.7 Cell culture media 
 
       Table 6: Cell culture media with supplements. 
Medium Supplements 
cHL-1 500 ml HL-1 medium (Whittaker) 
1% L-Glutamin with Penicillin  
/Streptomycin  ((200mM, PAA) 
1% MEM non-essential amino acids 
(100x, PAA) 
1 mM Sodium Pyruvat (Gibco) 
50 µM  β-Mercaptoethanol (Gibco) 
HAT-selection medium 
 
500 ml cIMDM medium 
12 ml Hypoxanthin/Thymidin (HT) 
0.6 ml Aminopterin 
cIMDM  500 ml IMDM medium containing L-
Glutamin  
8% Fetal calf serum (BioChrome) 
1% L-Glutamin with 
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Penicillin/Streptomycin (200mM, PAA) 
1% MEM non-essential amino acids 
(100x, PAA) 
1 mM Sodium Pyruvat (Gibco) 
50 µM β-Mercaptoethanol (Gibco) 
 
 
4.2  Methods 
 
4.2.1 Cell Culture  
 
4.2.1.1 Gerenal cell culture methods 
 
General cell culture conditions were at 37°C supplemented with 5% CO2 in complete 
medium consisting of IMDM supplemented with 10% FBS. Cells were passaged 
when 60–80% confluent at a 1:4 ratio. 
 
4.2.1.2 Ex vivo re-stimulation of PLP174-181-specific T cells 
 
Nine days after immunization with PLP160-184 peptide in CFA, mice were killed and 
the inguinal and poplietal lymph nodes were harvested for single cell preparations. 
Lymphocytes were resuspended in complete cIMDM medium (Table 6) containing 5 
µg PLP174-181 peptide and 4 x 10
6 cells/ml were seeded into 24-well plates. Cells that 
were cultured in medium only served as controls. At day 3 and day 7 of culture, 20 
U/ml recominbant human IL-2 (hIL2) were added. On day 10, testing the specificity 
of the growing clones in a proliferation assay. T cells were restimulated every 10 
days with 5 x 104 T cells with 4 x 105 lethally irradiated (3,000 rads) erythrocyte 
depleted, syngenic splenocytes or 3 x104 lethally irradiated bone-marrow derived 
dendritic cells together with 5 µg/ml cognate peptide.  
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4.2.1.3 Hybridoma generation 
 
Lymph node cells from the PLPKO single transgenic mice were stimulated with 
PLP174-181 in vitro. After 3 days, cells were washed extensively to remove the serum. 
The hybridoma fusion partner cell line BW5147 (which is a BW-cell line that 
additionally carry a GFP-reporter under the NFAT-promoter, a kind gift of Dr. 
Dominic van Essen, Institute de Recherche sur le Cancer et le Vieillissement, Nice) 
was also harvested and washed. Mix the activated T cells and BW5147 cells at a 
ratio of 1:3 and 0.5 ml of 50% polyethylene glycol (PEG) was added slowly with 
gentle mixing to promote fusion. New fused hybrodoma cells are incubated in 96-well 
plates in the HAT (Hypoxanthine Aminopetrin Thymidine) medium. Seven days later 
medium was replaced with HT medium, and growing clones were expanded in 
normal cIMDM. After 2 weeks, only the dividing HAT-resistant T-cell hybriodoma 
cells are able to survive and proliferate while unfused HAT-sensitive BW tumor cells 
died off and unfused T cells died off as well because of the lack of exogenous IL-2. 
 
4.2.1.4 Transfention of HEK 293T cells 
 
Human embryonic kidney (HEK) 293T cells were transfected by the calcium 
phosphate method.  Twenty-four hours prior to transfection, HEK 293T cells were 
seeded at a density of 1 x 106 cells in 90mm plate in 10 ml 10 mM HEPES. The 
following day, transfect cells. Preparing the following mix: 
 
450 µl H2O 
12.5 to 25 µg plasmid DNA 
50 µl 2.5 mM CaCl2 
 
The mix was incubated at 37°C for 5 to 7 minutes. After incubation, 37°C 500µl 
preheated HeBS was slowly added during vortexing. Keep 5 to 7 minutes at 37°C. 
Transfection mixture was carefully applied to the cells, then mix gently. Place the 
plate back in the incubator. 7 to 8 hours after transfection, gently changing the pre-
warmed fresh medium to the plate. Do not disturb the DNA-CaPO4 precipitates on 
the bottom of the plate. Harvest the cells 24 to 30 hours post-transfection by using 
ultracentrifugation.  
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4.2.1.5 Electroporation of cells with DNA construct 
 
In order to express pTcassette vectors containing DNA construct in A5 cells stably, 
the cells were electroporated pTα cassette vector, 25 µg linearised pTβ cassette 
vector together with 5 µg linearised NFAT-GFP vector that contained a puromycin 
resistance gene with a pulse of 250 mV at RT. After 10 minutes of incubation on ice, 
the electroporated cells were transferred into 10 ml medium. Next day the cells were 
harvested and plated into 96-well on seletion medium containing 3 µg/ml puromycin. 
The cells that were restistant to puromycin would be selected and analyzed for TCR-
expression and stimulation.  
 
4.2.1.6 Preparation of Bone-marrow derived dendritic cells (BmDCs) 
Mice were euthanized by CO2 asphyxiation. Both hind legs were removed at just 
below the knee-joint through ligaments, ensuring that the epiphysis remains intact. 
Using lint-free tissue free paper to remove the surrounding muscles and tissue on 
the tibia and femur. Keeping the bones in 70% ethanol for 1 min for disinfection and 
then the bones were transferred to PBS for rinsing off ethanol. Both ends of the bone 
were trimmed and the bone marrow cells were flushed out from tibia and femur with 
PBS using a 25G needle. The BM cells were centrifuged and then resuspended in 
tris-ammonium chloride at 37°C for 5 minutes to lyse RBC. The cells were 
centrifuged again and then strained through a filter before being resuspended in 1 ml 
cIMDM medium and counted. BM Cells were adjusted at 0.2 x 106 cells/ml 
containing 10ng/ml GM-CSF. After 3 days, the cells were passaged 1/2 in fresh 
medium with cytokines added and replated. On day 6, loosely adherent cells were 
then collected on day 6 and replated in fresh medium before being harvested on day 
7. Maturation of the DCs was induced by adding 300 ng/ml E.coli-derived LPS 
(Sigma) at 300 ng/ml. All cells were incubated at 37°C with 10% CO2.  
4.2.2 Molecular Biology 
 
4.2.2.1 PCR amplication of TCR-α and TCR-β gene  
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Genomic DNA was prepared from 1 x 106 A43-11-5 T hybridoma cells by digestion 
with proteinase K (Sigma), followed by phenol extraction and ethanol precipitation. 
Briefly, equal volume of Phenol was added to DNA, thoroughly mixed and 
centrifuged at 10,000 rpm for 5 minutes. The aqueous layer was transferred into a 
clean tube. 1/10th volumes of 3 M sodium acetate (Sigma) was added followed by 
the addition of 3 volumes of 100% ethanol (AppliChem), the reaction was incubated 
for 10 minutes at room temperature to precipitate the DNA. To remove ethanol 
solution, the DNA pellet was washed in 2 volumns of 70% ethanol. After briefly air 
drying the pellet, the DNA was dissolved in appropriate H2O. 
 
Once the genomic DNA is prepared, the PCR-based amplification process is started. 
Amplification is performed by adding genomic DNA 1 µl as the template, combined 
with primer (1.5 µl of forward and 1.5 µl of reverse primer at a concentration of 2.5 
µM), 1.5 µl of dNTP, and 1 µl advantage high-fidelity DNA polymerase and incubated 
using the following PCR programme: 
 
PCR programme for amplification of TCR cDNA: 
           2 min at 95° C 
 
 40sec at 95°C 
 45sec at 57°C 
 80sec at 72°C 
     
           5 min at 72°C 
 PCR products were loaded to 1 % agarose gels. 
    
4.2.2.2 Purify PCR products 
 
For general DNA purification purposes, 5 µg DNA was digested in a 50 µl total 
volume including: 1-2 ml of enzyme and 1x buffer (diluted from 10 x stock) specified 
by the manufacture for each enzyme (The XmaI/SacI restricted TCR-α DNA 
sequence and XhoI/SacII restricted TCR-β DNA sequences), addition of acetylated 
BSA can sometimes improve the quality and efficiency of enzyme assay for 1 hours 
at 37°C followed by agarose gel electrophoresis and Qiaquick gel purification to 
30cycles 
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isolate the required DNA fragments. 
 
4.2.2.3 Ligation  
 
After both insert and vector were successful isolated and prepared (Figure 30), the 
two fragments were ligated using T4 DNA ligase using the following reaction in a 
microcentrifuge tube on ice: 
 
1 µl Vector DNA (0.02pmol) 
3 µl Insert DNA (0.06pmol) 
1 µl T4 DNA Ligase 
Up to 10 µl Nuclease-free water  
 
Before ligation, 5'-end dephosphorylation was performed by treating alkaline 
phosphatase in order to prevent self ligation, according to the manufacturer’s 
protocol. 
 
 
Figure 30: Map of the cassette plasmid for the expression of TCR-α (A) and TCR-β 
genes (B). The XmaI/SacI restricted TCR-α DNA sequence and XhoI/SacII restricted TCR-β 
DNA sequences. 
 
 
A. 
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4.2.2.4 Transformation 
  
Plasmid DNA was prepared and screened for correct recombination, via 
transformation of the ligated DNA into competent bacterial cells. Competent E. coli 
cells were prepared as previously described in Hanahan, 1983244. Mix gently by 
pipetting up and down several times to mix the ligation mixture and the freshly 
thawed competent cells. The mixture placed on ice for 30 minutes followed by 42°C 
heat shock for 30 seconds and immediate transfer to ice to incubate for further 2 
minutes. 300 µl preheated LB medium were added to the mixture. The transformed 
cells were incubated at 37°C for 1 hour in a shaking bath. Spread 50 µl of the cells 
and ligation mixture onto LB-agar plates containing 100 mg/ml Ampicillin or 
Kanamycin depending on the antibiotic selection gene in the plasmid construct. 
Immediately palce agar plates upside down at 37°C and incubate overnight for 
production of colonies. 
 
4.2.2.5 Colony screening 
 
Well isolated colonies obtained above were picked and transferred into 5 ml LB 
medium containing appropriate antibiotic for overnight culture for DNA preparation 
using a Qiaquick Miniprep kit according to the manufacture’s protocol. Briefly, cells 
were harvested by centrifugation at 1200 rpm for 5 minutes, and resuspended the 
pellet bacterial cells in 250 µl buffer P1 followed by alkaline lysis in 250 µl buffer P2 
and neutralized by adding 350 µl buffer P3 which precipitated protein. Precipitated 
protein was removed by centrifugation for 10 minutes at 13,000 rpm. Apply the 
supernatants containing plasmid DNA to the columns and centrifuged for 1 min to 
combine DNA with membrane and remaining lysate discarded. The column is 
washed with buffers to remove any residual impurities by centrifugation at maximum 
speed. Plasmid DNA was finally eluted and released from column membrane by 
adding 50 µl dH2O and centrifugation at maximum speed for 1 min. Elution of DNA 
can be maximized by allowing the H2O to sit in the membrane for a few minutes 
before centrifugation. 
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4.2.2.6 Detection of recombinant pTα-PLP11 vector and pTβ-PLP11 vector 
To analyze the presence and orientation of the DNA insert into recombinant clones, 
restriction analysis was performed using appropriate restriction endonuclease 
enzymes. Plasmid DNA was isolated from an overnight bacterial culture and cut with 
different restriction endonucleases which found on the map of cloning vector. If the 
colony carries right orientation of the DNA insert, plasmid was sequenced with 
forward and reverse sequencing primers.  
 
Figure 31. Restriction endonuclease analysis of the recombinant pTα-PLP11 vector. 
Recombinant pTα-PLP11 vector and pTα empty cassette vector as negative control was 
digested by EcoRI, BamHI, EcoRI/BamHI, ClaI/SalI, XmaI/SacI, SalI, separated in a 1.5% 
agarose gel and stained by ethidium bromide. Line 1, 1kb DNA ladder marker; line2-3, 
EcoRI-degested DNA from two recombinant pTα-PLP11 clone and line4, pTα empty 
cassette vector; line5-6, BamHI-degested DNA from recombinant pTα-PLP11 and line7, pTa 
empty cassette vector; line8-9, EcoRI/BamHI-degested DNA from recombinant pTα-PLP11 
and line10, pTα empty cassette vector; line11-12, ClaI/SalI-degested DNA from recombinant 
pTα-PLP11 and line13, pTα empty cassette vector; line14-15, XmaI/SacI-degested DNA 
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from recombinant pTα-PLP11 and line16, pTα empty cassette vector; line17-18, SalI-
degested DNA from recombinant pTα-PLP11 and line19, pTα empty cassette vector; line 20,  
1kb DNA ladder marker. Red arrows indicate DNA fragments that belong to insertion of 
variable TCRVα gene at right direction. 
 
 
Figure 32. Restriction endonuclease analysis of the recombinant pTβ-PLP11 vector. 
Recombinant pTβ-PLP11 vectoe and pTβ empty cassette vector as negative control was 
digested by EcoRI, BamHI, EcoRI/BamHI, XhoI/SacII, PvuI, KpnI, separated in a 1.5% 
agarose gel and stained by ethidium bromide. Line 1, 1kb plus DNA ladder marker; Line 2, 
1kb DNA ladder marker; line3-4, EcoRI-degested DNA from recombinant pTβ-PLP11 clone 
(cl) and line5, pTβ empty cassette vector; line6-7, BamHI-degested DNA from recombinant 
pTβ-PLP11 and line8, pTβ empty cassette vector; line9-10, EcoRI/BamHI-degested DNA 
from recombinant pTβ-PLP11 and line11, pTβ empty cassette vector; line12-13, XhoI/SacII-
degested DNA from recombinant pTβ-PLP11 and line14, pTβ empty cassette vector; line15-
16, PvuI-degested DNA from recombinant pTβ-PLP11 and line17, pTβ empty cassette 
vector; line18-19, KpnI-degested DNA from recombinant pTβ-PLP11 and line20, pTβ empty 
cassette vector; Line 21, 1kb plus DNA ladder marker; Line 22, 1kb DNA ladder marker. Red 
arrows indicate DNA fragments that belong to insertion of variable TCRVβ gene at right 
direction. 
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For confirmation of variable TCRVα gene position in pTα cassette vector, XhoI and 
SacI restriction enzymes were selected because its restriction site is found in both 
variable TCRVα gene and pTa cassette vector. After digestion of pTa cassette 
vector containing variable TCRVα gene with XmaI and SacI restriction enzyme, 
variable TCRVα DNA fragments were observed (indicated as red arrow) (Figure 31). 
The recombinant pTα-PLP11 vector was also cut with other restriction endonuclease 
enzymes which were chosen from the map of pTα cassette vectors to further confirm 
the recombinant pTα-PLP11 vector containing the variable TCRVα gene at right 
position. 
Recombinant pTβ-PLP11 vector was also digested with XhoI and SacII restriction 
enzyme to confirm position of variable TCRVβ gene in the vector (Figure 32). 
TCRVβ gene contains XhoI and SacII restriction (indicated as red arrow), meanwhile, 
the backbone of the pTβ cassette vector was seen. Self ligation of pTβ-PLP11 vector 
was not seen the TCRVβ gene fragment after XhoI/SacII cut. Similarly, the 
recombinant pTβ-PLP11 vector was also cut with other restriction endonuclease 
enzymesto further confirm TCRVβ gene was constructed into pTβ cassette vector at 
right position and direction. 
As showed in the electropherogram of digestion product, which indicated 
recombinant pTα-PLP11 vector and recombinant pTβ-PLP11 vector had been 
successfully constructed.  
4.2.2.7 Large scale preparation of targeted DNA and purification 
 
Bacterial cultures for plasmid preparations should be grown from a single colony 
picked from a freshly streaked plate or a freshly transformed. Targeted DNA isolation 
was carried out according to the manufacturer recommendation of the large 
construct kit (Qiagen) with some modification to the supplied protocol. 500 µl of the 
starter culture were added into 4 flasks which contain the appropriate antibiotic in 
500ml LB medium, and then incubated for 12-16 hours at 37°C 300rpm. Bacteria 
cells were harvested by centrifugation at 3,500g for 10 minutes at 4°C. Pellets were 
resuspended in 12 ml P1 buffer/RNase A. Next, 12 ml P2 buffer were added and 
inverted the tube gently to obtain a cleared lysate. After adding P3 buffer the solution 
turn white and a precipitate forms indicating butter neutralization is complete. The 
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mixture was centrifuged at 14,000g for 30 minutes at 4°C. Cleared supernatant was 
transferred to the filter colomn and allowed the column to empty by gravity flow. The 
column was washed twice using buffer QC to remove contaminants in the plasmid 
DNA. DNA was eluted with 15ml pre-warmed Buffer QF. Eluted DNA was 
precipitated by adding 10 ml isopropanol and then centrifuged at 3,000g for 60 
minutes at 4°C. DNA pellet was washed with 5 ml 70% ethanol, and centrifuged at 
15,000g for 20 minutes at 4°C. Plasmid DNA was finally eluted by adding 200 µl-500 
µl dH2O, depending on pellet size. 
 
The purified DNA was linearized with the appropriate restriction enzyme (SalI sites in 
pTα cass, and KpnI sites in pTβ cass). Briefly, for the α chain, the targeted DNA was 
incubated at 37°C in the presence of 100U SalI in the presence of the appropriated 
reaction buffer in 400µl reactions. For the β chain, similarly, the targeted DNA was 
incubated at 37°C in the presence of 100U KpnI in the presence of the appropriated 
reaction buffer in 400µl reactions. The reactions were verified on a 1% agarose gel. 
Following linearization targeted DNA was cleaned up using a standard phenol 
extraction.  
 
4.2.2.8 Transgenic mouse production 
 
Transgenic mice were generated by injection of linearized DNA into pronuclei of 
C57BL/6 zygotes. Microinjection was performed by Ronald Naumann at the Max 
Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. 
Founders and offspring generated by backcrossing onto C57BL/6 were screened for 
transgene expression by PCR using genomic DNA. PCR products were visualized 
on 2% (w/v) agarose gels after electrophoresis. Microscopic images were acquired 
using Leica Application suite andfurther processed with Photoshop CS6. 
 
4.2.3 Immunological Methods  
 
4.2.3.1 T cell Proliferation Assay 
 
Proliferation responses were assessed by using 4 x 105 T cells plus 3 x 104  
irradiated (3,000 rads) BmDCs per well in cHL-1 medium alone as control or in the 
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presence of peptide at varied concentrations. Cultures were incubated for 72 hours 
at 37°C in 7% CO2 in round-bottom 96-well plates. Three days later, cells were 
pulsed with one microCurie of thymidine 3H-thyminidine for additional 20 hours and 
harvested onto filters according to manufacturer instructions. Measuring the amount 
of incorporated radioactive-labeled thymidine using a BetaPlate liquid scintillation 
counter (Wallac, Gaithersburg, MD).  
 
4.2.3.2 IL-2 ELISA 
 
Hybridoma cells (105/well in a 96-well plate) were incubated with 106 irradiated 
(3,000 rads) syngeneic splenocytes in medium alone or in the presence of 5 µg/ml 
individual peptides or 5 µg/ml ConA at 37°C, 10% CO2. The Supernatants were 
collected for analysis 72 hours after stimulation from the top of the culture by 
quantitative capture ELISA according to the manufacturers guidelines (BD OptEIA™, 
BD Bioscience). Assays were performed with TMB Microwell Peroxidase Substrate 
and read at 450nm. 
 
4.2.3.3 Cell surface staining 
 
Single cell suspensions were incubated in FCS buffer with diluted fluorochrome-
labeled antibodies on ice and under light protection for 30 minutes. Biotinylated 
antibodies were visualized by Streptavidin-PE-Cy7. After staining, cells were washed 
once and re-suspended in FACS buffer and analyzed on a FACSCanto (BD 
Bioscience). Flow cytometry data were acquired and analyzed with Flowjo software.  
 
4.2.3.4 Intracellular Foxp3 staining 
 
After surface staining, cells were fixed and permeabilized using the Foxp3 Staining 
Buffer according to manufacturer’s instructions. Briefly, cells were incubated in 
Fixation for 45 minutes. Fixed cells were washed twice with permeabilization Buffer. 
The Foxp3 antibody were added and incubated for another 30 minutes at 4 °C. 
Washed as above twice with Permeabilization Buffer and re-suspended in FACS 
buffer for subsequent FACS analysis. 
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4.2.3.5 In vivo Cell Division Analysis  
 
Total CD4+ T cells were isolated from the spleens and draining lymph nodes of TCR-
PLP1/TCR-PLP11 transgenic mice and stained with CFSE. A maximum 
concentration of 1 × 107 cells/ml were incubated in 5 µM CFSE in 0.1% BSA buffer 
for 10 minutes at 37°C. Cells were washed with FACS buffer and resuspended in 
PBS at a concentration of 2.5 × 107 splenocytes/ml. Subsequently, 5 × 106 TCR-
PLP1/TCR-PLP11 CD45.1+ splenocytes were injected intravenously into recipient 
PLPWT, PLPKO, and the different subsets of chimeric mice. 4 days later, pooled 
spleen and lymph node cells were harvested, subjected to CD4+ cell enrichment, and 
diluted levels of CFSE fluorescence on Plp1/Plp11-specific T cells, indicative of cell 
division, were analyzed by flow cytometry. 
 
4.2.4 Animal Experiments 
 
4.2.4.1 Genotyping of mice 
 
Transgenic animals were genotyped by PCR of genomic DNA extracted from tail 
biopsies. The tail biopsies were clipped after weaning and digested in 50 µl tail 
digestion buffer for 5 hours at 55°C, supplemented with Proteinase K (Invitrogen) at 
95°C for 5 minutes. 1 µl of the lysate was directly used as template in the PCR 
reactions, and the total volume of the PCR was 30 µl with the following composition: 
 
1 µl Tail genomic DNA 1 µl (10 ng-500 ng)  
6 µl 10x Taq buffer with MgCl2  
3 µl dNTP mix (2.5 mM)  
3 µl Forward Primer (10 µM stock)  
3 µl Reverse Primer (10 µM stock)  
1 µl Taq DNA Polymerase (5 units/µL)  
13 µl Sterile dH2O   
 
The PCR reactions for genotyping TCR-PLP1, TCR-PLP11, CD11c-Cre, DTA, PLPfl/fl, 
Foxn1-Cre, Rag1KO followed the TCR-program TD54x30:  
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           3min at 94° C 
 
 45sec at 94°C 
 45sec at 60°C 
 60sec at 72°C 
     
 45sec at 94°C 
 45sec at 58°C 
 60sec at 72°C 
   
 45sec at 94°C 
 45sec at 56°C 
 60sec at 72°C 
     
 45sec at 94°C 
 45sec at 54°C 
 60sec at 72°C    
            
          10min at 72°C 
 forever at 15 °C           
          
DNA products were separated by agarose (1.5 % in 1 x TBE buffer) gel 
electrophoresis according to their size. The gels contained 0.15 µg/ml ethidium 
bromide to visualize the separated DNA bands under UV light (312 nm). 
 
4.2.4.2 Immunization of animals  
Six- to eight-week-old male and female mice were immunized with 50 µg Plp1/Plp11 
peptide in equal amounts of complete Freund´s adjuvant (CFA) containing 
Mycobacterium tuberculosis (Sigma) at a final concentration of 1 mg/ml. 50 µl of this 
emulsion was injected subcutaneously into the footpad of the hindleg of the mouse.  
 
 
2 cycles 
	  
 2 cycles  
	  
2 cycles 
	  
30 cycles 
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4.2.4.3 Irradiation Bone Marrow Chimeras 
Lethally irradiated (950 rads) PLPWT or PLPKO mice were reconstituted intravenously 
with 107 bone marrow cells from the femurs of CD45.1 or CD45.2 congenic 
MHCWTPLPWT or MHCKOPLPWT mice. Lymphoid tissues from the resulting chimeric 
mice were harvested 8 weeks later for analysis of Plp1-specific T cells. 
4.2.4.4 T Cell Transfers 
Total CD4+ T cells from the pooled spleen and lymph nodes of TCR-PLP1/TCR-
PLP11 WT or PLPKO transgenic mice were magnetically purified (Miltenyi) and 5 × 
106 were transferred intravenously into CD45.1 or CD45.2 congenic WT mice. 
Recipient mice were immunized 6 hours ago before the cell transfer, and host TCR-
PLP1/11-specific CD4+ T cells were isolated and analyzed 3 days later. 
4.2.4.5 Induction and evaluation of EAE 
For triggering transfer EAE, CD4+ T cell from TCR-PLP1 PLPKO mice (3-5 x 106 per 
mouse) were injected into the tail vein of the PLPWT or PLPKO recipient mice. Mice 
were weighed and monitored daily for clinical symptoms (Table 7). The same scoring 
system was used for active EAE experiments.  
For active EAE induction, mice were injected at base of backs with 200 µg PLP 
peptide emulsified in equal amounts of CFA. Pertussis toxin (400 ng) was 
administered intraperitoneally (i.p.) on days 0 and 2 following immunization. Animals 
reaching a score of 4 were eliminated. 
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Table 7: Classification of assessment of EAE score. 
Score Clinical symptom 
0 No symptoms 
0.5 Patial loss of tail tonus 
1 Complete loss of tail tonus 
1.5 Flaccid tail and subtle gait disturbance 
2 Partial hind leg paralysis 
2.5 Paralysis of a single hind limb  
3 Complete hind limb paresis, mouse is able to move forward using 
their fore limbs 
3.5 The fore limbs of mouse is partially paralysis leading to impaired 
forward movement 
4 No moving but eating 
5 No mobility/moribund. 
 
 
4.2.5 Statistical analysis 
 
Statistical analyses were performed using Prism 5.0 (Graphpad). Data is always 
depicted as mean ± standard error of the mean (SEM). Two-tailed Student’s t test 
was performed to analyze the statistical significance.  
References 
	   	   	  98	  
5. References 
 
1. Miller, J.F. 1961. Immunological function of the thymus. Lancet 2:748-749. 
2. Bevan, M.J. 1977. In a radiation chimaera, host H-2 antigens determine the immune 
responsiveness of donor cytotoxic cells. Nature 269:417-418. 
3. Zinkernagel, R.M., G.N. Callahan, A. Althage, S. Cooper, P.A. Klein, and J. Klein. 
1978. On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for 
dual recognition? J Exp Med 147:882-896. 
4. Sainte-Marie, G., and C.P. Leblond. 1964. Cytologic features and cellular migration 
in the cortex and medulla of thymus in the young adult rat. Blood 23: 275-299. 
5. Cantor, H., and I. Weissman. 1976. Development and function of subpopulations of 
thymocytes and T lymphocytes. Prog Allergy 20:1-64. 
6. Petrie, H.T. 2003. Cell migration and the control of post-natal T-cell lymphopoiesis in 
the thymus. Nat Rev Immunol 3:859-866. 
7. Gray, D.H., T. Ueno, A.P. Chidgey, M. Malin, G.L. Goldberg, Y. Takahama, and R.L. 
Boyd. 2005. Controlling the thymic microenvironment. Curr Opin Immunol 17:137-143. 
8. Rossi, S.W., W.E. Jenkinson, G. Anderson, and E.J. Jenkinson. 2006. Clonal 
analysis reveals a common progenitor for thymic cortical and medullary epithelium. Nature 
441:988-991. 
9. Anderson, G, E.J. Jenkinson, N.C. Moore, and J.J. Owen. 1993. MHC class II-
positive epithelium and mesenchyme cells are both required for T-cell development in the 
thymus. Nature 362:70-73. 
10. Klug D.B., C. Carter, I.B. Gimenez-Conti, and E.R. Richie. 2002. Cutting edge: 
thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal 
thymus. J Immunol 169:2842-2845. 
11. Shores, E. W., W. van Ewijk, and A. Singer.1991. Disorganization and restoration of 
thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that 
receptor-bearing lymphocytes influence maturation of the thymic microenvironment. Eur J 
Immunol 21:1657-1661. 
12. van Ewijk, W., E.W. Shores, and A. Singer. 1994. Crosstalk in the mouse thymus. 
Immunol Today 15:214-217. 
13. Bleul, C. C. and T. Boehm. 2000 Chemokines define distinct microenvironments in 
the developing thymus. Eur J Immunol 30:3371-3379. 
14. Liu, C. 2005. The role of CCL21 in recruitment of T precursor cells to fetal thymus. 
Blood 105:31-39. 
15. Wurbel, M.A., M. Malissen, D. Guy-Grand, E. Meffre, M.C. Nussenzweig, M. 
Richelme, A. Carrier, and B. Malissen. 2001. Mice lacking the CCR9 CC-chemokine 
receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell 
receptor γδ+ gut intraepithelial lymphocytes. Blood 98:2626-2632. 
16. Rossi, F.M. 2005. Recruitment of adult thymic progenitors is regulated by P-selectin 
and its ligand PSGL-1. Nat Immunol 6:626-634. 
17. Godfrey, D.I., J. Kennedy, T. Suda, and A. Zlotnik. 1993. A developmental pathway 
involving four phenotypically and functionally distinct subsets of CD3−CD4−CD8− triple 
negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 
150:4244-4252. 
18. Anderson, G., N.C. Moore, J.J. Owen, and E.J. Jenkinson. 1996. Cellular interactions 
in thymocyte development. Annu Rev Immunol 14:73-99.  
19. Zúñiga-Pflücker, J.C., and M.J. Lenardo. 1996. Regulation of thymocyte 
development fromimmature progenitors. Curr Opin Immunol 8:215-224. 
20. Lind E.F., S.E. Prockop, H.E. Porritt, and H.T. Petrie. 2001. Mapping precursor 
movement through the postnatal thymus reveals specific microenvironments supporting 
defined stages of early lymphoid development. J Exp Med 194:127-134. 
21. Petrie H.T., and J.C. Zuniga-Pflücker. 2007. Zoned out: functional mapping of 
stromal signaling microenvironments in the thymus. Annu. Rev. Immunol. 25:649-79. 
References 
	   	   	  99	  
22. Shortman, K., and L. Wu. 1996. Early T lymphocyte progenitors. Annu Rev Immunol 
14: 29-47.  
23. Dunon, D., D. Courtois, O. Vainio, A. Six, C.H. Chen, M.D. Cooper, J.P. Dangy, and 
B.A. Imhof. 1997. Ontogeny of the immune system:  gamma/delta and  alpha/beta  T  cells 
migrate from thymus to the periphery in alternating waves. J Exp Med 186:977-988. 
24. Allman, D., A. Sambandam, S. Kim, J.P. Miller, A. Pagan, D. Well, A. Meraz, and A. 
Bhandoola. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat 
Immunol 4:168-174. 
25. Han, H., K. Tanigaki, N. Yamamoto, K. Kuroda, M. Yoshimoto, T. Nakahata, K. Ikuta, 
and T. Honjo. 2002. Inducible gene knockout of transcription factor recombination signal 
binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 
14:637-645. 
26. Schmitt, T.M., and J.C. Zúñiga-Pflücker. 2002. Induction of T cell development from 
hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749-756. 
27. Moore, T.A., and A. Zlotnik. 1995. T-cell lineage commitment and cytokine response 
of thymic progenitors. Blood 86:1850-1860. 
28. Schmitt, T.M., M. Ciofani, H.T. Petrie, and J.C. Zuniga-Pflucker. 2004. Maintenance 
of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. 
J Exp Med 200:469-479. 
29. Taghon, T.N., E.S. David, J.C. Zuniga-Pflucker, and E.V. Rothenberg. 2005.  
Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta 
signaling. Genes Dev 19:965-978. 
30. Durum, S.K., S. Candeias, H. Nakajima, W.J. Leonard, A.M. Baird, L.J. Berg, and K. 
Muegge. 1998. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: 
role of receptor-associated chains and locus accessibility. J Exp Med 188:2233-2241. 
31. Maraskovsky, E., M. Teepe, P.J. Morrissey, S. Braddy, R.E. Miller, D.H. Lynch, and 
and J.J. Peschon. 1996. Impaired Survival and Proliferation in IL-7 Receptor-Deficient 
Peripheral T Cells receptor-deficient peripheral T cells. J Immunol 157:5315-5323.  
32. Vissinga, C.S., D.J. Fatur-Saunders, and F. Takei. 1992. Dual role of IL-7 in the 
growth and differentiation of immature thymocytes. Exp Hematol 20:998-1003.  
33. Melichar H.J., K. Narayan, S.D. Der, Y. Hiraoka, N. Gardiol, and G. Jeannet. 2007. 
Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription 
factor SOX13. Science 315:230-233. 
34. Porritt, H.E., K.Gordon, and H.T. Petrie. 2003. Kinetics of Steady-state Differentiation 
and Mapping of Intrathymic-signaling Environments by Stem Cell Transplantation in 
Nonirradiated Mice.  J Exp Med 198:957-962. 
35. Godfrey, D.I., J. Kennedy, P. Mombaerts, S. Tonegawa, and A. Zlotnik. 1994. Onset 
of TCR-beta gene rearrangement and role of TCR-beta expression during CD3−CD4−CD8− 
thymocyte differentiation. J Immunol 152:4783-92. 
36. Capone, M., R.D. Hockett, and A. Zlotnik. 1998. Kinetics of T cell receptor beta, 
gamma, and delta rearrangements during adult thymic development: T cell receptor 
rearrangements are present in CD44+CD25+ Pro-T thymocytes. Proc Natl Acad Sci U S A 
95:12522-12527. 
37. Livak, F., M. Tourigny, D.G. Schatz, and H.T. Petrie. 1999. Characterization of TCR 
gene rearrangements during adult murine T cell development. J Immunol 162:2575-2580. 
38. Robey, E. and B.J. Fowlkes. 1994. Selective events in T-cell development. Annu Rev 
Immunol 12:675-705. 
39. von Boehmer, H. 2005. Unique features of the pre-T-cell receptor α-chain: not just a 
surrogate. Nat Rev Immunol 5:571-577. 
40. Taghon, T. and E.V. Rothenberg. 2008. Molecular mechanisms that control mouse 
and human TCR-αβ and TCR-γδ T cell development. Semin Immunopathol 30:383-398. 
41. Tanaka, Y., L. Ardouin, A. Gillet, S.Y. Lin, A. Magnan, B. Malissen, and M. Malissen. 
1995. Early T cell development in CD3-deficient mice. Immunol Rev 148:171-199. 
42. Groettrup, M. 1993. A novel disulfide-linked heterodimeron pre-T cells consists of the 
References 
	   	   	  100	  
T-cell receptor β-chain and a 33 kD glycoprotein. Cell 75:283-294. 
43. von Boehmer, H. and H.J. Fehling. 1997. Structure and function of the pre-T-cell 
receptor. Annu Rev Immunol 15:433-452. 
44. Aifantis, I., J. Feinberg, H.J. Fehling, J.P. Di Santo, and H. von Boehmer. 1999. Early 
T-cell receptor-β gene expression is regulated by the pre-T-cell-receptor-CD3 complex. J 
Exp Med 190:141-144. 
45. Saint-Ruf, C., K. Ungewiss, M. Groettrup, L. Bruno, H.J. Fehling, and. H. von 
Boehmer. 1994. Analysis and expression of a cloned pre-T cell receptor gene. Science 
266:1208-1212.  
46. Levelt, C.N., and K. Eichmann. 1995. Receptors and signals in early thymic selection. 
Immunity 3:667-672 
47. Wilson, A., W. Held, and H.R. MacDonald. 1994. Two waves of recombinase gene 
expression in developing thymocytes. J Exp Med 179:1355-1360 
48. Vasseur, F., A. Le Campion, and C. Penit. 2001. Scheduled kinetics of cell 
proliferation and phenotypic changes during immature thymocyte generation. Eur J Immunol 
31:3038-3047. 
49. Trampont, P.C. 2010. CXCR4 acts as a costimulator during thymic beta-selection. 
Nat Immunol 11:162-170. 
50. Maillard, I. 2006. The requirement for Notch signaling at the beta-selection 
checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med 
203:2239-2245. 
51. Peschon, J. J. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 
receptor-deficient mice. J Exp Med 180:1955-1960. 
52. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil, S.E. Burdach, and R. 
Murray. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a 
nonredundant cytokine. J Exp Med 181:1519-1526. 
53. Mombaerts, P., A.R. Clarke, M.A. Rudnicki, J. Iacomini, S. Itohara, J.J. Lafaille, L.L. 
Wang, Y. Ichikawa, R. Jaenisch, M.L. Hooper, and S. Tonegawa. 1992. Mutations in T-cell 
antigen receptor genes and block thymocyte development at different stages. Nature 
360:225-231. 
54. Shinkai, Y., S. Koyasu, K. Nakayama, K.M. Murphy, D.Y. Loh, E.L. Reinherz, and F. 
W. Alt. 1993. Restoration of T cell development in RAG-2-deficient mice by functional TCR 
transgenes. Science 259:822-825. 
55. Hoffman, E. S., L. Passoni, T. Crompton, T.M. Leu, D.G. Schatz, A. Koff, M.J. Owen, 
and A.C. Hayday. 1996. Productive T-cell receptor -chain gene rearrangement: coincident 
regulation of cell cycle and clonality during development in vivo. Genes Dev 10:948-962. 
56. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of 
thymocytes. Annu Rev Immunol 13:93-126. 
57. Starr, T.K., S.C. Jameson, and K.A. Hogquist. 2003. Positive and negative selection 
of T cells. Annu Rev Immunol 21:139-176. 
58. Godfrey, D.I., and A. Zlotnik. 1993. Control points in early T-cell development. 
Immunol Today 14:547-553. 
59. Kisielow, P., and H. von Boehmer. 1995. Development and selection of T cells: facts 
and puzzles. Adv Immunol 58:87-209. 
60. Biddison, W.E., P.E., Rao, M.A Talle,., G. Goldstein, and S. Shaw. 1982. Possible 
involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens. Evidence 
from studies of cytotoxic T lymphocytes specific for SB antigens. J Exp Med 156:1065-1076. 
61. Swain, S. L. 1983. T-cell subsets and the recognition of MHC class. Immunol Rev 
74:129-142. 
62. Chi, A.W., J.J. Bell, D.A. Zlotoff, and A. Bhandoola. 2009. Untangling the T branch of 
the hematopoiesis tree. Curr Opin Immunol 21:121-126. 
63. Maillard, I., T. Fang, and W.S. Pear. 2005. Regulation of lymphoid development, 
differentiation, and function by the Notch pathway. Annu Rev Immunol 23:945-974. 
64. Radtke, F., N. Fasnacht, and H.R. Macdonald. 2010. Notch signaling in the immune 
References 
	   	   	  101	  
system. Immunity 32:14-27. 
65. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., Aguet M. 
1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. 
Immunity 10:547-558.  
66. Pui, J.C., D. Allman, L. Xu, S. DeRocco, F.G. Karnell, S. Bakkour, J.Y. Lee, T. 
Kadesch, R.R. Hardy, J.C. Aster, and W.S. Pear. 1999. Notch1 expression in early 
lymphopoiesis influences B versus T lineage determination. Immunity 11:299-308.  
67. Wolfer, A., T. Bakker, A. Wilson, M. Nicolas, V. Ioannidis, D.R. Littman, P.P. Lee, 
C.B. Wilson, W. Held, H.R. MacDonald, and F. Radtke. 2001. Inactivation of Notch 1 in 
immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol 2:235-
241. 
68. Haks, M.C. 2005. Attenuation of γδTCR signaling efficiently diverts thymocytes to the 
αβ lineage. Immunity 22:595-606. 
69. Garbe, A.I., A. Krueger, F. Gounari, J.C. Zuniga-Pflucker, and H. von Boehmer. 2006. 
Differential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage 
fate. J Exp Med 203:1579-1590. 
70. Lauritsen, J.P. 2009. Marked induction of the helix-loop-helix protein Id3 promotes 
the γδ T cell fate and renders their functional maturation Notch independent. Immunity 
31:565-575. 
71. Taghon, T., M.A. Yui, R. Pant, R.A. Diamond, and E.V. Rothenberg. 2006. 
Developmental and molecular characterization of emerging β- and γδ-selected pre-T cells in 
the adult mouse thymus. Immunity 24:53-64. 
72. Cobaleda, C., A. Schebesta, A. Delogu, and M. Busslinger. 2007. Pax5: the guardian 
of B cell identity and function. Nat Immunol 8:463-470. 
73. Benoist, C. and D. Mathis. 1989. Positive selection of the T cell repertoire: where and 
when does it occur? Cell 58:1027-1033. 
74. Kisielow, P., H.S. Teh, H. Bluthmann, and H. von Boehmer. 1988. Positive selection 
of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730-733. 
75. Sakaguchi, S. 2005. Naturally arising CD4+ regulatory T cells for immunologic self-
tolerance and negative control of immune responses. Ann Rev Immunol 22:531-562. 
76. Watanabe, N. 2005. Hassall’s corpuscles instruct dendritic cells to induce 
CD4+CD25+ regulatory T cells in human thymus. Nature 436:1181-1185. 
77. Fontenot, J.D. 2005. Regulatory T cell lineage specification by the forkhead 
transcription factor Foxp3. Immunity 22:329-341.     
78. Tanaka, K. and M. Kasahara. 1998. The MHC class I ligand-generating system: roles 
of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. 
Immunol Rev 163:161-176. 
79. Murata, S. 2007. Regulation of CD8+ T cell development by thymus-specific 
proteasomes. Science 316, 1349-1353.       
80. Florea, B.I., M. Verdoes, N. Li, W.A. van der Linden, and P.P. Geurink. 2010. 
Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit 
beta5t. Chem biol 17:795-801.  
81. Murata, S., Y. Takahama, and K. Tanaka. 2008. Thymoproteasome: probable role in 
generating positively selecting peptides. Curr Opin Immunol 20:192-196. 
82. Nitta, T. 2010. Thymoproteasome shapes immunocompetent repertoire of CD8+ T 
cells. Immunity 32:29-40. 
83. Hsing, L.C. and A.Y. Rudensky. 2005. The lysosomal cysteine proteases in MHC 
class II antigen presentation. Immunol Rev 207:229-241. 
84. Klein, L., M. Hinterberger, G. Wirnsberger, and B. Kyewski. 2009. Antigen 
presentation in the thymus for positive selection and central tolerance induction. Nat Rev 
Immunol 9:833-844.    
85. Nakagawa, T. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell 
selection in the thymus. Science 280:450-453.    
86. Gommeaux, J. 2009. Thymus-specific serine protease regulates positive selection of 
References 
	   	   	  102	  
a subset of CD4+ thymocytes. Eur J Immunol 39:956-964.     
87. Hsing, L.C. 2010. Roles for cathepsins S, L, and B in insulitis and diabetes in the 
NOD mouse. J autoimmun 34:96-104. 
88. Viret, C., S. Leung-Theung-Long, L. Serre, C. Lamare, D.A. Vignali, B. Malissen, A 
Carrier, and S. Guerder. 2011. Thymus-specific serine protease controls autoreactive CD4 T 
cell development and autoimmune diabetes in mice. J Clin Invest 121:1810-1821. 
89. Maehr, R. 2005. Cathepsin L is essential for onset of autoimmune diabetes in NOD 
mice. J Clin Invest 115:2934-2943. 
90. Chicz, R.M. 1993. Specificity and promiscuity among naturally processed peptides 
bound to HLA-DR alleles. J Exp Med 178:27-47. 
91. Brazil, M.I., S. Weiss, and B. Stockinger. 1997. Excessive degradation of intracellular 
protein in macrophages prevents presentation in the context of major histocompatibility 
complex class II molecules. Eur J Immunol 27:1506-1514. 
92. Schmid, D., M. Pypaert, and C. Munz. 2007. Antigen-loading compartments for major 
histocompatibility complex class II molecules continuously receive input from 
autophagosomes. Immunity 26:79-92. 
93. Nedjic, J., M. Aichinger, J. Emmerich, N. Mizushima, and L. Klein. 2008.  Autophagy  
in  thymic  epithelium  shapes  the  T-cell  repertoire and  is  essential  for  tolerance. Nature 
455:396-400. 
94. Nedjic, J., M. Aichinger, N. Mizushima, and L. Klein. 2009. Macroautophagy, 
endogenous MHC  II  loading  and  T  cell  selection:  the  benefits  of breaking the rules. 
Curr Opin Immunol 21:92-97. 
95. von Boehmer, H. and F. Melchers. 2010. Checkpoints in lymphocyte development 
and autoimmune disease. Nat Immunol 11:14-20. 
96. Kyewski, B. and Derbinski, J. 2004. Self-representation in the thymus: an extended 
view. Nat Rev Immunol 4:688-698. 
97. Zuklys, S. 2000. Normal thymic architecture and negative selection are associated                          
with Aire expression, the gene defective in the autoimmunepolyendocrinopathy-candidiasis-
ectodermal dystrophy (APECED). J Immunol 165:1976-1983. 
98. Derbinski, J., J. Gäbler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. 
Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic 
epithelial cells is regulated at multiple levels. J Exp Med 202:33-45. 
99. Klein, L., T. Klein, U. Ruther, and B. Kyewski. 1998. CD4 T cell tolerance to human 
C- reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. 
J Exp Med 188:5-16. 
100. Liston, A., S. Lesage, J. Wilson, L. Peltonen, and C.C. Goodnow. 2003. Aire 
regulates negative selection of organ-specific T cells. Nat Immunol 4:350-354.100. Rev 
Immunol 4:688-698. 
101. Anderson, M.S., E.S. Venanzi, Z. Chen, S.P. Berzins, C. Benoist, and D. Mathis. 
2005. The cellular mechanism of Aire control of T cell tolerance. Immunity 23:227-239. 
102. Hinterberger, M., M. Aichinger, O. Prazeres da Costa, D. Voehringer, R. Hoffmann, 
and  L. Klein. 2010. Autonomous role of medullary thymic epithelial cells in central CD4(+) T 
cell tolerance. Nat Immunol 11:512-519.  
103. Ohnmacht, C., A. Pullner, S.B. King, I. Drexler, S. Meier, T. Brocker, and D. 
Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells 
and results in spontaneous fatal autoimmunity. J Exp Med 206:549-559.  
104. Brocker, T. 1999. The role of dendritic cells in T cell selection and survival. J Leukoc 
Biol 66:331-335. 
105. Carlow, D.A., S.J. Teh, N.S. van Oers, R.G. Miller, and H.S. Teh. 1992. Peripheral 
tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol 4:599-610. 
106. McCaughtry, T.M., T.A. Baldwin, M.S. Wilken, and K.A. Hogquist. 2008. Clonal 
deletion of thymocytes can occur in the cortex with no involvement of the medulla. J Exp 
Med 205:2575-2584.   
107. Miyama-Inaba, M., S. Kuma, K. Inaba, H. Ogata, H. Iwai, R. Yasumizu, S. 
References 
	   	   	  103	  
Muramatsu, R.M. Steinman, and S. Ikehara.1988. Unusual phenotype of B cells in the 
thymus of normal mice. J Exp Med 168: 811-816. 
108. Berg, L.J., A.M. Pullen, B. Fazekas de St Groth, D. Mathis, C. Benoist, and M.M. 
Davis. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the 
presence of their MHC ligand. Cell 58:1035-1046. 
109. Bensinger, S.J., A. Bandeira, M.S. Jordan, A.J. Caton, and T.M. Laufer. 2001. Major 
histocompatibility complex class II-positive cortical epithelium mediates the selection of 
CD4+25+ immunoregulatory T cells. J Exp Med 194:427-438.  
110. Liston, A., K.M. Nutsch, A.G. Farr, J.M. Lund, J.P. Rasmussen, P.A. Koni, and A.Y. 
Rudensky 2008. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl 
Acad Sci U S A 105:11903-11908. 
111. Xing, Y., S.C. Jameson, and K.A. Hogquist. 2013. Thymoproteasome subunit-β5T 
generates peptide-MHC complexes specialized for positive selection. . Proc Natl Acad Sci U 
S A 110:6979-6984.  
112. Sebzda, E. 1994. Positive and negative thymocyte selection induced by different 
concentrations of a single peptide. Science 263:1615-1618. 
113. Alam, S.M. 1996.  T-cell-receptor affinity and thymocyte  positive selection. Nature 
381:616-620. 
114. Viret, C. 2011. Thymus-specific serine protease contributes to the diversification of 
the functional endogenous CD4 T cell receptor repertoire. J Exp Med 208:3-11  
115. Honey, K. 2002. Cathepsin L regulates CD4+ T cell selection independently of its 
effect on invariant chain: a role in the generation of positively selecting peptide ligands. J 
Exp Med 195:1349-1358  
116. Kasai, M. 1996. Difference in antigen presentation pathways between cortical and 
medullary thymic epithelial cells. Eur J Immunol 26:2101-2107.  
117. Klein, L., B. Roettinger, and B. Kyewski. 2001. Sampling of complementing self-
antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur J 
Immunol 31:2476-2486.      
118. Oukka, M. 1997. Selectivity of the major histocompatibility complex class II 
presentation pathway of cortical thymic epithelial cell lines. Eur J Immunol 27:855-859.  
119. Munz, C. 2009. Enhancing immunity through autophagy. Annu Rev Immunol 27:423-
449.  
120. Mathis, D., and C. Benoist. 2009. Aire. Annu Rev Immunol 27:287-312. 
121. Peterson, P., T. Org, and A. Rebane. 2008. Transcriptional regulation by AIRE: 
molecular mechanisms of central tolerance. Nat Rev Immunol 8:948-957. 
122. Surh, C.D. 1992. Two subsets of epithelial cells in the thymic medulla. J Exp Med 
176:495-505.   
123. Nelson, A.J., S. Hosier, W. Brady, P.S. Linsley, and A.G. Farr. 1993. Medullary 
thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J Immunol 151:2453-
2461.   
124. Gabler, J., J. Arnold, and B. Kyewski. 2007. Promiscuous gene expression and the 
developmental dynamics of medullary thymic epithelial cells. Eur J Immunol 37: 3363-3372.  
125. Gray, D., J. Abramson, C. Benoist, and D. Mathis. 2007. Proliferative arrest and rapid 
turnover of thymic epithelial cells expressing Aire. J Exp Med 204:2521-2528. 
126. Consortium, F.G. 1997. An autoimmune disease, APECED, caused by mutations in a 
novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17:399-403.  
127. Nagamine, K., P. Peterson, H.S. Scott, J. Kudoh, S. Minoshima, and M. Heino, K.J. 
Krohn, M.D. Lalioti, P.E. Mullis, S.E. Antonarakis, K. Kawasaki, S. Asakawa, F. Ito, and N. 
Shimizu. 1997. Positional cloning of the APECED gene. Nat Genet 17:393-398. 
128. Jiang, W., M.S. Anderson, R. Bronson, D. Mathis, and C. Benoist. 2005. Modifier loci 
condition autoimmunity provoked by Aire deficiency. J Exp Med 202:805-15.  
129. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene 
expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 
2:1032-1039.   
References 
	   	   	  104	  
130. Klein, L., B. Kyewski, P.M. Allen, K.A. Hogquist. 2014. Positive and negative 
selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 
14:377-91.  
131. Aschenbrenner, K., L.M. D'Cruz, E.H. Vollmann, M. Hinterberger, J. Emmerich, L. K 
Swee, A. Rolink, and L. Klein. 2007. Selection of Foxp3+ regulatory T cells  specific for self 
antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 
8:351-358. 
132. Gallegos, A.M. and M.J. Bevan. 2004. Central tolerance to tissue-specific antigens 
mediated by direct and indirect antigen presentation. J Exp Med 200:1039-1049. 
133. Wu, L., and K. Shortman. 2005. Heterogeneity of thymic dendritic cells. Semin 
immunol 17:304-312.   
134. Li, J., J. Park, D. Foss, and I. Goldschneider. 2009. Thymus-homing peripheral 
dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state 
thymus. J Exp Med 206:607-622.   
135. Joffre, O.P., E. Segura, A. Savina, and S. Amigorena. 2012. Cross-presentation by 
dendritic cells. Nat Rev Immunol 12:557-569. 
136. Proietto, A.I., M.H. Lahoud, and L. Wu. 2008. Distinct functional capacities of mouse 
thymic and splenic dendritic cell populations. Immunol Cell Biol 86:700-708. 
137. Hadeiba, H., K. Lahl, A. Edalati, C. Oderup, A. Habtezion, R. Pachynski, L. Nguyen, 
A. Ghodsi, S. Adler, and E.C Butcher. 2012. Plasmacytoid dendritic cells transport peripheral 
antigens to the thymus to promote central tolerance. Immunity 36:438-450. 
138. Atibalentja, D.F., C.A. Byersdorfer, and E.R. Unanue, 2009. Thymus-blood protein 
interactions are highly effective in negative selection and regulatory T cell induction. J 
Immunol 183:7909-7918. 
139. Villadangos, J.A., and L. Young. 2008. Antigen-presentation properties of 
plasmacytoid dendritic cells. Immunity 29:352-361.  
140. van Meerwijk, J.P., S. Marguerat, R.K. Lees, R.N. Germain, B.J. Fowlkes, and H.R. 
MacDonald. 1997. Quantitative impact of thymic clonal deletion on the T cell repertoire. J 
Exp Med 185:377-383.  
141. Proietto, A.I., D.S. van, P. Zhou, A. Rizzitelli, A. D'Amico, R.J. Steptoe, S.H. Naik, M. 
H. Lahoud, Y. Liu, P. Zheng, K, Shortman, and L. Wu. 2008. Dendritic cells in the thymus 
contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A 105:19869-19874.  
142. Wirnsberger, G., F. Mair, and L. Klein. 2009. Regulatory T cell differentiation of 
thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic 
developmental control. Proc Natl Acad Sci U S A 106:10278-10283. 
143. Li, M.O., and A.Y. Rudensky. 2016. T cell receptor signalling in the control of 
regulatory T cell differentiation and function. Nat Rev Immunol 16:220-233.  
144. Kappler, J.W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal 
elimination in the thymus. Cell 49:273-280.  
145. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance 
induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 
342:559-561.  
146. Josefowicz, S.Z, L.F. Lu, and A.Y. Rudensky. 2012. Regulatory T cells: mechanisms 
of dif- ferentiation and function. Annu Rev Immunol 30:531-564. 
147. Hodgkin, P.D., W.R. Heath, and A.G. Baxter. 2007. The clonal selection theory: 50 
years since the revolution. Nat Immunol 8:1019-1026. 
148. Modigliani, Y., A. Coutinho, P. Pereira, N. Le Douarin, V. Thomas-Vaslin, O. Burlen-
Defranoux, J. Salaun, and A. Bandeira. 1996. Establishment of tissue- specific tolerance is 
driven by regulatory T cells selected by thymic epithelium. Eur J Immunol 26:1807-1815.      
149. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic 
self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). 
Breakdown of a single mechanism of self- tolerance causes various autoimmune diseases. J 
Immunol 155:1151-1164.     
150.  Modigliani, Y., P. Pereira, V. Thomas-Vaslin, J. Salaun, O. Burlen-Defranoux, A. 
References 
	   	   	  105	  
Coutinho, N. Le Douarin, and A. Bandeira. 1995. Regulatory T cells in thymic epithelium-
induced tolerance. I. Suppression of mature peripheral non-tolerant T cells. Eur J Immunol 
25:2563-2571. 
151. Baldwin, T.A., M.M. Sandau, S.C. Jameson, and K.A. Hogquist. 2005. The timing of 
TCRa expression critically influences T cell development and selection. J Exp Med 202:111-
121. 
152. Punt, J.A., B.A. Osborne, Y. Takahama, S.O. Sharrow, and A. Singer. 1994. 
Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires 
a costimulatory signal that can be provided by CD28. J Exp Med 179:709-713. 
153. Kishimoto, H., and J. Sprent. 1999. Several different cell surface molecules control 
negative selection of medullary thymocytes. J Exp Med 190:65-73. 
154. Pinon, J.D., V. Labi, A. Egle, and A. Villunger. 2008. Bim and Bmf in tissue 
homeostasis and malignant disease. Oncogene 1:41-52. 
155. Bouillet, P. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of 
autoreactive thymocytes. Nature 415:922-926. 
156. McCarty, N. 2005. Signaling by the kinase MINK is essential in the negative selection 
of autoreactive thymocytes. Nat Immunol 6:65-72. 
157. Thompson, J. and A. Winoto. 2008. During negative selection, Nur77 family proteins 
translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic 
BH3 domain. J Exp Med 205:1029-1036. 
158. Buhlmann, J.E., S.K. Elkin, and A.H. Sharpe. 2003. A role for the B7-1/B7-2: 
CD28/CTLA-4 pathway during negative selection. J Immunol 170:5421-5428. 
159. Takahashi, S., H. Kataoka, S. Hara, T. Yokosuka, K. Takase, S. Yamasaki, W. 
Kobayashi, Y. Saito, and T. Saito. 2005. In vivo overexpression of CTLA-4 suppresses 
lymphoproliferative diseases and thymic negative selection. Eur J Immunol 35: 399-407. 
160. Ohki, H., C. Martin, M. Coltey, and N.M. Le Douarin. 1988. Implants of quail thymic 
epithelium generate permanent tolerance in embryonically constructed quail/chick chimeras. 
Development 104:619-630. 
161. Ohki, H., C. Martin, C. Corbel, M. Coltey, and N.M. Le Douarin. 1987. Tolerance 
induced by thymic epithelial grafts in birds. Science 237:1032-1035. 
162. Salaun, J. 1990. Thymic epithelium tolerizes for histocompatibility antigens. Science 
247:1471-1474. 
163. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific 
autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the 
active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible 
cause of autoimmune disease. J Exp Med 161:72-87. 
164. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell 
development by the transcription factor Foxp3. Science 299:1057-1061. 
165. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the 
development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-336. 
166. Williams, L.M., and A.Y. Rudensky. 2007. Maintenance of the Foxp3- dependent 
developmental program in mature regulatory T cells requires continued expression of Foxp3. 
Nat Immunol 8:277-284. 
167. Lin, W., D. Haribhai, L.M. Relland, N. Truong, M.R. Carlson, C.B. Williams, and T.A. 
Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat 
Immunol 8:359-368. 
168. Liston, A. and A.Y. Rudensky. 2007. Thymic development and peripheral 
homeostasis of regulatory T cells. Curr Opin Immunol 19:176-185. 
169. Tang, Q., K.J. Henriksen, E.K. Boden, A.J. Tooley, J. Ye, S.K. Subudhi, X.X. Zheng, 
T.B. Strom, and J.A. Bluestone. 2003. Cutting edge: CD28 controls peripheral homeostasis 
of CD4+CD25+ regulatory T cells. J Immunol 171:3348-3352. 
170. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. 
Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ 
immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440. 
References 
	   	   	  106	  
171. Yao, Z. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 
109:4368-4375. 
172. Antov, A., L. Yang, M. Vig, D. Baltimore, and L. Van Parijs. 2003. Essential role for 
STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-
tolerance. J Immunol 171:3435-3441. 
173. Vang, K.B., J. Yang, S.A. Mahmud, M.A. Burchill, A.L. Vegoe, and M.A. Farrar. 2008. 
IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ 
regulatory T cell development. J Immunol 181:3285-3290. 
174. Fontenot, J.D., J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky. 2005. A function 
for interleukin 2 in Foxp3-expressing regulatory T cells. Nat immunol 6:1142-1151. 
175. Liu, Y. 2008. A critical function for TGF-beta signaling in the development of natural 
CD4+CD25+Foxp3+ regulatory T cells. Nat immunol 9:632-640. 
176. Walker, L.S., and A.K. Abbas. 2002. The enemy within: keeping self-reactive T cells 
at bay in the periphery. Nat Rev Immunol 2:11-19. 
177. Xing, Y., and K.A. Hogquist. 2012. T-cell tolerance: central and peripheral. Cold 
Spring Harb Perspect Biol, 4:a006957. 
178. Alegre, M.L., K.A. Frauwirth, C.B. Thompson. 2001. T-cell regulation by CD28 and 
CTLA-4. Nat Rev Immunol 1:220-228. 
179. Mueller, D.L. 2010. Mechanisms maintaining peripheral tolerance. Nat Immunol 
11:21-27. 
180. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus 
functional clonal inactivation: a costimulatory signalling pathway determines the outcome of 
T cell antigen receptor occupancy. Annu Rev Immunol 7:445-480. 
181. Krummel, M.F., and J.P. Allison. 1996. CTLA-4 engagement inhibits IL-2 
accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 
183:2533-2540. 
182. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, 
C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T 
cell activation. Immunity 1:405-413. 
183. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. 
Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan 
tissue destruction, revealing a critical negative regulatory role of CTLA- 4. Immunity 3:541-
547. 
184. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, 
C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early 
lethality in mice deficient in Ctla-4. Science 270:985-988. 
185. Perez, V.L., L. Van Parijs, A. Biuckians, X.X. Zheng, T.B. Strom, and A.K. Abbas. 
1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 
6:411- 417. 
186. Kurtz, J., F. Raval, C. Vallot, J. Der, and M. Sykes. 2009. CTLA-4 on alloreactive 
CD4 T cells interacts with recipient CD80/86 to promote tolerance. Blood 113:3475-3484. 
187. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. 
Nomura, and S. Sakaguchi. 2008. CTLA-4 Control over Foxp3+ Regulatory T Cell Function. 
Science 322:271-275. 
188. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of 
lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-
carrying immunoreceptor. Immunity 11:141-151. 
189. Keir, M.E., S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, L.A. Albacker, M. 
Koulmanda, G.J. Freeman, M.H. Sayegh, and A.H. Sharpe. 2006. Tissue expression of PD-
L1 mediates peripheral T cell tolerance. J Exp Med 203:883-895. 
190. Probst, H.C., K. McCoy, T. Okazaki, T. Honjo, M. van den Broek. 2005. Resting 
dendritic cells induce peripheral CD8þ T cell tolerance through PD-1 and CTLA-4. Nat 
Immunol 6:280-286. 
191. Chambers, C. A. 2001. The expanding world of co-stimulation: the two-signal model 
References 
	   	   	  107	  
revisited. Trends Immunol  22:217–223. 
192. Morelli, A.E., and A.W. Thomson. 2007. Tolerogenic dendritic cells and the quest for 
transplant tolerance. Nat Rev Immunol 7:610 – 621. 
193. Mahnke, K., E. Schmitt, L. Bonifaz, A.H. Enk, and H. Jonuleit. 2002. Immature, but 
not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80:477-
483. 
194. Mellor, A.L., and D.H. Munn. 2004. IDO expression by dendritic cells: tolerance and 
tryptophan catabolism. Nat Rev Immunol 4:762-774. 
195. Brunner, T., R.J.  Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, 
W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas 
(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. 
Nature 373:441-444. 
196. Combadière, B., M. Freedman, L. Chen, E.W. Shores, P. Love, and M.J. Lenardo. 
1996. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T 
cell apoptosis. J Exp Med 183:2109-17. 
197. Lenardo, M.J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for 
apoptosis. Nature 353:858-861. 
198. Sytwu, H.K., R.S. Liblau, and H.O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) 
and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. 
Immunity 5:17-30. 
199. Hildeman, D.A. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 
family member bim. Immunity 16:759-767. 
200. Pellegrini, M. 2003.  Shutdown of an acute T cell immune response to viral infection 
is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci U S 
A 100:14175-14180. 
201. Bouillet, P. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic 
responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738. 
202. Hoglund, P. 1999. Initiation of autoimmune diabetes by developmentally regulated 
presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331-339. 
203. Andre, I. 1996. Checkpoints in the progression of autoimmune disease: lessons from 
diabetes models. Proc Natl Acad Sci U S A 93:2260-2263. 
204. Compston, A. and A. Coles. 2002. Multiple sclerosis. Lancet 359:1221-1231. 
205. Lafaille, J.J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of 
spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T 
cell receptor transgenic mice. Cell 78:399-408. 
206. Waldner, H., M.J. Whitters, R.A. Sobel, M. Collins, and V.K. Kuchroo. 2000. 
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for 
the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A 97:3412-
3417.       
207. Bettelli, E., M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. Kuchroo. 
2003. Myelin oligodendrocyte glycoprotein-specific t cell receptor transgenic mice develop 
spontaneous autoimmune optic neuritis, J Exp Med 197:1073-1081. 
208. Greer, J.M., and M.B. Lees. 2002. Myelin proteolipid protein-the first 50 years. Int J 
Biochem Cell Biol 34:211-215. 
209. Anderson, T.J., P. Montague, N. Nadon, K.A. Nave, and I.R. Griffiths. 1997. 
Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and 
DM20 isoproteins are targeted to different cellular domains. J Neurosci Res 50:13-22. 
210. Kuchroo, V.K., A.C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L.B. 
Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role 
of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T 
cell repertoire. Annu Rev Immunol 20:101-123. 
211. Knapp, P.E., R.P. Skoff, and D.W. Redstone. 1986. Oligodendroglial cell death in 
jimpy mice: an explanation for the myelin deficit. J Neurosci 6:2813–2822. 
212. Hodes, M.E., V.M. Pratt, and S.R. Dlouhy. 1994. Genetics of Pelizaeus-Merzbacher 
References 
	   	   	  108	  
disease. Dev Neurosci 15:383-394. 
213. Nave, K.A., and O. Boespflug-Tanguy. 1996. Developmental defects of myelin 
formation: from X-linked mutations to human dysmyelinating diseases. Neuroscientist 2:33-
38. 
214. Klugmann, M., M.H. Schwab, A, Pühlhofer, A. Schneider, F. Zimmermann, I.R. 
Griffiths, and K.A. Nave. 1997. Assembly of CNS myelin in the absence of proteolipid protein. 
Neuron 18:59-70. 
215. Greer, J.M.  2013. Autoimmune t-cell reactivity to myelin proteolipids and glycolipids 
inmultiple sclerosis. Mult Scler Int  2013:151427. 
216. Voskuhl, R.R. 1998. Myelin protein expression in lymphoid tissues: implications for 
peripheral tolerance. Immunol Rev 164:81-92. 
217. Tuohy, V.K., R.A. Sobel, and M.B. Lees. 1988. Myelin proteolipid protein-induced 
experimental allergic encephalomyelitis. Variations of disease expression in different strains 
of mice. J Immunol 140:1868-1873. 
218. Whitham, R.H., D.N. Bourdette, G.A. Hashim, R.M. Herndon, R.C. Ilg, A.A. 
Vandenbark, and H. Offner. 1991. Lymphocytes from SJL/J mice immunized with spinal cord 
respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating 
experimental autoimmune encephalomyelitis. J Immunol 146:101-107. 
219. Klein, L., M. Klugmann, K.A. Nave, V.K. Tuohy, and B. Kyewski. 2000. Shaping of 
the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic 
epithelial cells. Nat Med 6:56-61. 
220. Thompson, S.D., J. Pelkonen, J.L. Hurwitz. 1990. Concomitant T-cell receptor alpha 
and delta gene rearrangements in individual T-cell precursors. Proc Natl Acad Sci U S A 
87:5583-5586. 
221. Kouskoff, V., K Signorelli, C Benoist, and D Mathis. 1995. Cassette vectors directing 
expression of t cell receptor genes in transgenic mice. J Immunol Methods 180:273-280. 
222. Brocker, T., M. Riedinger, and K. Karjalainen. 1996. Redirecting the complete T cell 
receptor/CD3 signaling machinery towards native antigen via modified T cell receptor. Eur J 
Immunol 26:1770–1774. 
223. Andersen, P.S., C. Geisler, S. Buus, R.A. Mariuzza, and K. Karjalainen. 2001. Role 
of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol 
Chem 276: 33452–33457. 
224. Akkaraju, S., W.Y. Ho, D. Leong, K. Canaan, M.M. Davis, and C.C. Goodnow. 1997. 
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows 
nondestructive thyroiditis or insulitis. Immunity 7: 255–271. 
225. Kurts, C., W.R. Heath, F.R. Carbone, J. Allison, J.F. Miller, and H. Kosaka. 1996. 
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 
184: 923–930. 
226. Goverman, J., A. Woods, L. Larson, L.P. Weiner, L. Hood, and D.M. Zaller 1993. 
Transgenic mice that express a myelin basic protein-specific T cell receptor develop 
spontaneous autoimmunity. Cell 72:551-560 
227. Lafaille, J.J. 2004. T-cell receptor transgenic mice in the study of autoimmune 
diseases. J Autoimmun 22:95-106. 
228. Kohm, A.P., P.A. Carpentier, H.A. Anger, and S.D. Miller. 2002. Cutting edge: 
CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses 
and central nervous system inflammation during active experimental autoimmune 
encephalomyelitis. J Immunol 169:4712-4716. 
229. Reddy, J., H. Waldner, X. Zhang, Z. Illes, K.W. Wucherpfennig, and R.A. Sobel. 2005. 
Cutting edge: CD4+CD25+ regulatoryT cells contribute to gender differences in susceptibility 
to experimental autoimmune encephalomyelitis. J Immunol 175:5591–5595 
230. Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R. Sobel, K.W. 
Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ 
regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. 
Proc Natl Acad Sci U S A 101:15434–15439.  
References 
	   	   	  109	  
231. Hogquist, K.A., T.A. Baldwin, and S.C. Jameson. 2005. Central tolerance: Learning 
self-control in the thymus. Nat Rev Immunol 5:772-782. 
232. Anderson, G., K. Partington, and E. Jenkinson. 1998. Differential effects of peptide 
diversity and stromal cell type in positive and negative selection in the thymus. J Immunol 
161:6599–6603.  
233. Klein, L., and B. Kyewski. 2000. Self-antigen presentation by thymic stromal cells: a 
subtle division of labor. Curr Opin Immunol. 12:179–186.  
234. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated 
antigen-presenting cell? Nature 338:74–76. 
235. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major 
histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can 
induce negative but not positive selection of thymocytes in vivo. J Exp Med 185:541–550. 
236. Merkenschlager M., M.O. Power, H. Pircher, and A.G. Fisher. 1999. Intrathymic 
deletion of MHC class I-restricted cytotoxic T cell precursors by constitutive cross-
presentation of exogenous antigen. Eur J Immunol 29:1477–1486.  
237. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 
248:1349.  
238. Martinez, R.J., N. Zhang, S.R. Thomas, S.L. Nandiwada, M.K. Jenkins, B.A. Binstadt, 
and D.L. Mueller. 2012. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi 
anergic state in the presence of Foxp3+ regulatory T cells. J Immunol 188:170-181. 
239. Tuettenberg, A., E. Huter, M. Hubo, J. Horn, J. Knop, B. Grimbacher, R.A. Kroczek, 
S. Stoll, and H. Jonuleit. 2009. The role of ICOS in directing T cell responses: ICOS-
dependent induction of T cell anergy by tolerogenic dendritic cells. J Immunol 182:3349-
3356. 
240. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. 
Regulatory T cells: how do they suppress immune responses? Int Immunol 21:1105-1111. 
241. Smith, A.J., Y. Liu, H. Peng, R. Beers, M.K. Racke, and A.E. Lovett-Racke. 2011. 
Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction 
of experimental autoimmune encephalomyelitis. J Neuroimmunol 237:33-38.  
242. Kyburz, D., and M. Corr. 2003. The KRN mouse model of inflammatory arthritis. 
Springer Semin Immunopathol 25:79-90. 
243. Gordon, J., S. Xiao, B. 3rd. Hughes, D.M. Su, S.P. Navarre, B.G. Condie, and N.R. 
Manley. 2007. Specific expression of lacz and cre recombinase in fetal thymic epithelial cells 
by multiplex gene targeting at the foxn1 locus. BMC Dev Biol 7:69. 
244. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J Mol 
Biol 166:557-580. 
 
 
 
Appendix	  	  
	   	   	  110	  
6. Appendix 
 
6.1 Abbreviations 
 
APC   Antigen presenting cell 
BM       Bone marrow 
bp    Base pairs 
CD  Cluster of differentiation  
cDNA   complementary DNA 
CFA  Complete Freund's adjuvant  
CFSE Carboxy-fluorescein diacetate succinimidyl ester 
CMJ Cortico-medullary junction  
CNS  Central nervous system 
cTEC    Cortical thymic epithelial cells 
CTLA-4         Cytotoxic T-lymphocyte-associated protein 4 
DC      Dendritic cell 
DN   Double negative 
DNA      Deoxyribonucleic acid 
dNTP       Deoxynucleoside Triphosphate 
DP        Double positive 
EAE Experimental autoimmune encephalomyelitis  
GFP    Green fluorescent protein 
ELISA  Enzyme linked immunosorbent assa  
ETPs Early thymic progenitors   
FACS  Fluorescent activated cell scanning  
i.p     Intraperitoneal 
i.v    Intravenous 
kDa    Kilodalton 
KO    Knockout 
MBP     Myelin basic protein 
MHC Major histocompatibility complex  
MOG     Myelin oligodendrocyte protein 
MS Multiple sclerosis  
mTEC    Medullary thymic epithelial cells 
NK cells Natural killer cells  
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NOD  Non-obese diabetic 
OVA Ovalbumin 
PBS     Phosphate buffered saline 
PCR      Polymerase chain reaction 
PLP     Proteolipid protein 
PSG1 Platelet-selectin glycoprotein ligand 1  
RAG Recombination-activating gene  
SD   Standard deviation 
SEM    Standard error of the mean 
SP        Single positive 
SPF     Specific pathogen free 
TBE    Tris buffer EDTA 
TBS    Tris buffer saline 
TCR T cell receptor 
Tg Transgenic 
Treg    Regulatory T cell 
WT     Wild-type 
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